UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
 
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2017
Or
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to              .
Commission File Number: 0-17089
BOSTON PRIVATE FINANCIAL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)  
 
 
Commonwealth of Massachusetts
04-2976299
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification Number)
 
 
Ten Post Office Square
Boston, Massachusetts
02109
(Address of principal executive offices)
(Zip Code)
 
 
Registrant’s telephone number, including area code: (617) 912-1900
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes x      No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes  x      No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer  x
 
 
 
Accelerated filer  o     
 
 
Non-accelerated filer  o    
 
(Do not check if a smaller reporting company)
 
Smaller reporting company o     
 
 
 
 
 
 
Emerging growth company o     
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes  o  No  x
APPLICABLE ONLY TO CORPORATE ISSUERS
Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of November 3, 2017 :
Common Stock, Par Value $1.00 Per Share
84,240,520
(class)
(outstanding)
 



BOSTON PRIVATE FINANCIAL HOLDINGS, INC.
FORM 10-Q
TABLE OF CONTENTS

PART I—FINANCIAL INFORMATION
Item 1
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 2
 
 
 
 
 
 
 
Results of Operations
 
 
 
 
 
 
 
 
 
 
 
 
Item 3
 
Item 4
 
PART II—OTHER INFORMATION
Item 1
 
Item 1A
 
Item 2
 
Item 3
 
Item 4
 
Item 5
 
Item 6
 
 
 
 
 
Certifications
 



i



PART I. FINANCIAL INFORMATION, ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS (Unaudited)

 
September 30, 2017
 
December 31, 2016
 
(In thousands, except share and per share data)
Assets:
 
 
 
Cash and cash equivalents
$
110,440

 
$
106,557

Investment securities available-for-sale (amortized cost of $1,196,635 and $1,283,161 at September 30, 2017 and December 31, 2016, respectively)
1,189,827

 
1,264,132

Investment securities held-to-maturity (fair value of $83,878 and $92,604 at September 30, 2017 and December 31, 2016, respectively)
84,090

 
93,079

Stock in Federal Home Loan Bank and Federal Reserve Bank
61,714

 
44,077

Loans held for sale
1,957

 
3,464

Total loans
6,413,201

 
6,114,354

Less: Allowance for loan losses
74,873

 
78,077

Net loans
6,338,328

 
6,036,277

Other real estate owned (“OREO”)

 
1,690

Premises and equipment, net
36,546

 
31,827

Goodwill
142,554

 
142,554

Intangible assets, net
22,447

 
26,725

Fees receivable
12,560

 
13,400

Accrued interest receivable
21,823

 
20,479

Deferred income taxes, net
46,088

 
55,460

Other assets
201,024

 
130,753

Total assets
$
8,269,398

 
$
7,970,474

Liabilities:
 
 
 
Deposits
$
6,262,347

 
$
6,085,146

Securities sold under agreements to repurchase
59,903

 
59,624

Federal funds purchased
70,000

 
80,000

Federal Home Loan Bank borrowings
812,773

 
734,205

Junior subordinated debentures
106,363

 
106,363

Other liabilities
127,069

 
119,683

Total liabilities
7,438,455

 
7,185,021

Redeemable Noncontrolling Interests
15,882

 
16,972

Shareholders’ Equity:
 
 
 
Preferred stock, $1.00 par value; authorized: 2,000,000 shares;
 Series D, 6.95% Non-Cumulative Perpetual, issued and outstanding: 50,000 shares at September 30, 2017 and December 31, 2016; liquidation preference: $1,000 per share
47,753

 
47,753

Common stock, $1.00 par value; authorized: 170,000,000 shares; issued and outstanding: 84,082,250 shares at September 30, 2017 and 83,731,769 shares at December 31, 2016
84,082

 
83,732

Additional paid-in capital
606,802

 
597,454

Retained earnings
76,455

 
47,929

Accumulated other comprehensive income/ (loss)
(4,823
)
 
(12,548
)
Total Company’s shareholders’ equity
810,269

 
764,320

Noncontrolling interests
4,792

 
4,161

Total shareholders’ equity
815,061

 
768,481

Total liabilities, redeemable noncontrolling interests and shareholders’ equity
$
8,269,398

 
$
7,970,474

See accompanying notes to consolidated financial statements.

1


BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

 
Three months ended September 30,
 
Nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
 
(In thousands, except share and per share data)
Interest and dividend income:
 
 
 
 
 
 
 
Loans
$
58,096

 
$
50,074

 
$
169,468

 
$
149,851

Taxable investment securities
1,569

 
1,537

 
4,831

 
4,638

Non-taxable investment securities
1,664

 
1,444

 
4,925

 
4,234

Mortgage-backed securities
3,267

 
3,079

 
10,266

 
9,126

Federal funds sold and other
916

 
469

 
2,347

 
1,381

Total interest and dividend income
65,512

 
56,603

 
191,837

 
169,230

Interest expense:
 
 
 
 
 
 
 
Deposits
5,356

 
4,163

 
14,836

 
12,420

Federal Home Loan Bank borrowings
2,657

 
1,929

 
7,257

 
6,021

Junior subordinated debentures
761

 
591

 
2,148

 
1,753

Repurchase agreements and other short-term borrowings
111

 
49

 
182

 
117

Total interest expense
8,885

 
6,732

 
24,423

 
20,311

Net interest income
56,627

 
49,871

 
167,414

 
148,919

Provision/ (credit) for loan losses
(432
)
 
(138
)
 
(6,727
)
 
(5,806
)
Net interest income after provision/ (credit) for loan losses
57,059

 
50,009

 
174,141

 
154,725

Fees and other income:
 
 
 
 
 
 
 
Investment management fees
11,274

 
10,717

 
33,194

 
32,002

Wealth advisory fees
13,279

 
12,750

 
39,063

 
38,013

Wealth management and trust fees
11,619

 
10,826

 
33,606

 
32,950

Other banking fee income
2,726

 
3,447

 
6,384

 
9,662

Gain on sale of loans, net
169

 
156

 
366

 
562

Gain/ (loss) on sale of investments, net
230

 
273

 
486

 
519

Gain/ (loss) on OREO, net

 
137

 
(46
)
 
417

Other
970

 
1,706

 
1,738

 
704

Total fees and other income
40,267

 
40,012

 
114,791

 
114,829

Operating expense:
 
 
 
 
 
 
 
Salaries and employee benefits
45,168

 
40,924

 
134,486

 
124,098

Occupancy and equipment
11,283

 
9,521

 
32,711

 
29,036

Professional services
3,308

 
2,290

 
9,728

 
8,820

Marketing and business development
2,216

 
1,623

 
5,847

 
5,604

Contract services and data processing
1,608

 
1,865

 
4,829

 
5,281

Amortization of intangibles
1,426

 
1,568

 
4,278

 
4,740

FDIC insurance
647

 
722

 
2,292

 
2,757

Restructuring

 

 

 
2,017

Other
3,690

 
3,157

 
11,776

 
10,757

Total operating expense
69,346

 
61,670

 
205,947

 
193,110

Income before income taxes
27,980

 
28,351

 
82,985

 
76,444

Income tax expense
8,289

 
8,652

 
24,805

 
23,716

Net income from continuing operations
19,691

 
19,699

 
58,180

 
52,728

Net income from discontinued operations
1,186

 
1,047

 
3,881

 
4,357

Net income before attribution to noncontrolling interests
20,877

 
20,746

 
62,061

 
57,085

(Continued)
 
 
 
 
 
 
 

2


BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

 
Three months ended September 30,
 
Nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
Less: Net income attributable to noncontrolling interests
1,074

 
1,110

 
3,190

 
3,010

Net income attributable to the Company
$
19,803

 
$
19,636

 
$
58,871

 
$
54,075

Adjustments to net income attributable to the Company to arrive at net income attributable to common shareholders
$
(1,146
)
 
$
(1,006
)
 
$
(2,889
)
 
$
(2,265
)
Net income attributable to common shareholders for earnings per share calculation
$
18,657

 
$
18,630

 
$
55,982

 
$
51,810

Basic earnings per share attributable to common shareholders:
 
 
 
 
 
 
 
From continuing operations:
$
0.21

 
$
0.22

 
$
0.63

 
$
0.58

From discontinued operations:
$
0.01

 
$
0.01

 
$
0.05

 
$
0.05

Total attributable to common shareholders:
$
0.23

 
$
0.23

 
$
0.68

 
$
0.64

Weighted average basic common shares outstanding
82,556,225

 
81,301,499

 
82,270,849

 
81,280,014

Diluted earnings per share attributable to common shareholders:
 
 
 
 
 
 
 
From continuing operations:
$
0.21

 
$
0.21

 
$
0.61

 
$
0.57

From discontinued operations:
$
0.01

 
$
0.01

 
$
0.05

 
$
0.05

Total attributable to common shareholders:
$
0.22

 
$
0.22

 
$
0.66

 
$
0.62

Weighted average diluted common shares outstanding
84,888,311

 
83,562,283

 
84,741,172

 
83,430,480


  See accompanying notes to consolidated financial statements.

3


BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

 
Three months ended September 30,
 
Nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
 
(In thousands)
Net income attributable to the Company
$
19,803

 
$
19,636

 
$
58,871

 
$
54,075

Other comprehensive income/ (loss), net of tax:
 
 
 
 
 
 
 
Unrealized gain/ (loss) on securities available-for-sale
1,114

 
(2,976
)
 
7,588

 
12,322

Reclassification adjustment for net realized (gain)/ loss included in net income
(141
)
 
(172
)
 
(293
)
 
(330
)
Net unrealized gain/ (loss) on securities available-for-sale
973

 
(3,148
)
 
7,295

 
11,992

Unrealized gain/ (loss) on cash flow hedges
70

 
379

 
(140
)
 
(1,119
)
Reclassification adjustment for net realized (gain)/ loss included in net income
172

 
249

 
558

 
761

Net unrealized gain/ (loss) on cash flow hedges
242

 
628

 
418

 
(358
)
Net unrealized gain/ (loss) on other

 

 
12

 

Other comprehensive income/ (loss), net of tax
1,215

 
(2,520
)
 
7,725

 
11,634

Total comprehensive income attributable to the Company, net
$
21,018

 
$
17,116

 
$
66,596

 
$
65,709

  See accompanying notes to consolidated financial statements.


4


BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (Unaudited)

 
Preferred
Stock
 
Common
Stock
 
Additional
Paid-in
Capital
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income/
(Loss)
 
Non-
controlling
Interests
 
Total
 
(In thousands, except share data)
Balance, December 31, 2015
$
47,753

 
$
83,411

 
$
600,670

 
$
12,886

 
$
(1,500
)
 
$
3,393

 
$
746,613

Net income attributable to the Company

 

 

 
54,075

 

 

 
54,075

Other comprehensive income/ (loss), net

 

 

 

 
11,634

 

 
11,634

Dividends paid to common shareholders:
$0.30 per share

 

 

 
(24,940
)
 

 

 
(24,940
)
Dividends paid to preferred shareholders

 

 

 
(2,606
)
 

 

 
(2,606
)
Net change in noncontrolling interests

 

 

 

 

 
389

 
389

Repurchase of 684,442 shares of common stock

 
(684
)
 
(7,336
)
 

 

 

 
(8,020
)
Net proceeds from issuance of:
 
 
 
 
 
 
 
 
 
 
 
 
 
165,934 shares of common stock

 
166

 
1,413

 

 

 

 
1,579

591,234 shares of incentive stock grants, net of 326,834 shares canceled or forfeited and 63,235 shares withheld for employee taxes

 
201

 
(939
)
 

 

 

 
(738
)
Amortization of stock compensation and employee stock purchase plan

 

 
2,186

 

 

 

 
2,186

Stock options exercised

 
101

 
688

 

 

 

 
789

Tax benefit/ (deficiency) from certain stock compensation awards

 

 
(728
)
 

 

 

 
(728
)
Other equity adjustments

 

 
1,255

 

 

 

 
1,255

Balance at September 30, 2016
$
47,753

 
$
83,195

 
$
597,209

 
$
39,415

 
$
10,134

 
$
3,782

 
$
781,488

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, December 31, 2016
$
47,753

 
$
83,732

 
$
597,454

 
$
47,929

 
$
(12,548
)
 
$
4,161

 
$
768,481

Net income attributable to the Company

 

 

 
58,871

 

 

 
58,871

Other comprehensive income/ (loss), net

 

 

 

 
7,725

 

 
7,725

Dividends paid to common shareholders:
$0.33 per share

 

 

 
(27,739
)
 

 

 
(27,739
)
Dividends paid to preferred shareholders

 

 

 
(2,606
)
 

 

 
(2,606
)
Net change in noncontrolling interests

 

 

 

 

 
631

 
631

Net proceeds from issuance of:
 
 
 
 
 
 
 
 
 
 
 
 
 
140,284 shares of common stock

 
140

 
1,461

 

 

 

 
1,601

90,848 incentive stock grant shares canceled or forfeited and 62,087 shares withheld for employee taxes

 
(153
)
 
(816
)
 

 

 

 
(969
)
Exercise of warrants

 
261

 
1,618

 

 

 

 
1,879

Amortization of stock compensation and employee stock purchase plan

 

 
6,183

 

 

 

 
6,183

Stock options exercised

 
102

 
725

 

 

 

 
827

Other equity adjustments

 

 
177

 

 

 

 
177

Balance at September 30, 2017
$
47,753

 
$
84,082

 
$
606,802

 
$
76,455

 
$
(4,823
)
 
$
4,792

 
$
815,061


See accompanying notes to consolidated financial statements.

5


BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

 
Nine months ended September 30,
 
2017
 
2016
 
(In thousands)
Cash flows from operating activities:
 
 
 
Net income attributable to the Company
$
58,871

 
$
54,075

Adjustments to arrive at net income from continuing operations
 
 
 
Net income attributable to noncontrolling interests
3,190

 
3,010

Less: Net income from discontinued operations
(3,881
)
 
(4,357
)
Net income from continuing operations
58,180

 
52,728

Adjustments to reconcile net income from continuing operations to net cash provided by/ (used in) operating activities:
 
 
 
Depreciation and amortization
15,835

 
16,997

Net income attributable to noncontrolling interests
(3,190
)
 
(3,010
)
Stock compensation, net of cancellations
6,183

 
2,186

Provision/ (credit) for loan losses
(6,727
)
 
(5,806
)
Loans originated for sale
(38,099
)
 
(61,768
)
Proceeds from sale of loans held for sale
39,972

 
65,086

Deferred income tax expense/ (benefit)
4,141

 
3,721

Net decrease/ (increase) in other operating activities
(9,407
)
 
(2,134
)
Net cash provided by/ (used in) operating activities of continuing operations
66,888

 
68,000

Net cash provided by/ (used in) operating activities of discontinued operations
3,881

 
4,357

Net cash provided by/ (used in) operating activities
70,769

 
72,357

Cash flows from investing activities:
 
 
 
Available-for-sale investment securities:
 
 
 
Purchases
(138,623
)
 
(323,271
)
Sales
119,238

 
41,961

Maturities, calls, redemptions, and principal payments
100,065

 
131,245

Held-to-maturity investment securities:
 
 
 
Purchases
(14,945
)
 

Maturities and principal payments
23,541

 
16,907

(Investments)/ distributions in trusts, net
(747
)
 
(539
)
Purchase of additional Bank Owned Life Insurance (“BOLI”)
(50,000
)
 

(Purchase)/ redemption of Federal Home Loan Bank and Federal Reserve Bank stock
(17,637
)
 
(903
)
Net (increase)/ decrease in portfolio loans
(298,304
)
 
(156,688
)
Proceeds from recoveries of loans previously charged-off
4,082

 
8,347

Proceeds from sale of OREO
1,644

 
1,337

Capital expenditures, net of sale proceeds
(10,769
)
 
(7,099
)
Net cash provided by/ (used in) investing activities of continuing operations
(282,455
)
 
(288,703
)
Net cash provided by/ (used in) investing activities
(282,455
)
 
(288,703
)
(Continued)
 
 
 

6


BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

 
Nine months ended September 30,
 
2017
 
2016
Cash flows from financing activities:
 
 
 
Net increase/ (decrease) in deposits
177,201

 
(122,406
)
Net increase/ (decrease) in securities sold under agreements to repurchase
279

 
19,251

Net increase/ (decrease) in federal funds purchased
(10,000
)
 
125,000

Net increase/ (decrease) in short-term Federal Home Loan Bank borrowings
110,000

 
95,000

Advances of long-term Federal Home Loan Bank borrowings
50,110

 
67,179

Repayments of long-term Federal Home Loan Bank borrowings
(81,542
)
 
(100,822
)
Dividends paid to common shareholders
(27,739
)
 
(24,940
)
Dividends paid to preferred shareholders
(2,606
)
 
(2,606
)
Proceeds from warrant exercises
1,879

 

Repurchase of common stock

 
(8,020
)
Tax benefit/ (deficiency) from certain stock compensation awards

 
(728
)
Proceeds from stock option exercises
827

 
789

Proceeds from issuance of common stock, net
632

 
841

Distributions paid to noncontrolling interests
(3,197
)
 
(2,905
)
Other equity adjustments
(275
)
 
(350
)
Net cash provided by/ (used in) financing activities of continuing operations
215,569

 
45,283

Net cash provided by/ (used in) financing activities
215,569

 
45,283

Net increase/ (decrease) in cash and cash equivalents
3,883

 
(171,063
)
Cash and cash equivalents at beginning of year
106,557

 
238,694

Cash and cash equivalents at end of period
$
110,440

 
$
67,631

Supplementary schedule of non-cash investing and financing activities:
 
 
 
Cash paid for interest
$
23,681

 
$
20,489

Cash paid for income taxes, (net of refunds received)
32,051

 
27,554

Change in unrealized gain/ (loss) on available-for-sale securities, net of tax
7,295

 
11,992

Change in unrealized gain/ (loss) on cash flow hedges, net of tax
418

 
(358
)
Change in unrealized gain/ (loss) on other, net of tax
12

 

Non-cash transactions:
 
 
 
Loans transferred into other real estate owned from loan portfolio

 
1,944

Loans charged-off
(559
)
 
(3,372
)
Premises and equipment transferred into/ (out of) other assets held for sale

 
891

Deposits transferred into/ (out of) held for sale

 
105,788


See accompanying notes to consolidated financial statements.


7

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements



1.     Basis of Presentation and Summary of Significant Accounting Policies
Boston Private Financial Holdings, Inc. (the “Company” or “BPFH”), is a bank holding company (the “Holding Company”) with four reportable segments: Private Banking, Wealth Management and Trust, Investment Management, and Wealth Advisory.
The Private Banking segment is comprised of the banking operations of Boston Private Bank & Trust Company (the “Bank” or “Boston Private Bank”), a trust company chartered by The Commonwealth of Massachusetts, insured by the Federal Deposit Insurance Corporation (the “FDIC”), and a wholly-owned subsidiary of the Company. On July 28, 2017, Boston Private Bank became a member of the Federal Reserve Bank of Boston. Boston Private Bank currently operates in three geographic markets: New England, the San Francisco Bay Area, and Southern California.
The Wealth Management and Trust segment is comprised of the operations of Boston Private Wealth LLC (“Boston Private Wealth”), a wholly-owned subsidiary of Boston Private Bank, and the trust operations of Boston Private Bank. The segment offers investment management, wealth management, family office, and trust services to individuals, families, and institutions. The Wealth Management and Trust segment operates in New England; South Florida; California; and Madison, Wisconsin.
The Investment Management segment has two consolidated affiliates, consisting of Dalton, Greiner, Hartman, Maher & Co., LLC (“DGHM”) and Anchor Capital Advisors, LLC (“Anchor”) (together, the “Investment Managers”).
The Wealth Advisory segment has two consolidated affiliates, consisting of KLS Professional Advisors Group, LLC (“KLS”) and Bingham, Osborn & Scarborough, LLC (“BOS”) (together, the “Wealth Advisors” and, together with the Wealth Management and Trust and Investment Management segments, the “Wealth and Investment businesses”).
The Company conducts substantially all of its business through its four reportable segments. All significant intercompany accounts and transactions have been eliminated in consolidation.
The unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”), and include all necessary adjustments of a normal recurring nature which, in the opinion of management, are required for a fair presentation of the results of operations and financial condition of the Company. The interim results of consolidated operations are not necessarily indicative of the results for the entire year.
The information in this report should be read in conjunction with the consolidated financial statements and accompanying notes included in the Annual Report on Form 10-K for the year ended December 31, 2016 , as filed with the Securities and Exchange Commission (“SEC”). Prior period amounts are reclassified whenever necessary to conform to the current period presentation.
The Company’s significant accounting policies are described in Part II. Item 8. “Financial Statements and Supplementary Data - Note 1: Basis of Presentation and Summary of Significant Accounting Policies” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 , as filed with the SEC. For interim reporting purposes, the Company follows the same significant accounting policies, except for the new accounting pronouncements from the Financial Accounting Standards Board (the “FASB”) that were adopted effective January 1, 2017, Accounting Standards Update (“ASU”) 2016-09, Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting (“ASU 2016-09”), and ASU 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (“ASU 2017-04”). ASU 2016-09 had no cumulative effect on prior periods, and for cash flow purposes the provisions were adopted prospectively. The Company elected to early adopt ASU 2017-04 as of January 1, 2017, and the adoption of ASU 2017-04 could increase or decrease the amount of a goodwill impairment charge should any of the Company’s reporting units with goodwill fail a Step 1 test in the future, as compared to the amount of a goodwill impairment charge under the existing standards depending on the fair value of the reporting unit’s assets.



8

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

2.    Earnings Per Share
The treasury stock method of calculating earnings per share (“EPS”) is presented below for the three and nine months ended September 30, 2017 and 2016 . The following tables present the computations of basic and diluted EPS:
 
Three months ended September 30,
 
Nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
(In thousands, except share and per share data)
 
Basic earnings per share - Numerator:
 
 
 
 
 
 
 
Net income from continuing operations
$
19,691

 
$
19,699

 
$
58,180

 
$
52,728

Less: Net income attributable to noncontrolling interests
1,074

 
1,110

 
3,190

 
3,010

Net income from continuing operations attributable to the Company
18,617

 
18,589

 
54,990

 
49,718

Decrease/ (increase) in noncontrolling interests’ redemption values (1)
(278
)
 
(138
)
 
(283
)
 
341

Dividends on preferred stock
(868
)
 
(868
)
 
(2,606
)
 
(2,606
)
Total adjustments to income attributable to common shareholders
(1,146
)
 
(1,006
)
 
(2,889
)
 
(2,265
)
Net income from continuing operations attributable to common shareholders, treasury stock method
17,471

 
17,583

 
52,101

 
47,453

Net income from discontinued operations
1,186

 
1,047

 
3,881

 
4,357

Net income attributable to common shareholders, treasury stock method
$
18,657

 
$
18,630

 
$
55,982

 
$
51,810

 
 
 
 
 
 
 
 
Basic earnings per share - Denominator:
 
 
 
 
 
 
 
Weighted average basic common shares outstanding
82,556,225

 
81,301,499

 
82,270,849

 
81,280,014

Per share data - Basic earnings per share from:
 
 
 
 
 
 
 
Continuing operations
$
0.21

 
$
0.22

 
$
0.63

 
$
0.58

Discontinued operations
$
0.01

 
$
0.01

 
$
0.05

 
$
0.05

Total attributable to common shareholders
$
0.23

 
$
0.23

 
$
0.68

 
$
0.64



 
Three months ended September 30,
 
Nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
(In thousands, except share and per share data)
 
 
 
 
 
 
 
Diluted earnings per share - Numerator:
 
 
 
 
 
 
 
Net income from continuing operations attributable to common shareholders, after assumed dilution
$
17,471

 
$
17,583

 
$
52,101

 
$
47,453

Net income from discontinued operations
1,186

 
1,047

 
3,881

 
4,357

Net income attributable to common shareholders, after assumed dilution
$
18,657

 
$
18,630

 
$
55,982

 
$
51,810

Diluted earnings per share - Denominator:
 
 
 
 
 
 
 
Weighted average basic common shares outstanding
82,556,225

 
81,301,499

 
82,270,849

 
81,280,014

Dilutive effect of:
 
 
 
 
 
 
 
Stock options, performance-based and time-based restricted stock, and performance-based and time-based restricted stock units, and other dilutive securities (2)
1,233,888

 
956,446

 
1,333,830

 
959,917

Warrants to purchase common stock (2)
1,098,198

 
1,304,338

 
1,136,493

 
1,190,549

Dilutive common shares
2,332,086

 
2,260,784

 
2,470,323

 
2,150,466

Weighted average diluted common shares outstanding (2)
84,888,311

 
83,562,283

 
84,741,172

 
83,430,480

Per share data - Diluted earnings per share from:
 
 
 
 
 
 
 
Continuing operations
$
0.21

 
$
0.21

 
$
0.61

 
$
0.57

Discontinued operations
$
0.01

 
$
0.01

 
$
0.05

 
$
0.05

Total attributable to common shareholders
$
0.22

 
$
0.22

 
$
0.66

 
$
0.62

Dividends per share declared and paid on common stock
$
0.11

 
$
0.10

 
$
0.33

 
$
0.30

_____________________

9

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

(1)
See Part II. Item 8. “Financial Statements and Supplementary Data—Note 14: Noncontrolling Interests” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 for a description of the redemption values related to the redeemable noncontrolling interests. In accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”), an increase in redemption value from period to period reduces income attributable to common shareholders. Decreases in redemption value from period to period increase income attributable to common shareholders, but only to the extent that the cumulative change in redemption value remains a cumulative increase since adoption of this standard in the first quarter of 2009.
(2)
The diluted EPS computations for the three and nine months ended September 30, 2017 and 2016 do not assume the conversion, exercise, or contingent issuance of the following shares for the following periods because the result would have been anti-dilutive for the periods indicated. As a result of the anti-dilution, the potential common shares excluded from the diluted EPS computation are as follows:
 
Three months ended September 30,
 
Nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
Shares excluded due to exercise price exceeding the average market price of common shares during the period (total outstanding):
(In thousands)
Potential common shares from:
 
 
 
 
 
 
 
Stock options
48

 
224

 
74

 
285

Total shares excluded due to exercise price exceeding the average market price of common shares during the period
48

 
224

 
74

 
285


3.    Reportable segments
Management Reporting
The Company has four reportable segments (Private Banking, Wealth Management and Trust, Investment Management, and Wealth Advisory) and the Holding Company (Boston Private Financial Holdings, Inc.). The financial performance of the Company is managed and evaluated by these five areas, including the four reportable segments. The segments are managed separately as a result of the concentrations in each function.
Measurement of Segment Profit and Assets
The accounting policies of the segments are the same as those described in Part II. Item 8. “Financial Statements and Supplementary Data - Note 1: Basis of Presentation and Summary of Significant Accounting Policies” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 .
Revenues, expenses, and assets are recorded by each segment, and separate financial statements are reviewed by their management and the Company’s segment chief executive officers.
Reconciliation of Reportable Segment Items
The following tables present a reconciliation of the revenues, profits, assets, and other significant items of reportable segments as of and for the three and nine months ended September 30, 2017 and 2016 . Interest expense on junior subordinated debentures is reported at the Holding Company.

10

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

 
Three months ended September 30,
 
Nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
Private Banking
(In thousands)
Net interest income
$
57,295

 
$
50,419

 
$
169,334

 
$
150,553

Fees and other income
3,720

 
5,528

 
8,182

 
11,132

Total revenues
61,015

 
55,947

 
177,516

 
161,685

Provision/ (credit) for loan losses
(432
)
 
(138
)
 
(6,727
)
 
(5,806
)
Operating expense
38,482

 
30,439

 
110,444

 
93,808

Income before income taxes
22,965

 
25,646

 
73,799

 
73,683

Income tax expense
6,634

 
8,226

 
22,112

 
23,638

Net income from continuing operations
16,331

 
17,420

 
51,687

 
50,045

Net income attributable to the Company
$
16,331

 
$
17,420

 
$
51,687

 
$
50,045

 
 
 
 
 
 
 
 
Assets
$
8,113,836

 
$
7,512,884

 
$
8,113,836

 
$
7,512,884

Depreciation
$
1,431

 
$
1,094

 
$
4,145

 
$
3,365

 
Three months ended September 30,
 
Nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
Wealth Management and Trust
(In thousands)
Fees and other income
$
11,739

 
$
10,921

 
$
33,934

 
$
33,277

Operating expense (1)
11,752

 
12,307

 
37,562

 
41,897

Income/ (loss) before income taxes
(13
)
 
(1,386
)
 
(3,628
)
 
(8,620
)
Income tax expense/ (benefit)
(125
)
 
(538
)
 
(1,530
)
 
(3,448
)
Net income/ (loss) from continuing operations
112

 
(848
)
 
(2,098
)
 
(5,172
)
Net income/ (loss) attributable to the Company
$
112

 
$
(848
)
 
$
(2,098
)
 
$
(5,172
)
 
 
 
 
 
 
 
 
Assets
$
73,511

 
$
86,349

 
$
73,511

 
$
86,349

Amortization of intangibles
$
727

 
$
745

 
$
2,181

 
$
2,235

Depreciation
$
330

 
$
317

 
$
1,008

 
$
818

 
Three months ended September 30,
 
Nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
Investment Management
(In thousands)
Net interest income
$
8

 
$
4

 
$
16

 
$
12

Fees and other income
11,280

 
10,717

 
33,230

 
32,023

Total revenues
11,288

 
10,721

 
33,246

 
32,035

Operating expense
8,407

 
7,986

 
25,107

 
23,904

Income before income taxes
2,881

 
2,735

 
8,139

 
8,131

Income tax expense
981

 
898

 
2,719

 
2,675

Net income from continuing operations
1,900

 
1,837

 
5,420

 
5,456

Noncontrolling interests
451

 
507

 
1,425

 
1,453

Net income attributable to the Company
$
1,449

 
$
1,330

 
$
3,995

 
$
4,003

 
 
 
 
 
 
 
 
Assets
$
93,910

 
$
93,669

 
$
93,910

 
$
93,669

Amortization of intangibles
$
650

 
$
650

 
$
1,951

 
$
1,951

Depreciation
$
62

 
$
68

 
$
189

 
$
215


11

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

 
Three months ended September 30,
 
Nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
Wealth Advisory
(In thousands)
Net interest income
$
36

 
$
4

 
$
82

 
$
10

Fees and other income
13,299

 
12,778

 
39,122

 
38,099

Total revenues
13,335

 
12,782

 
39,204

 
38,109

Operating expense
9,174

 
8,975

 
27,560

 
27,839

Income before income taxes
4,161

 
3,807

 
11,644

 
10,270

Income tax expense
1,562

 
1,398

 
4,360

 
3,812

Net income from continuing operations
2,599

 
2,409

 
7,284

 
6,458

Noncontrolling interests
623

 
603

 
1,765

 
1,557

Net income attributable to the Company
$
1,976

 
$
1,806

 
$
5,519

 
$
4,901

 
 
 
 
 
 
 
 
Assets
$
77,289

 
$
79,133

 
$
77,289

 
$
79,133

Amortization of intangibles
$
49

 
$
173

 
$
146

 
$
554

Depreciation
$
237

 
$
219

 
$
698

 
$
653

 
Three months ended September 30,
 
Nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
Holding Company and Eliminations
(In thousands)
Net interest income
$
(711
)
 
$
(556
)
 
$
(2,018
)
 
$
(1,656
)
Fees and other income
229

 
68

 
323

 
298

Total revenues
(482
)
 
(488
)
 
(1,695
)
 
(1,358
)
Operating expense
1,531

 
1,963

 
5,274

 
5,662

Income/ (loss) before income taxes
(2,013
)
 
(2,451
)
 
(6,969
)
 
(7,020
)
Income tax expense/ (benefit)
(763
)
 
(1,332
)
 
(2,856
)
 
(2,961
)
Net income/ (loss) from continuing operations
(1,250
)
 
(1,119
)
 
(4,113
)
 
(4,059
)
Discontinued operations
1,186

 
1,047

 
3,881

 
4,357

Net income/ (loss) attributable to the Company
$
(64
)
 
$
(72
)
 
$
(232
)
 
$
298

 
 
 
 
 
 
 
 
Assets
$
(89,148
)
 
$
(90,485
)
 
$
(89,148
)
 
$
(90,485
)
Depreciation
$

 
$
8

 
$

 
$
29


12

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

 
Three months ended September 30,
 
Nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
Total Company
(In thousands)
Net interest income
$
56,627

 
$
49,871

 
$
167,414

 
$
148,919

Fees and other income
40,267

 
40,012

 
114,791

 
114,829

Total revenues
96,894

 
89,883

 
282,205

 
263,748

Provision/ (credit) for loan losses
(432
)
 
(138
)
 
(6,727
)
 
(5,806
)
Operating expense
69,346

 
61,670

 
205,947

 
193,110

Income before income taxes
27,980

 
28,351

 
82,985

 
76,444

Income tax expense
8,289

 
8,652

 
24,805

 
23,716

Net income from continuing operations
19,691

 
19,699

 
58,180

 
52,728

Noncontrolling interests
1,074

 
1,110

 
3,190

 
3,010

Discontinued operations
1,186

 
1,047

 
3,881

 
4,357

Net income attributable to the Company
$
19,803

 
$
19,636

 
$
58,871

 
$
54,075

 
 
 
 
 
 
 
 
Assets
$
8,269,398

 
$
7,681,550

 
$
8,269,398

 
$
7,681,550

Amortization of intangibles
$
1,426

 
$
1,568

 
$
4,278

 
$
4,740

Depreciation
$
2,060

 
$
1,706

 
$
6,040

 
$
5,080

_____________________
(1)
Operating expense related to the Wealth Management and Trust segment includes no restructuring expense for the three and nine months ended September 30, 2017 . There was no restructuring expense for the three months ended September 30, 2016 and $2.0 million of restructuring expense for the nine months ended September 30, 2016 .




13

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

4.    Investments
The following table presents a summary of investment securities:
 
Amortized
Cost
 
Unrealized
 
Fair
Value
Gains
 
Losses
 
(In thousands)
As of September 30, 2017
 
 
 
 
 
 
 
Available-for-sale securities at fair value:
 
 
 
 
 
 
 
U.S. government and agencies
$
35,129

 
$
24

 
$
(590
)
 
$
34,563

Government-sponsored entities
305,210

 
789

 
(1,143
)
 
304,856

Municipal bonds
301,436

 
4,900

 
(1,829
)
 
304,507

Mortgage-backed securities (1)
539,064

 
739

 
(10,180
)
 
529,623

Other
15,796

 
485

 
(3
)
 
16,278

Total
$
1,196,635

 
$
6,937

 
$
(13,745
)
 
$
1,189,827

 
 
 
 
 
 
 
 
Held-to-maturity securities at amortized cost:
 
 
 
 
 
 
 
U.S. government and agencies
$
4,996

 
$

 
$

 
$
4,996

Mortgage-backed securities (1)
79,094

 
89

 
(301
)
 
78,882

Total
$
84,090

 
$
89

 
$
(301
)
 
$
83,878

 
 
 
 
 
 
 
 
As of December 31, 2016
 
 
 
 
 
 
 
Available-for-sale securities at fair value:
 
 
 
 
 
 
 
U.S. government and agencies
$
40,704

 
$
86

 
$
(854
)
 
$
39,936

Government-sponsored entities
337,865

 
1,058

 
(2,259
)
 
336,664

Municipal bonds
296,271

 
2,116

 
(4,990
)
 
293,397

Mortgage-backed securities (1)
584,960

 
928

 
(15,561
)
 
570,327

Other
23,361

 
447

 

 
23,808

Total
$
1,283,161

 
$
4,635

 
$
(23,664
)
 
$
1,264,132

 
 
 
 
 
 
 
 
Held-to-maturity securities at amortized cost:
 
 
 
 
 
 
 
Mortgage-backed securities (1)
$
93,079

 
$
1

 
$
(476
)
 
$
92,604

Total
$
93,079

 
$
1

 
$
(476
)
 
$
92,604

_____________________
(1)
 All mortgage-backed securities are guaranteed by U.S. government agencies or government-sponsored entities.
The following table presents the maturities of available-for-sale investment securities, based on contractual maturity, as of September 30, 2017 . Certain securities are callable before their final maturity. Additionally, certain securities (such as mortgage-backed securities) are shown within the table below based on their final (contractual) maturity, but due to prepayments and amortization are expected to have shorter lives.
 
Available-for-sale Securities
Amortized
cost
 
Fair
value
(In thousands)
Within one year
$
60,984

 
$
61,511

After one, but within five years
342,959

 
344,253

After five, but within ten years
321,379

 
315,209

Greater than ten years
471,313

 
468,854

Total
$
1,196,635

 
$
1,189,827


14

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

The following table presents the maturities of held-to-maturity investment securities, based on contractual maturity, as of September 30, 2017 .
 
Held-to-maturity Securities
Amortized
cost
 
Fair
value
(In thousands)
Within one year
$
4,996

 
$
4,996

After one, but within five years

 

After five, but within ten years
13,418

 
13,409

Greater than ten years
65,676

 
65,473

Total
$
84,090

 
$
83,878

The following table presents the proceeds from sales, gross realized gains and gross realized losses for available-for-sale securities that were sold or called during the following periods:
 
Three months ended September 30,
 
Nine months ended September 30,
2017
 
2016
 
2017
 
2016
(In thousands)
Proceeds from sales and calls
$
16,207

 
$
12,829

 
$
119,238

 
$
41,961

Realized gains
235

 
273

 
509

 
520

Realized losses
(5
)
 

 
(23
)
 
(1
)
The following tables present information regarding securities as of September 30, 2017 and December 31, 2016 having temporary impairment, due to the fair values having declined below the amortized cost of the individual securities, and the time period that the investments have been temporarily impaired.
 
Less than 12 months
 
12 months or longer
 
Total
 
Fair
value
 
Unrealized
losses
 
Fair
value
 
Unrealized
losses
 
Fair
value
 
Unrealized
losses
 
# of
securities
September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
 
Available-for-sale securities
(In thousands)
U.S. government and agencies
$
14,883

 
$
(129
)
 
$
9,690

 
$
(461
)
 
$
24,573

 
$
(590
)
 
4

Government-sponsored entities
101,977

 
(818
)
 
10,351

 
(325
)
 
112,328

 
(1,143
)
 
16

Municipal bonds
42,281

 
(399
)
 
40,093

 
(1,430
)
 
82,374

 
(1,829
)
 
45

Mortgage-backed securities (1)
265,098

 
(3,376
)
 
219,521

 
(6,804
)
 
484,619

 
(10,180
)
 
99

Other
21

 
(3
)
 

 

 
21

 
(3
)
 
2

Total
$
424,260

 
$
(4,725
)
 
$
279,655

 
$
(9,020
)
 
$
703,915

 
$
(13,745
)
 
166

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Held-to-maturity securities
 
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage-backed securities (1)
$
54,384

 
$
(239
)
 
$
4,008

 
$
(62
)
 
$
58,392

 
$
(301
)
 
11

Total
$
54,384

 
$
(239
)
 
$
4,008

 
$
(62
)
 
$
58,392

 
$
(301
)
 
11


15

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

 
Less than 12 months
 
12 months or longer
 
Total
 
Fair
value
 
Unrealized
losses
 
Fair
value
 
Unrealized
losses
 
Fair
value
 
Unrealized
losses
 
# of
securities
 
(In thousands, except number of securities)
December 31, 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
Available-for-sale securities
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. government and agencies
$
19,094

 
$
(838
)
 
$
643

 
$
(16
)
 
$
19,737

 
$
(854
)
 
4

Government-sponsored entities
125,412

 
(2,259
)
 

 

 
125,412

 
(2,259
)
 
18

Municipal bonds
182,395

 
(4,957
)
 
2,720

 
(33
)
 
185,115

 
(4,990
)
 
109

Mortgage-backed securities (1)
492,008

 
(13,988
)
 
41,544

 
(1,573
)
 
533,552

 
(15,561
)
 
99

Other

 

 

 

 

 

 

Total
$
818,909

 
$
(22,042
)
 
$
44,907

 
$
(1,622
)
 
$
863,816

 
$
(23,664
)
 
230

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Held-to-maturity securities
 
 
 
 
 
 
 
 
 
 
 
 
 
Mortgage-backed securities (1)
$
87,483

 
$
(476
)
 
$

 
$

 
$
87,483

 
$
(476
)
 
15

Total
$
87,483

 
$
(476
)
 
$

 
$

 
$
87,483

 
$
(476
)
 
15

_____________________
(1)
 All mortgage-backed securities are guaranteed by U.S. government agencies or government-sponsored entities.
As of September 30, 2017 , the U.S. government and agencies securities, government-sponsored entities securities, and mortgage-backed securities in the first table above had current Moody’s credit ratings of Aaa. The municipal bonds in the first table above had a current Standard and Poor’s credit rating of at least AA- or a current Moody’s credit rating of at least Aa3. The other securities in the first table above consisted of equity securities. At September 30, 2017 , the Company does not consider these investments other-than-temporarily impaired because the decline in fair value on investments is primarily attributed to changes in interest rates and not credit quality.
At September 30, 2017 and December 31, 2016 , the amount of investment securities in an unrealized loss position greater than 12 months, as well as in total, was primarily due to changes in interest rates. As of September 30, 2017 , the Company had no intent to sell any securities in an unrealized loss position and it is not more likely than not that the Company would be forced to sell any of these securities prior to the full recovery of all unrealized loss amounts.
Cost method investments, which are included in other assets, can be temporarily impaired when the fair values decline below the amortized costs of the individual investments. There were no cost method investments with unrealized losses as of September 30, 2017 or December 31, 2016 . The Company’s cost method investments primarily include low income housing partnerships which generate tax credits. The Company also holds partnership interests in venture capital funds formed to provide financing to small businesses and to promote community development. The Company had $40.4 million and $34.2 million in cost method investments included in other assets as of September 30, 2017 and December 31, 2016 , respectively.

5.    Fair Value Measurements
Fair value is defined under GAAP as the exchange price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants on the measurement date. The Company determines the fair values of its financial instruments based on the fair value hierarchy established in ASC 820, Fair Value Measurements and Disclosures (“ASC 820”), which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value. Financial instruments are considered Level 1 when valuation can be based on quoted prices in active markets for identical assets or liabilities. Level 2 financial instruments are valued using quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or models using inputs that are observable or can be corroborated by observable market data of substantially the full term of the assets or liabilities. Financial instruments are considered Level 3 when their values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable and when determination of the fair value requires significant management judgment or estimation.

16

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

The following tables present the Company’s assets and liabilities measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016 , aggregated by the level in the fair value hierarchy within which those measurements fall:
 
As of September 30, 2017
 
Fair value measurements at reporting date using:
Quoted prices in
active markets
for identical
assets (Level 1)
 
Significant 
other
observable
inputs (Level 2)
 
Significant
unobservable
inputs (Level 3)
(In thousands)
Assets:
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
U.S. government and agencies
$
34,563

 
$
34,358

 
$
205

 
$

Government-sponsored entities
304,856

 

 
304,856

 

Municipal bonds
304,507

 

 
304,507

 

Mortgage-backed securities
529,623

 

 
529,623

 

Other
16,278

 
16,278

 

 

Total available-for-sale securities
1,189,827

 
50,636

 
1,139,191

 

Derivatives - interest rate customer swaps
15,314

 

 
15,314

 

Derivatives - interest rate swaps
39

 

 
39

 

Derivatives - risk participation agreement
1

 

 
1

 

Other investments
6,857

 
6,857

 

 

 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
Derivatives - interest rate customer swaps
$
15,536

 
$

 
$
15,536

 
$

Derivatives - interest rate swaps
360

 

 
360

 

Derivatives - risk participation agreement
137

 

 
137

 

Other liabilities
6,857

 
6,857

 

 




17

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

 
 
 
Fair value measurements at reporting date using:
As of December 31, 2016
 
Quoted prices in
active markets
for identical
assets (Level 1)
 
Significant 
other
observable
inputs (Level 2)
 
Significant
unobservable
inputs (Level 3)
(In thousands)
Assets:
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
U.S. government and agencies
$
39,936

 
$
39,293

 
$
643

 
$

Government-sponsored entities
336,664

 

 
336,664

 

Municipal bonds
293,397

 

 
293,397

 

Mortgage-backed securities
570,327

 

 
570,327

 

Other
23,808

 
23,808

 

 

Total available-for-sale securities
1,264,132

 
63,101

 
1,201,031

 

Derivatives - interest rate customer swaps
17,032

 

 
17,032

 

Derivatives - risk participation agreement
15

 

 
15

 

Other investments
6,110

 
6,110

 

 

 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
Derivatives - interest rate customer swaps
$
16,560

 
$

 
$
16,560

 
$

Derivatives - interest rate swaps
1,040

 

 
1,040

 

Derivatives - risk participation agreement
6

 

 
6

 

Other liabilities
6,110

 
6,110

 

 

As of September 30, 2017 and December 31, 2016 , available-for-sale securities consisted primarily of U.S. government and agencies securities, government-sponsored entities securities, municipal bonds, mortgage-backed securities, and other available-for-sale securities. The equities (which are categorized as other available-for-sale securities) are valued with prices quoted in active markets. The U.S. Treasury securities (which are categorized as U.S. government and agencies securities), as of both September 30, 2017 and December 31, 2016 , are valued with prices quoted in active markets. Therefore, they have been categorized as a Level 1 measurement. The government-sponsored entities securities, municipal bonds, mortgage-backed securities, and certain investments in Small Business Administration (“SBA”) loans (which are categorized as U.S. government and agencies securities) generally have quoted prices but are traded less frequently than exchange-traded securities and can be priced using market data from similar assets. Therefore, they have been categorized as a Level 2 measurement. No investments held as of September 30, 2017 or December 31, 2016 were categorized as Level 3. There were no changes in the valuation techniques used for measuring the fair value of available-for-sale securities in the nine month periods ended September 30, 2017 or 2016.
In managing its interest rate risk, the Company utilizes derivative instruments such as interest rate customer swaps, interest rate swaps, and risk participation agreements. As a service to its customers, the Company may utilize derivative instruments such as customer foreign exchange forward contracts to manage its foreign exchange risk, if any. The valuation of these instruments is determined using widely accepted valuation techniques including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. Therefore, they have been categorized as a Level 2 measurement as of September 30, 2017 and December 31, 2016 . See Part I. Item 1. “Notes to Unaudited Consolidated Financial Statements-Note 8: Derivatives and Hedging Activities” for further details.
To comply with the provisions of ASC 820, the Company incorporates credit valuation adjustments to appropriately reflect both its own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts and guarantees. Counterparty exposure is evaluated by netting positions that are subject to master netting agreements, as well as considering the amount of collateral securing the position.
The Company has determined that the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, although the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of

18

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

current credit spreads to evaluate the likelihood of default by itself and its counterparties. As a result, the Company has determined that its derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy as of September 30, 2017 and December 31, 2016 .
Other investments, which are not considered available-for-sale investments, consist of deferred compensation trusts, which consist of publicly traded mutual fund investments that are valued at prices quoted in active markets. Therefore, they have been categorized as a Level 1 measurement as of September 30, 2017 and December 31, 2016 .
There were no transfers between levels for assets or liabilities recorded at fair value on a recurring basis during the three or nine month periods ended September 30, 2017 and 2016 .
There were no Level 3 assets valued on a recurring basis at September 30, 2017 or December 31, 2016 .
The following tables present the Company’s assets and liabilities measured at fair value on a non-recurring basis during the periods ended September 30, 2017 and 2016 , respectively, aggregated by the level in the fair value hierarchy within which those measurements fall:
 
As of September 30, 2017
 
Fair value measurements at reporting date using:
 
Gain (losses) from fair value changes
Quoted prices in
active markets
for identical
assets (Level 1)
 
Significant 
other
observable
inputs (Level 2)
 
Significant
unobservable
inputs (Level 3)
 
Three months ended September 30, 2017
 
Nine months ended September 30, 2017
(In thousands)
Assets:
 
 
 
 
 
 
 
 
 
 
 
Impaired loans (1)
$
1,978

 
$

 
$

 
$
1,978

 
$
(255
)
 
$
(474
)
_____________________
(1)
Collateral-dependent impaired loans held at September 30, 2017 that had write-downs in fair value or whose specific reserve changed during the first nine months of 2017 .
 
As of September 30, 2016
 
Fair value measurements at reporting date using:
 
Gain (losses) from fair value changes
Quoted prices in
active markets
for identical
assets (Level 1)
 
Significant 
other
observable
inputs (Level 2)
 
Significant
unobservable
inputs (Level 3)
 
Three months ended September 30, 2016
 
Nine months ended September 30, 2016
(In thousands)
Assets:
 
 
 
 
 
 
 
 
 
 
 
Impaired loans (1)
$
11,936

 
$

 
$

 
$
11,936

 
$
(418
)
 
$
(2,098
)
_____________________
(1)
Collateral-dependent impaired loans held at September 30, 2016 that had write-downs in fair value or whose specific reserve changed during the first nine months of 2016 .
The following table presents additional quantitative information about assets measured at fair value on a non-recurring basis for which the Company has utilized Level 3 inputs to determine fair value:
 
As of September 30, 2017
 
Fair Value
 
Valuation
Technique
 
Unobservable
Input
 
Range of
Inputs
Utilized
 
Weighted
Average of
Inputs
Utilized
 
(In thousands)
 
 
Impaired Loans
$
1,978

 
Appraisals of Collateral
 
Discount for costs to sell
 
0% - 7%
 
4%
Appraisal adjustments
 
0% - 51%
 
17%



19

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

 
As of September 30, 2016
 
Fair Value
 
Valuation
Technique
 
Unobservable
Input
 
Range of
Inputs
Utilized
 
Weighted
Average of
Inputs
Utilized
 
(In thousands)
 
 
Impaired Loans
$
11,936

 
Appraisals of Collateral
 
Discount for costs to sell
 
5% - 78%
 
5%
Appraisal adjustments
 
0% - 20%
 
16%
Impaired loans include those loans that were adjusted to the fair value of underlying collateral as required under ASC 310, Receivables . The amount does not include impaired loans that are measured based on expected future cash flows discounted at the respective loan’s original effective interest rate, as that amount is not considered a fair value measurement. The Company uses appraisals, which management may adjust to reflect estimated fair value declines, or apply other discounts to appraised values for unobservable factors resulting from its knowledge of the property or consideration of broker quotes. The appraisers use a market, income, and/or a cost approach in determining the value of the collateral. Therefore they have been categorized as a Level 3 measurement.
The following tables present the carrying values and fair values of the Company’s financial instruments that are not measured at fair value on a recurring basis:
 
As of September 30, 2017
Book Value
 
Fair Value
 
Quoted prices 
in active
markets for
identical assets 
(Level 1)
 
Significant 
other
observable
inputs (Level 2)
 
Significant
unobservable
inputs (Level 3)
(In thousands)
FINANCIAL ASSETS:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
110,440

 
$
110,440

 
$
110,440

 
$

 
$

Investment securities held-to-maturity
84,090

 
83,878

 
4,996

 
78,882

 

Loans held for sale
1,957

 
2,013

 

 
2,013

 

Loans, net
6,338,328

 
6,340,308

 

 

 
6,340,308

Other financial assets
96,097

 
96,097

 

 
96,097

 

FINANCIAL LIABILITIES:
 
 
 
 
 
 
 
 
 
Deposits
6,262,347

 
6,262,234

 

 
6,262,234

 

Securities sold under agreements to repurchase
59,903

 
59,903

 

 
59,903

 

Federal funds purchased
70,000

 
70,000

 

 
70,000

 

Federal Home Loan Bank borrowings
812,773

 
813,535

 

 
813,535

 

Junior subordinated debentures
106,363

 
96,363

 

 

 
96,363

Other financial liabilities
2,684

 
2,684

 

 
2,684

 



20

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

 
As of December 31, 2016
Book Value
 
Fair Value
 
Quoted prices 
in active
markets for
identical assets 
(Level 1)
 
Significant 
other
observable
inputs (Level 2)
 
Significant
unobservable
inputs (Level 3)
(In thousands)
FINANCIAL ASSETS:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
106,557

 
$
106,557

 
$
106,557

 
$

 
$

Investment securities held-to-maturity
93,079

 
92,604

 

 
92,604

 

Loans held for sale
3,464

 
3,428

 

 
3,428

 

Loans, net
6,036,277

 
6,021,611

 

 

 
6,021,611

Other financial assets
77,956

 
77,956

 

 
77,956

 

FINANCIAL LIABILITIES:
 
 
 
 
 
 
 
 
 
Deposits
6,085,146

 
6,084,765

 

 
6,084,765

 

Securities sold under agreements to repurchase
59,624

 
59,624

 

 
59,624

 

Federal funds purchased
80,000

 
80,000

 

 
80,000

 

Federal Home Loan Bank borrowings
734,205

 
734,941

 

 
734,941

 

Junior subordinated debentures
106,363

 
96,363

 

 

 
96,363

Other financial liabilities
1,942

 
1,942

 

 
1,942

 

The estimated fair values have been determined by using available quoted market information or other appropriate valuation methodologies. The aggregate fair value amounts presented above do not represent the underlying value of the financial assets and liabilities to the Company taken as a whole as they do not reflect any premium or discount the Company might recognize if the asset were sold or the liability sold, settled or redeemed. An excess of fair value over book value on financial assets represents a premium, or gain, the Company might recognize if the asset were sold, while an excess of book value over fair value on financial liabilities represents a premium, or gain, the company might recognize if the liability were sold, settled, or redeemed prior to maturity. Conversely, losses would be recognized if an asset was sold where the book value exceeded the fair value or a liability was sold where the fair value exceeded the book value.
The fair value estimates provided are made at a specific point in time, based on relevant market information and the characteristics of the financial instrument. The estimates do not provide for any premiums or discounts that could result from concentrations of ownership of a financial instrument. Because no active market exists for some of the Company’s financial instruments, certain fair value estimates are based on subjective judgments regarding current economic conditions, risk characteristics of the financial instruments, future expected loss experience, prepayment assumptions, and other factors. The resulting estimates involve uncertainties and are considered best estimates. Changes made to any of the underlying assumptions could significantly affect the estimates.
Cash and cash equivalents
The carrying value reported in the balance sheets for cash and cash equivalents approximates fair value due to the short-term nature of their maturities and are classified as Level 1.
Held-to-maturity investment securities
Held-to-maturity securities currently include mortgage-backed securities and U.S. Treasury securities. The U.S. Treasury securities as of September 30, 2017 are valued with prices quoted in active markets. Therefore, they have been categorized as a Level 1 measurement. There were no U.S. Treasury securities held-to-maturity as of December 31, 2016 . The mortgage-backed securities are fixed income instruments that are not quoted on an exchange, but may be traded in active markets. The fair value of these securities is based on quoted market prices obtained from external pricing services. The principal market for our securities portfolio is the secondary institutional market, with an exit price that is predominantly reflective of bid level pricing in that market. Accordingly, these held-to-maturity mortgage-backed securities are included in the Level 2 fair value category.

21

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

Loans held for sale
Loans held for sale are recorded at the lower of cost or fair value in the aggregate. Fair value estimates are based on actual commitments to sell the loans to investors at an agreed upon price or current market prices if rates have changed since the time the loan closed. Accordingly, loans held for sale are included in the Level 2 fair value category.
Loans, net
Fair value estimates are based on loans with similar financial characteristics. Fair values of commercial and residential mortgage loans are estimated by discounting contractual cash flows adjusted for prepayment estimates and using discount rates approximately equal to current market rates on loans with similar credit and interest rate characteristics and maturities. The fair value estimates for home equity and other loans are based on outstanding loan terms and pricing in the local markets. The method of estimating the fair value of the loans disclosed in the table above does not incorporate the exit price concept in the presentation of the fair value of these financial instruments. Net loans are included in the Level 3 fair value category based upon the inputs and valuation techniques used.
Other financial assets
Other financial assets consist of accrued interest and fees receivable, and stock in the Federal Home Loan Bank (“FHLB”) and the Federal Reserve Bank ("FRB"), for which the carrying amount approximates fair value, and are classified as Level 2.
Deposits
The fair values reported for transaction accounts (demand, NOW, savings, and money market) equal their respective book values reported on the balance sheets and are classified as Level 2. The fair values disclosed are, by definition, equal to the amount payable on demand at the reporting date. The fair values for certificates of deposit are based on the discounted value of contractual cash flows. The discount rates used are representative of approximate rates currently offered on certificates of deposit with similar remaining maturities and are classified as Level 2.
Securities sold under agreements to repurchase
The fair value of securities sold under agreements to repurchase is estimated based on contractual cash flows discounted at the Bank’s incremental borrowing rate for FHLB borrowings with similar maturities and therefore these securities have been classified as Level 2.
Federal funds purchased
The carrying amounts of federal funds purchased approximate fair value due to their short-term nature and therefore these funds have been classified as Level 2.
Federal Home Loan Bank borrowings
The fair value reported for FHLB borrowings is estimated based on the discounted value of contractual cash flows. The discount rate used is based on the Bank’s estimated current incremental borrowing rate for FHLB borrowings of similar maturities and therefore these borrowings have been classified as Level 2.
Junior subordinated debentures
The fair value of the junior subordinated debentures issued by Boston Private Capital Trust I and Boston Private Capital Trust II were estimated using Level 3 inputs such as the interest rates on these securities, current rates for similar debt, a consideration for illiquidity of trading in the debt, and regulatory changes that would result in an unfavorable change in the regulatory capital treatment of this type of debt.
Other financial liabilities
Other financial liabilities consist of accrued interest payable for which the carrying amount approximates fair value and is classified as Level 2.
Financial instruments with off-balance sheet risk
The Bank’s commitments to originate loans and for unused lines and outstanding letters of credit are primarily at market interest rates and therefore, the carrying amount approximates fair value.

22

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)


6.    Loan Portfolio and Credit Quality
The Bank’s lending activities are conducted principally in the regions of New England, the San Francisco Bay Area, and Southern California. The Bank originates single and multi-family residential loans, commercial real estate loans, commercial and industrial loans, commercial tax exempt loans, construction and land loans, and home equity and other consumer loans. Most loans are secured by borrowers’ personal or business assets. The ability of the Bank’s single family residential and consumer borrowers to honor their repayment commitments is generally dependent on the level of overall economic conditions within the Bank’s lending areas. Commercial, construction, and land borrowers’ ability to repay is generally dependent upon the health of the economy and real estate values, including, in particular, the performance of the construction sector. Accordingly, the ultimate collectability of a substantial portion of the Bank’s loan portfolio is susceptible to changing conditions in the New England, the San Francisco Bay Area, and Southern California economies and real estate markets.
Total loans include deferred loan origination (fees)/ costs, net, of $7.1 million and $5.9 million as of September 30, 2017 and December 31, 2016 , respectively.
The following table presents a summary of the loan portfolio by portfolio segment and class of receivable as of the dates indicated:
 
September 30, 2017
 
December 31, 2016
 
(In thousands)
Commercial and industrial
$
618,256

 
$
611,370

Commercial tax exempt
431,350

 
398,604

Total commercial and industrial
1,049,606

 
1,009,974

Commercial real estate
2,363,159

 
2,302,244

Construction and land
118,291

 
104,839

Residential
2,600,788

 
2,379,861

Home equity
107,227

 
118,817

Consumer and other
174,130

 
198,619

Total
$
6,413,201

 
$
6,114,354

The following table presents nonaccrual loans receivable by portfolio segment and class of receivable as of the dates indicated:
 
September 30, 2017
 
December 31, 2016
 
(In thousands)
Commercial and industrial
$
968

 
$
572

Commercial tax exempt

 

Total commercial and industrial
968

 
572

Commercial real estate
2,601

 
4,583

Construction and land
206

 
179

Residential
8,765

 
10,908

Home equity
1,062

 
1,072

Consumer and other
21

 
1

Total
$
13,623

 
$
17,315

The Bank’s policy is to discontinue the accrual of interest on a loan when the collectability of principal or interest is in doubt. In certain instances, although infrequent, loans that have become 90 days or more past due may remain on accrual status if the value of the collateral securing the loan is sufficient to cover principal and interest and the loan is in the process of collection. There were no loans 90 days or more past due, but still accruing as of both September 30, 2017 and December 31, 2016 . The Bank’s policy for returning a loan to accrual status requires the loan to be brought current and for the client to show a history of making timely payments (generally six consecutive months). For troubled debt restructured loans (“TDRs”), a return

23

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

to accrual status generally requires timely payments for a period of six months in accordance with the restructured loan terms, along with meeting other criteria.
The following tables show the payment status of loans by class of receivable as of the dates indicated:
 
September 30, 2017
 
Accruing Past Due
 
Nonaccrual Loans
 
 
 
 
 
30-59 Days Past Due
 
60-89 Days Past Due
 
Total Accruing Past Due
 
Current
 
30-89 Days Past Due
 
90 Days or
Greater
Past Due
 
Total Non-Accrual Loans
 
Current Accruing Loans
 
Total
Loans
Receivable
 
(In thousands)
Commercial and industrial
$
945

 
$
14

 
$
959

 
$
400

 
$
350

 
$
218

 
$
968

 
$
616,329

 
$
618,256

Commercial tax exempt

 

 

 

 

 

 

 
431,350

 
431,350

Commercial real estate
663

 
244

 
907

 
670

 

 
1,931

 
2,601

 
2,359,651

 
2,363,159

Construction and land
413

 

 
413

 
59

 
4

 
143

 
206

 
117,672

 
118,291

Residential

 
226

 
226

 
5,063

 
152

 
3,550

 
8,765

 
2,591,797

 
2,600,788

Home equity
402

 
1,800

 
2,202

 
72

 

 
990

 
1,062

 
103,963

 
107,227

Consumer and other
568

 
17

 
585

 
13

 

 
8

 
21

 
173,524

 
174,130

Total
$
2,991

 
$
2,301

 
$
5,292

 
$
6,277

 
$
506

 
$
6,840

 
$
13,623

 
$
6,394,286

 
$
6,413,201

 
December 31, 2016
 
Accruing Past Due
 
Nonaccrual Loans
 
 
 
 
 
30-59 Days Past Due
 
60-89 Days Past Due
 
Total Accruing Past Due
 
Current
 
30-89 Days Past Due
 
90 Days or Greater Past Due
 
Total Non-Accrual Loans
 
Current Accruing Loans
 
Total Loans Receivable
 
(In thousands)
Commercial and industrial
$
541

 
$
1,078

 
$
1,619

 
$
537

 
$

 
$
35

 
$
572

 
$
609,179

 
$
611,370

Commercial tax exempt

 

 

 

 

 

 

 
398,604

 
398,604

Commercial real estate
3,096

 

 
3,096

 
2,311

 
835

 
1,437

 
4,583

 
2,294,565

 
2,302,244

Construction and land

 

 

 
129

 
12

 
38

 
179

 
104,660

 
104,839

Residential
3,646

 
536

 
4,182

 
2,148

 
1,274

 
7,486

 
10,908

 
2,364,771

 
2,379,861

Home equity
245

 

 
245

 

 
80

 
992

 
1,072

 
117,500

 
118,817

Consumer and other
5,995

 

 
5,995

 
1

 

 

 
1

 
192,623

 
198,619

Total
$
13,523

 
$
1,614

 
$
15,137

 
$
5,126

 
$
2,201

 
$
9,988

 
$
17,315

 
$
6,081,902

 
$
6,114,354

Nonaccrual and delinquent loans are affected by many factors, such as economic and business conditions, interest rates, unemployment levels, and real estate collateral values, among others. In periods of prolonged economic decline, borrowers may become more severely affected over time as liquidity levels decline and the borrower’s ability to continue to make payments deteriorates. With respect to real estate collateral values, the declines from the peak, as well as the value of the real estate at the time of origination versus the current value, can impact the level of problem loans. For instance, if the loan to value ratio at the time of renewal has increased due to the decline in the real estate value since origination, the loan may no longer meet the Bank’s underwriting standards and may be considered for classification as a problem loan dependent upon a review of risk factors.
Generally when a collateral dependent loan becomes impaired, an updated appraisal of the collateral, if appropriate, is obtained. If the impaired loan has not been upgraded to a performing status within a reasonable amount of time, the Bank will continue to obtain updated appraisals as deemed necessary, especially during periods of declining property values.
The past due status of a loan is determined in accordance with its contractual repayment terms. All loan types are reported past due when one scheduled payment is due and unpaid for 30 days or more.

24

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

Credit Quality Indicators
The Bank uses a risk rating system to monitor the credit quality of its loan portfolio. Loan classifications are assessments made by the Bank of the status of the loans based on the facts and circumstances known to the Bank, including management’s judgment, at the time of assessment. Some or all of these classifications may change in the future if there are unexpected changes in the financial condition of the borrower, including but not limited to, changes resulting from continuing deterioration in general economic conditions on a national basis or in the local markets in which the Bank operates adversely affecting, among other things, real estate values. Such conditions, as well as other factors which adversely affect borrowers’ ability to service or repay loans, typically result in changes in loan default and charge-off rates, and increased provisions for loan losses, which would adversely affect the Company’s financial performance and financial condition. These circumstances are not entirely foreseeable and, as a result, it may not be possible to accurately reflect them in the Company’s analysis of credit risk. Generally, only commercial loans, including commercial real estate, other commercial and industrial loans, commercial tax exempt loans, and construction and land loans, are given a numerical grade.
A summary of the rating system used by the Bank, repeated here from Part II. Item 8. “Financial Statements and Supplementary Data—Note 1: Basis of Presentation and Summary of Significant Accounting Policies,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016, follows:
Pass - All loans graded as pass are considered acceptable credit quality by the Bank and are grouped for purposes of calculating the allowance for loan losses. For residential, home equity and consumer loans, the Bank classifies loans as pass unless there is known information such as delinquency or client requests for modifications which, due to financial difficulty, would then generally result in a risk rating such as special mention or more severe depending on the factors.
Special Mention - Loans rated in this category are defined as having potential weaknesses that deserve management’s close attention. If left uncorrected, these potential weaknesses may, at some future date, result in the deterioration of the repayment prospects for the credit or the Bank’s credit position. These loans are currently protected but have the potential to deteriorate to a substandard rating. For commercial loans, the borrower’s financial performance may be inconsistent or below forecast, creating the possibility of liquidity problems and shrinking debt service coverage. In loans having this rating, the primary source of repayment is still good, but there is increasing reliance on collateral or guarantor support. Collectability of the loan is not yet in jeopardy. In particular, loans in this category are considered more variable than other categories, since they will typically migrate through categories more quickly.
Substandard - Loans rated in this category are inadequately protected by the current sound worth and paying capacity of the obligor or of the collateral pledged, if any. A substandard credit has a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. They are characterized by the distinct possibility that the Bank will sustain some loss if the deficiencies are not corrected. Substandard loans may be either still accruing or nonaccruing depending upon the severity of the risk and other factors such as the value of the collateral, if any, and past due status.
Doubtful - Loans rated in this category indicate that collection or liquidation in full on the basis of currently existing facts, conditions, and values, is highly questionable and improbable. Loans in this category are usually on nonaccrual and classified as impaired.
The following tables present the loan portfolio’s credit risk profile by internally assigned grade and class of receivable as of the dates indicated:

25

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

 
September 30, 2017
 
By Loan Grade or Nonaccrual Status
 
 
 
Pass
 
Special Mention
 
Accruing Substandard
 
Nonaccrual Loans
 
Total
 
(In thousands)
Commercial and industrial
$
598,691

 
$
10,459

 
$
8,138

 
$
968

 
$
618,256

Commercial tax exempt
425,759

 
5,591

 

 

 
431,350

Commercial real estate
2,265,871

 
57,381

 
37,306

 
2,601

 
2,363,159

Construction and land
106,154

 
5,243

 
6,688

 
206

 
118,291

Residential
2,590,665

 

 
1,358

 
8,765

 
2,600,788

Home equity
106,165

 

 

 
1,062

 
107,227

Consumer and other
173,858

 

 
251

 
21

 
174,130

Total
$
6,267,163

 
$
78,674

 
$
53,741

 
$
13,623

 
$
6,413,201

 
December 31, 2016
 
By Loan Grade or Nonaccrual Status
 
 
 
Pass
 
Special Mention
 
Accruing Substandard
 
Nonaccrual Loans
 
Total
 
(In thousands)
Commercial and industrial
$
591,388

 
$
10,133

 
$
9,277

 
$
572

 
$
611,370

Commercial tax exempt
388,544

 
10,060

 

 

 
398,604

Commercial real estate
2,230,732

 
17,233

 
49,696

 
4,583

 
2,302,244

Construction and land
101,254

 
109

 
3,297

 
179

 
104,839

Residential
2,367,554

 

 
1,399

 
10,908

 
2,379,861

Home equity
117,745

 

 

 
1,072

 
118,817

Consumer and other
198,616

 

 
2

 
1

 
198,619

Total
$
5,995,833

 
$
37,535

 
$
63,671

 
$
17,315

 
$
6,114,354


26

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

The following tables present, by class of receivable, the balance of impaired loans with and without a related allowance, the associated allowance for those impaired loans with a related allowance, and the total unpaid principal on impaired loans:
 
As of and for the three and nine months ended September 30, 2017
 
Recorded Investment (1)
 
Unpaid Principal Balance
 
Related Allowance
 
QTD Average Recorded Investment
 
YTD Average Recorded Investment
 
QTD Interest Income Recognized while Impaired
 
YTD Interest Income Recognized while Impaired
 
(In thousands)
With no related allowance recorded:
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial and industrial
$
1,371

 
$
1,988

 
n/a
 
$
1,626

 
$
1,665

 
$
18

 
$
43

Commercial tax exempt

 

 
n/a
 

 
1,301

 

 
80

Commercial real estate
2,463

 
5,972

 
n/a
 
2,690

 
3,465

 
107

 
1,077

Construction and land
207

 
241

 
n/a
 
218

 
191

 

 

Residential
8,859

 
9,231

 
n/a
 
9,069

 
8,938

 
98

 
277

Home equity

 

 
n/a
 

 

 

 

Consumer and other

 

 
n/a
 

 

 

 

Subtotal
12,900

 
17,432

 
n/a
 
13,603

 
15,560

 
223

 
1,477

With an allowance recorded:
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial and industrial
598

 
598

 
$
242

 
149

 
60

 
1

 
1

Commercial tax exempt

 

 

 

 

 

 

Commercial real estate
6,911

 
7,341

 
415

 
6,955

 
7,012

 
76

 
247

Construction and land

 

 

 

 

 

 

Residential
1,200

 
1,200

 
127

 
2,175

 
2,938

 
18

 
80

Home equity
36

 
36

 
21

 
36

 
37

 

 
1

Consumer and other

 

 

 

 

 

 

Subtotal
8,745

 
9,175

 
805

 
9,315

 
10,047

 
95

 
329

Total:
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial and industrial
1,969

 
2,586

 
242

 
1,775

 
1,725

 
19

 
44

Commercial tax exempt

 

 

 

 
1,301

 

 
80

Commercial real estate
9,374

 
13,313

 
415

 
9,645

 
10,477

 
183

 
1,324

Construction and land
207

 
241

 

 
218

 
191

 

 

Residential
10,059

 
10,431

 
127

 
11,244

 
11,876

 
116

 
357

Home equity
36

 
36

 
21

 
36

 
37

 

 
1

Consumer and other

 

 

 

 

 

 

Total
$
21,645

 
$
26,607

 
$
805

 
$
22,918

 
$
25,607

 
$
318

 
$
1,806

_____________________
(1)
Recorded investment represents the client loan balance net of historical charge-offs and historical nonaccrual interest paid, which was applied to principal.


27

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

 
As of and for the three and nine months ended September 30, 2016
 
Recorded Investment (1)
 
Unpaid Principal Balance
 
Related Allowance
 
QTD Average Recorded Investment
 
YTD Average Recorded Investment
 
QTD Interest Income Recognized while Impaired
 
YTD Interest Income Recognized while Impaired
 
(In thousands)
With no related allowance recorded:
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial and industrial
$
11,742

 
$
13,874

 
n/a
 
$
10,774

 
$
6,325

 
$
98

 
$
169

Commercial tax exempt

 

 
n/a
 

 

 

 

Commercial real estate
5,966

 
11,148

 
n/a
 
7,288

 
9,672

 
332

 
874

Construction and land
224

 
548

 
n/a
 
400

 
1,332

 
48

 
48

Residential
6,472

 
6,832

 
n/a
 
7,345

 
7,345

 
59

 
173

Home equity

 

 
n/a
 

 

 

 

Consumer and other

 

 
n/a
 

 

 

 

Subtotal
24,404

 
32,402

 
n/a
 
25,807

 
24,674

 
537

 
1,264

With an allowance recorded:
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial and industrial
37

 
37

 
$
22

 
37

 
33

 

 
1

Commercial tax exempt

 

 

 

 

 

 

Commercial real estate
7,164

 
7,593

 
593

 
7,194

 
7,259

 
79

 
237

Construction and land

 

 

 

 
660

 

 

Residential
6,877

 
6,877

 
701

 
5,977

 
5,994

 
36

 
115

Home equity

 

 

 

 

 

 

Consumer and other

 

 

 

 

 

 

Subtotal
14,078

 
14,507

 
1,316

 
13,208

 
13,946

 
115

 
353

Total:
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial and industrial
11,779

 
13,911

 
22

 
10,811

 
6,358

 
98

 
170

Commercial tax exempt

 

 

 

 

 

 

Commercial real estate
13,130

 
18,741

 
593

 
14,482

 
16,931

 
411

 
1,111

Construction and land
224

 
548

 

 
400

 
1,992

 
48

 
48

Residential
13,349

 
13,709

 
701

 
13,322

 
13,339

 
95

 
288

Home equity

 

 

 

 

 

 

Consumer and other

 

 

 

 

 

 

Total
$
38,482

 
$
46,909

 
$
1,316

 
$
39,015

 
$
38,620

 
$
652

 
$
1,617

_____________________
(1)
Recorded investment represents the client loan balance net of historical charge-offs and historical nonaccrual interest paid, which was applied to principal.



28

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

 
As of and for the year ended December 31, 2016
 
Recorded Investment (1)
 
Unpaid Principal Balance
 
Related Allowance
 
 Average Recorded Investment
 
Interest Income Recognized while Impaired
 
(In thousands)
With no related allowance recorded:
 
 
 
 
 
 
 
 
 
Commercial and industrial
$
1,793

 
$
2,155

 
n/a
 
$
5,288

 
$
249

Commercial tax exempt

 

 
n/a
 

 

Commercial real estate
4,488

 
9,647

 
n/a
 
8,520

 
1,032

Construction and land
179

 
507

 
n/a
 
1,069

 
48

Residential
8,134

 
8,506

 
n/a
 
7,446

 
211

Home equity

 

 
n/a
 

 

Consumer and other

 

 
n/a
 

 

Subtotal
14,594

 
20,815

 
n/a
 
22,323

 
1,540

With an allowance recorded:
 
 
 
 
 
 
 
 
 
Commercial and industrial

 

 
$

 
31

 
1

Commercial tax exempt

 

 

 

 

Commercial real estate
7,115

 
7,544

 
548

 
7,230

 
314

Construction and land

 

 

 
507

 

Residential
4,284

 
4,284

 
565

 
5,505

 
143

Home equity
37

 
37

 
22

 
3

 

Consumer and other

 

 

 

 

Subtotal
11,436

 
11,865

 
1,135

 
13,276

 
458

Total:
 
 
 
 
 
 
 
 
 
Commercial and industrial
1,793

 
2,155

 

 
5,319

 
250

Commercial tax exempt

 

 

 

 

Commercial real estate
11,603

 
17,191

 
548

 
15,750

 
1,346

Construction and land
179

 
507

 

 
1,576

 
48

Residential
12,418

 
12,790

 
565

 
12,951

 
354

Home equity
37

 
37

 
22

 
3

 

Consumer and other

 

 

 

 

Total
$
26,030

 
$
32,680

 
$
1,135

 
$
35,599

 
$
1,998

_____________________
(1)
Recorded investment represents the client loan balance net of historical charge-offs and historical nonaccrual interest paid, which was applied to principal.
When management determines that it is probable that the Bank will not collect all principal and interest on a loan in accordance with the original loan terms, the loan is designated as impaired.
Loans that are designated as impaired require an analysis to determine the amount of impairment, if any. Impairment would be indicated as a result of the carrying value of the loan exceeding the estimated collateral value, less costs to sell, for collateral dependent loans or the net present value of the projected cash flow, discounted at the loan’s contractual effective interest rate, for loans not considered to be collateral dependent. Generally, shortfalls in the analysis on collateral dependent loans would result in the impairment amount being charged-off to the allowance for loan losses. Shortfalls on cash flow dependent loans may be carried as specific allocations to the general reserve unless a known loss is determined to have occurred, in which case such known loss is charged-off.
Loans in the held for sale category are carried at the lower of amortized cost or estimated fair value in the aggregate and are excluded from the allowance for loan losses analysis.
The Bank may, under certain circumstances, restructure loans as a concession to borrowers who are experiencing financial difficulty. Such loans are classified as TDRs and are included in impaired loans. TDRs typically result from the Bank’s loss mitigation activities which, among other things, could include rate reductions, payment extensions, and/or principal

29

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

forgiveness. As of September 30, 2017 and December 31, 2016 , TDRs totaled $14.7 million and $18.1 million , respectively. As of September 30, 2017 , $11.5 million of the $14.7 million in TDRs were on accrual status. As of December 31, 2016 , $12.4 million of the $18.1 million in TDRs were on accrual status.
Since all TDR loans are considered impaired loans, they are individually evaluated for impairment. The resulting impairment, if any, would have an impact on the allowance for loan losses as a specific reserve or charge-off. If, prior to the classification as a TDR, the loan was not impaired, there would have been a general or allocated reserve on the particular loan. Therefore, depending upon the result of the impairment analysis, there could be an increase or decrease in the related allowance for loan losses. Many loans initially categorized as TDRs are already on nonaccrual status and are already considered impaired. Therefore, there is generally not a material change to the allowance for loan losses when a nonaccruing loan is categorized as a TDR.
The following tables present the balance of TDRs that were restructured or defaulted during the periods indicated and the types of concessions granted:
 
As of and for the three and nine months ended September 30, 2017
 
Restructured in the current
quarter and year to date
 
TDRs that defaulted
that were
restructured in prior twelve months
 
# of
Loans
 
Pre-
modification
recorded
investment
 
Post-
modification
recorded
investment
 
# of
Loans
 
Post-
modification
recorded
investment
 
(Dollars in thousands)
Commercial and industrial

 
$

 
$

 

 
$

Commercial tax exempt

 

 

 

 

Commercial real estate

 

 

 

 

Construction and land

 

 

 

 

Residential (1)
1

 
108

 
109

 

 

Home equity

 

 

 

 

Consumer and other

 

 

 

 

Total
1

 
$
108

 
$
109

 

 
$

_____________________
(1)
Represents the following concession: temporary rate reduction.







30

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

 
As of and for the three months ended September 30, 2016
 
Restructured in the current quarter
 
TDRs that defaulted
that were
restructured in prior twelve months
 
# of
Loans
 
Pre-
modification
recorded
investment
 
Post-
modification
recorded
investment
 
# of
Loans
 
Post-
modification
recorded
investment
 
(Dollars in thousands)
Commercial and industrial

 
$

 
$

 

 
$

Commercial tax exempt

 

 

 

 

Commercial real estate

 

 

 
1

 
1,276

Construction and land

 

 

 

 

Residential

 

 

 

 

Home equity

 

 

 

 

Consumer and other

 

 

 

 

Total

 
$

 
$

 
1

 
$
1,276



 
As of and for the nine months ended September 30, 2016
 
Restructured in the current year to date
 
TDRs that defaulted
that were
restructured in prior twelve months
 
# of
Loans
 
Pre-
modification
recorded
investment
 
Post-
modification
recorded
investment
 
# of
Loans
 
Post-
modification
recorded
investment
 
(Dollars in thousands)
Commercial and industrial
3

 
$
7,384

 
$
7,209

 

 
$

Commercial tax exempt

 

 

 

 

Commercial real estate
1

 
1,276

 
1,276

 
1

 
1,276

Construction and land

 

 

 

 

Residential
2

 
260

 
261

 

 

Home equity

 

 

 

 

Consumer and other

 

 

 

 

Total
6

 
$
8,920

 
$
8,746

 
1

 
$
1,276



31

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

 
As of and for the nine months ended September 30, 2016
 
Extension of term
 
Temporary rate reduction
 
Payment deferral
 
Combination of concessions (1)
 
Total concessions
 
# of
Loans
 
Post-
modifi-
cation
recorded
invest-
ment
 
# of
Loans
 
Post-
modifi-
cation
recorded
invest-
ment
 
# of
Loans
 
Post-
modifi-
cation
recorded
invest-
ment
 
# of
Loans
 
Post-
modifi-
cation
recorded
invest-
ment
 
# of
Loans
 
Post-
modifi-
cation
recorded
invest-
ment
 
(Dollars in thousands)
Commercial and industrial
2

 
$
7,209

 

 
$

 

 
$

 
1

 
$

 
3

 
$
7,209

Commercial tax exempt

 

 

 

 

 

 

 

 

 

Commercial real estate

 

 

 

 

 

 
1

 
1,276

 
1

 
1,276

Construction and land

 

 

 

 

 

 

 

 

 

Residential

 

 
2

 
261

 

 

 

 

 
2

 
261

Home equity

 

 

 

 

 

 

 

 

 

Consumer and other

 

 

 

 

 

 

 

 

 

_____________________
(1)
Combination of concessions includes loans that have had more than one modification, including extension of term, temporary reduction of interest rate, and/or payment deferral.

7.    Allowance for Loan Losses
The allowance for loan losses is reported as a reduction of outstanding loan balances, and totaled $74.9 million and $78.1 million at September 30, 2017 and December 31, 2016 , respectively.
The following tables present a summary of the changes in the allowance for loan losses for the periods indicated:
 
As of and for the three months ended September 30,
 
As of and for the nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
 
(In thousands)
Allowance for loan losses, beginning of period:
 
 
 
 
 
 
 
Commercial and industrial
$
11,672

 
$
13,246

 
$
12,751

 
$
15,814

Commercial real estate
48,136

 
45,507

 
50,412

 
44,215

Construction and land
3,585

 
4,740

 
3,039

 
6,322

Residential
10,282

 
10,752

 
10,449

 
10,544

Home equity
929

 
1,139

 
1,035

 
1,085

Consumer and other
405

 
369

 
391

 
520

Total allowance for loan losses, beginning of period
75,009

 
75,753

 
78,077

 
78,500

Loans charged-off:
 
 
 
 
 
 
 
Commercial and industrial

 
(285
)
 
(218
)
 
(2,393
)
Commercial real estate

 

 

 

Construction and land

 

 

 
(400
)
Residential

 

 
(58
)
 
(501
)
Home equity

 

 

 

Consumer and other
(38
)
 
(52
)
 
(283
)
 
(78
)
Total charge-offs
(38
)
 
(337
)
 
(559
)
 
(3,372
)

32

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

 
As of and for the three months ended September 30,
 
As of and for the nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
 
(In thousands)
Recoveries on loans previously charged-off:
 
 
 
 
 
 
 
Commercial and industrial
241

 
81

 
395

 
1,457

Commercial real estate
76

 
1,767

 
3,605

 
5,709

Construction and land
13

 
490

 
13

 
1,117

Residential

 
49

 
47

 
53

Home equity

 

 

 

Consumer and other
4

 
4

 
22

 
11

Total recoveries
334

 
2,391

 
4,082

 
8,347

Provision/ (credit) for loan losses:
 
 
 
 
 
 
 
Commercial and industrial
973

 
859

 
(42
)
 
(977
)
Commercial real estate
(1,173
)
 
1,038

 
(6,978
)
 
(1,612
)
Construction and land
182

 
(2,086
)
 
728

 
(3,895
)
Residential
(431
)
 
103

 
(587
)
 
808

Home equity
(15
)
 
(62
)
 
(121
)
 
(8
)
Consumer and other
32

 
10

 
273

 
(122
)
Total provision/(credit) for loan losses
(432
)
 
(138
)
 
(6,727
)
 
(5,806
)
Allowance for loan losses at end of period:
 
 
 
 
 
 
 
Commercial and industrial
12,886

 
13,901

 
12,886

 
13,901

Commercial real estate
47,039

 
48,312

 
47,039

 
48,312

Construction and land
3,780

 
3,144

 
3,780

 
3,144

Residential
9,851

 
10,904

 
9,851

 
10,904

Home equity
914

 
1,077

 
914

 
1,077

Consumer and other
403

 
331

 
403

 
331

Total allowance for loan losses at end of period
$
74,873

 
$
77,669

 
$
74,873

 
$
77,669


The allowance for loan losses is an estimate of the inherent risk of loss in the loan portfolio as of the consolidated balance sheet dates. Management estimates the level of the allowance based on all relevant information available. Changes to the required level in the allowance result in either a provision for loan loss expense, if an increase is required, or a credit to the provision, if a decrease is required. Loan losses are charged to the allowance when available information confirms that specific loans, or portions thereof, are uncollectible. Recoveries on loans previously charged-off are credited to the allowance when received in cash.

The provision/ (credit) for loan losses and related balance in the allowance for loan losses for tax exempt commercial and industrial loans are included with commercial and industrial. The provision/ (credit) for loan losses and related balance in the allowance for loan losses for tax exempt commercial real estate loans are included with commercial real estate. There were no charge-offs or recoveries, for any period presented, for both commercial and industrial and commercial real estate tax exempt loans.
The following tables present the Company’s allowance for loan losses and loan portfolio at September 30, 2017 and December 31, 2016 by portfolio segment, disaggregated by method of impairment analysis. The Company had no loans acquired with deteriorated credit quality at September 30, 2017 or December 31, 2016 .

33

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

 
September 30, 2017
 
Individually Evaluated
for Impairment
 
Collectively Evaluated
for Impairment
 
Total
 
Recorded investment
(loan balance)
 
Allowance for loan losses
 
Recorded investment
(loan balance)
 
Allowance for loan losses
 
Recorded investment
(loan balance)
 
Allowance for loan losses
 
(In thousands)
Commercial and industrial
$
1,969

 
$
242

 
$
1,047,637

 
$
12,644

 
$
1,049,606

 
$
12,886

Commercial real estate
9,374

 
415

 
2,353,785

 
46,624

 
2,363,159

 
47,039

Construction and land
207

 

 
118,084

 
3,780

 
118,291

 
3,780

Residential
10,059

 
127

 
2,590,729

 
9,724

 
2,600,788

 
9,851

Home equity
36

 
21

 
107,191

 
893

 
107,227

 
914

Consumer

 


 
174,130

 
403

 
174,130

 
403

Total
$
21,645

 
$
805

 
$
6,391,556

 
$
74,068

 
$
6,413,201

 
$
74,873

 
December 31, 2016
 
Individually Evaluated
for Impairment
 
Collectively Evaluated
for Impairment
 
Total
 
Recorded investment
(loan balance)
 
Allowance for loan losses
 
Recorded investment
(loan balance)
 
Allowance for loan losses
 
Recorded investment
(loan balance)
 
Allowance for loan losses
 
(In thousands)
Commercial and industrial
$
1,793

 
$

 
$
1,008,181

 
$
12,751

 
$
1,009,974

 
$
12,751

Commercial real estate
11,603

 
548

 
2,290,641

 
49,864

 
2,302,244

 
50,412

Construction and land
179

 

 
104,660

 
3,039

 
104,839

 
3,039

Residential
12,418

 
565

 
2,367,443

 
9,884

 
2,379,861

 
10,449

Home equity
37

 
22

 
118,780

 
1,013

 
118,817

 
1,035

Consumer

 

 
198,619

 
391

 
198,619

 
391

Total
$
26,030

 
$
1,135

 
$
6,088,324

 
$
76,942

 
$
6,114,354

 
$
78,077


8.    Derivatives and Hedging Activities
The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and, to a lesser extent, the use of derivative financial instruments. Additionally, as a service to its customers, the Company may utilize derivative instruments such as customer foreign exchange forward contracts to manage its foreign exchange risk, if any. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are generally determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to certain loans, deposits, and borrowings.

34

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

The following table presents the fair value of the Company’s derivative financial instruments as well as their classification on the consolidated balance sheets as of September 30, 2017 and December 31, 2016 :
 
September 30, 2017
 
December 31, 2016
 
Asset derivatives
 
Liability derivatives
 
Asset derivatives
 
Liability derivatives
 
Balance
sheet
location
 
Fair value (1)
 
Balance
sheet
location
 
Fair value (1)
 
Balance
sheet
location
 
Fair value (1)
 
Balance
sheet
location
 
Fair value (1)
 
(In thousands)
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate products
Other
assets
 
$
39

 
Other
liabilities
 
$
(360
)
 
Other
assets
 
$

 
Other
liabilities
 
$
(1,040
)
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate products
Other
assets
 
15,314

 
Other
liabilities
 
(15,536
)
 
Other
assets
 
17,032

 
Other
liabilities
 
(16,560
)
Risk participation agreements
Other
assets
 
1

 
Other
liabilities
 
(137
)
 
Other
assets
 
15

 
Other
liabilities
 
(6
)
Total
 
 
$
15,354

 
 
 
$
(16,033
)
 
 
 
$
17,047

 
 
 
$
(17,606
)
_____________________
(1)
For additional details, see Part I. Item 1. “Notes to Unaudited Consolidated Financial Statements-Note 5: Fair Value Measurements.”

35

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

The following tables present the effect of the Company’s derivative financial instruments in the consolidated statements of operations for the three and nine months ended September 30, 2017 and 2016 :
Derivatives in cash
flow hedging
relationships
 
Amount of gain or (loss) recognized in OCI on derivatives (effective portion) (1)
 
Location of gain or (loss) reclassified from accumulated OCI into income (effective portion)
 
Amount of gain or (loss) reclassified from accumulated OCI into income (effective portion)
 
Three months ended September 30,
 
 
Three months ended September 30,
 
2017
 
2016
 
 
2017
 
2016
(In thousands)
Interest rate products
 
$
121

 
$
663

 
Interest expense
 
$
(293
)
 
$
(405
)
Total
 
$
121

 
$
663

 
 
 
$
(293
)
 
$
(405
)
_____________________
(1)
There was an additional $(1) thousand loss related to the ineffective portion for the three months ended as of September 30, 2017 and a $(19) thousand loss related to the ineffective portion for the three months ended as of September 30, 2016 .

Derivatives in cash
flow hedging
relationships
 
Amount of gain or (loss) recognized in OCI on derivatives (effective portion) (1)
 
Location of gain or (loss) reclassified from accumulated OCI into income (effective portion)
 
Amount of gain or (loss) reclassified from accumulated OCI into income (effective portion)
 
Nine months ended September 30,
 
 
Nine months ended September 30,
 
2017
 
2016
 
 
2017
 
2016
(In thousands)
Interest rate products
 
$
(237
)
 
$
(1,928
)
 
Interest expense
 
$
(953
)
 
$
(1,319
)
Total
 
$
(237
)
 
$
(1,928
)
 
 
 
$
(953
)
 
$
(1,319
)
____________________
(1)
There was an additional $(3) thousand loss related to the ineffective portion for the nine months ended as of September 30, 2017 and a $26 thousand gain related to the ineffective portion for the nine months ended as of September 30, 2016 .

The following table presents the components of the Company’s accumulated other comprehensive income/ (loss) related to the derivatives for the three and nine months ended September 30, 2017 and 2016 :
 
Three months ended September 30,
 
Nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
 
(In thousands)
Accumulated other comprehensive income/ (loss) on cash flow hedges, balance at beginning of period
$
(429
)
 
$
(2,109
)
 
$
(605
)
 
$
(1,123
)
Net change in unrealized gain/ (loss) on cash flow hedges
242

 
628

 
418

 
(358
)
Accumulated other comprehensive income/ (loss) on cash flow hedges, balance at end of period
$
(187
)
 
$
(1,481
)
 
$
(187
)
 
$
(1,481
)
The Bank has agreements with its derivative counterparties that contain provisions where, if the Bank defaults on any of its indebtedness, including default where repayment of the indebtedness has not been accelerated by the lender, then the Bank could also be declared in default on its derivative obligations. The Bank was in compliance with these provisions as of September 30, 2017 and December 31, 2016 .
The Bank also has agreements with certain of its derivative counterparties that contain provisions where, if the Bank fails to maintain its status as a well- or adequately-capitalized institution, then the counterparty could terminate the derivative positions and the Bank would be required to settle its obligations under the agreements. The Bank was in compliance with these provisions as of September 30, 2017 and December 31, 2016 .
Certain of the Bank’s agreements with its derivative counterparties contain provisions where, if specified, events or conditions occur that materially change the Bank’s creditworthiness in an adverse manner, the Bank may be required to fully collateralize its obligations under the derivative instruments. The Bank was in compliance with these provisions as of September 30, 2017 and December 31, 2016 .

36

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

As of September 30, 2017 and December 31, 2016 , the termination amounts related to collateral determinations of derivatives in a liability position were $3.6 million and $3.4 million , respectively. The Company has minimum collateral posting thresholds with its derivative counterparties and pledged securities with market values of $5.6 million and $1.9 million , respectively, as of September 30, 2017 and December 31, 2016 , against its obligations under these agreements. The collateral posted is typically greater than the current liability position; however, due to timing of liability position changes at period end, the funding of a collateral shortfall may take place shortly following period end.
Cash Flow Hedges of Interest Rate Risk
The Company’s objectives in using interest rate derivatives are to add stability to interest income and expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company has entered into interest rate swaps as part of its interest rate risk management strategy.  These interest rate swaps are designated as cash flow hedges and involve the receipt of variable rate amounts from a counterparty in exchange for the Company making fixed payments.  The Company has entered into interest rate swaps to hedge London Interbank Offered Rate (“LIBOR”) -indexed brokered deposits and the LIBOR component of the total cost of certain FHLB borrowings.
To accomplish this objective and strategy, the Bank has entered into a total of seven interest rate swaps, two during 2017 with effective dates of March 22, 2017 and five during 2013 with effective dates of December 1, 2014, September 2, 2014, June 1, 2014, March 1, 2014, and August 1, 2013.
The two interest rate swaps entered into during 2017 have notional amounts of $40 million and $60 million with terms of 1.75 and 2.25 years, respectively. These interest rate swaps will effectively fix the Bank’s interest payments on $100 million in interest-related cash outflows attributable to changes in the LIBOR component of FHLB borrowing liabilities at rates of 1.55% and 1.65%, respectively, with a weighted average rate of 1.61%. The borrowings hedged will initially be expected to be issuances and quarterly rollovers of 3-month FHLB advances but may also then include future issuances of 3-month repurchase agreements with similar characteristics and/or future issuances of either floating or fixed rate borrowings that are issued with the specific intent to replace the quarterly rollovers of the advances or repurchase agreements.
The five interest rate swaps entered into during 2013 each have a notional amount of $25 million and have terms ranging from three to six years from their respective effective dates. The interest rate swaps effectively fix the Bank’s interest payments on $125 million of its LIBOR-indexed deposit liabilities at rates between 1.68% and 2.32%, with a weighted average rate of 1.98%.
The Company uses the “Hypothetical Derivative Method” described in ASC 815, Derivatives and Hedging (“ASC 815”), for quarterly prospective and retrospective assessments of hedge effectiveness, as well as for measurements of hedge ineffectiveness. Under this method, the Company assesses the effectiveness of each hedging relationship by comparing the changes in cash flows of the derivative hedging instrument with the changes in cash flows of the designated hedged transactions. The effective portion of changes in the fair value of the derivative is initially reported in other comprehensive income (“OCI”) (outside of earnings) and subsequently reclassified to earnings in interest and dividend income when the hedged transactions affect earnings. Ineffectiveness resulting from the hedge is recorded as a gain or loss in the consolidated statement of operations as part of fees and other income. There was an immaterial amount of hedge ineffectiveness during the three and nine months ended September 30, 2017 and 2016 . The Company monitors the risk of counterparty default on an ongoing basis.
A portion of the balance reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made or received on the Company’s interest rate swaps. During the next twelve months, the Company estimates that $0.4 million will be reclassified as an increase in interest expense.

37

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

Non-designated Hedges
Derivatives not designated as hedges are not speculative and result from two different services the Bank provides to qualified commercial clients. The Bank offers certain derivative products directly to such clients. The Bank economically hedges derivative transactions executed with commercial clients by entering into mirror-image, offsetting derivatives with third parties. Derivative transactions executed as part of these programs are not designated in ASC 815-qualifying hedging relationships and are, therefore, marked-to-market through earnings each period. Because the derivatives have mirror-image contractual terms, the changes in fair value substantially offset through earnings. The net effect on earnings is primarily driven by changes in the credit valuation adjustment (“CVA”). The CVA represents the dollar amount of fair value adjustment related to nonperformance risk of both the Bank and its counterparties. Fees earned in connection with the execution of derivatives related to this program are recognized in the consolidated statement of operations in other income. As of September 30, 2017 and December 31, 2016 , the Bank had 138 and 136 derivatives, respectively, related to this program, comprised of interest rate swaps and caps, with an aggregate notional amount of $1.1 billion for each period. As of September 30, 2017 , there were no foreign currency exchange contracts outstanding related to this program, and as of December 31, 2016 , there was one foreign currency exchange contract with an aggregate notional amount of less than $0.1 million .
In addition, as a participant lender, the Bank has guaranteed performance on the pro-rated portion of swaps executed by other financial institutions. As the participant lender, the Bank is providing a partial guarantee, but is not a direct party to the related swap transactions. The Bank has no obligations under the risk participation agreements unless the borrower defaults on their swap transaction with the lead bank and the swap is in a liability position to the borrower. In that instance, the Bank has agreed to pay the lead bank a portion of the swap’s termination value at the time of the default. The derivative transactions entered into as part of these agreements are not designated, as per ASC 815, as qualifying hedging relationships and are, therefore, marked-to-market through earnings each period. As of September 30, 2017 , there were six of these risk participation transactions with an aggregate notional amount of $48.1 million and, as of December 31, 2016 , there were two of these risk participation transactions with an aggregate notional amount of $13.3 million .
The Bank has also participated out to another financial institution a pro-rated portion of two swaps executed by the Bank. The other financial institution has no obligations under the risk participation agreements unless the borrowers default on their swap transactions with the Bank and the swaps are in liability positions to the borrower. In those instances, the other financial institution has agreed to pay the Bank a portion of the swap’s termination value at the time of the default. The derivative transactions entered into as part of these agreements are not designated, as per ASC 815, as qualifying hedging relationships and are, therefore, marked-to-market through earnings each period. The pro-rated notional amount of these risk participation transactions was $6.1 million as of both September 30, 2017 and December 31, 2016 .
The following table presents the effect of the Bank’s derivative financial instruments not designated as hedging instruments in the consolidated statement of operations for the three and nine months ended September 30, 2017 and 2016 .
 
 
 
 
Amount of gain or (loss), net, recognized in income on derivatives
Derivatives not designated as
hedging instruments
 
Location of gain or (loss) recognized in income on derivatives
 
Three months ended September 30,
 
Nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
 
 
 
 
(In thousands)
Interest rate products
 
Other income/ (expense)
 
$
(49
)
 
$
1,224

 
$
(695
)
 
$
(935
)
Risk participation agreements
 
Other income/ (expense)
 
5

 
(7
)
 
325

 
6

Total
 
 
 
$
(44
)
 
$
1,217

 
$
(370
)
 
$
(929
)


38

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

9.    Income Taxes
The following table presents the components of income tax expense for continuing operations, discontinued operations, noncontrolling interests and the Company:
 
Nine months ended September 30,
 
2017
 
2016
 
(In thousands)
Income from continuing operations:
 
 
 
Income before income taxes
$
82,985

 
$
76,444

Income tax expense
24,805

 
23,716

Net income from continuing operations
$
58,180

 
$
52,728

Effective tax rate, continuing operations
29.9
%
 
31.0
%
 
 
 
 
Income from discontinued operations:
 
 
 
Income before income taxes
$
6,631

 
$
7,432

Income tax expense
2,750

 
3,075

Net income from discontinued operations
$
3,881

 
$
4,357

Effective tax rate, discontinued operations
41.5
%
 
41.4
%
 
 
 
 
Less: Income attributable to noncontrolling interests:
 
 
 
Income before income taxes
$
3,190

 
$
3,010

Income tax expense

 

Net income attributable to noncontrolling interests
$
3,190

 
$
3,010

Effective tax rate, noncontrolling interests
%
 
%
 
 
 
 
Income attributable to the Company
 
 
 
Income before income taxes
$
86,426

 
$
80,866

Income tax expense
27,555

 
26,791

Net income attributable to the Company
$
58,871

 
$
54,075

Effective tax rate attributable to the Company
31.9
%
 
33.1
%
The effective tax rate for continuing operations for the nine months ended September 30, 2017 of 29.9% , with related tax expense of $24.8 million , was calculated based on a projected 2017 annual effective tax rate. The effective tax rate was less than the statutory rate of 35% due primarily to earnings from tax-exempt investments, income tax credits, and income attributable to noncontrolling interests. These items were partially offset by state and local income taxes.
The effective tax rate for continuing operations for the nine months ended September 30, 2016 of 31.0% , with related tax expense of $23.7 million , was calculated based on a projected 2016 annual effective tax rate. The effective tax rate was less than the statutory rate of 35% due primarily to earnings from tax-exempt investments, income tax credits, and income attributable to noncontrolling interests. These items were partially offset by state and local income taxes.
The effective tax rate for continuing operations for the nine months ended September 30, 2017 is lower than the effective tax rate for the same period in 2016 due primarily to a projected increase in earnings from tax-exempt investments and loans in 2017 as compared to 2016.
In the first quarter of 2017, the Company adopted ASU 2016-09. The impact of ASU 2016-09 for the nine months ended September 30, 2017, was a decrease in income tax expense of $0.3 million due to the fair value at the time of vesting of share-based compensation as compared to the grant date fair value, partially offset by stock options expiring unexercised due to being out of the money. There was no significant change to the Company’s effective tax rate related to the adoption of this ASU.


39

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

10.    Noncontrolling Interests
At the Company, noncontrolling interests consist of equity owned by management of the Company’s respective majority-owned affiliates. Net income attributable to noncontrolling interests in the consolidated statements of operations represents the net income allocated to the noncontrolling interest owners of the affiliates. Net income allocated to the noncontrolling interest owners was $1.1 million for each of the three month periods ended September 30, 2017 and 2016 , and $3.2 million and $3.0 million for the nine month periods ended September 30, 2017 and 2016 , respectively.
On the consolidated balance sheets, noncontrolling interests are included as the sum of the capital and undistributed profits allocated to the noncontrolling interest owners. Typically, this balance is included in a company’s permanent shareholders’ equity in the consolidated balance sheets. When the noncontrolling interest owners’ rights include certain redemption features, as described in ASC 480, Distinguishing Liabilities from Equity , such redeemable noncontrolling interests are classified as mezzanine equity and are not included in permanent shareholders’ equity. Due to the redemption features of the noncontrolling interests, the Company had redeemable noncontrolling interests held in mezzanine equity in the accompanying consolidated balance sheets of $15.9 million and $17.0 million at September 30, 2017 and December 31, 2016 , respectively. The aggregate amount of such redeemable noncontrolling equity interests are recorded at the estimated maximum redemption values. In addition, the Company had $4.8 million and $4.2 million in noncontrolling interests included in permanent shareholder’s equity at September 30, 2017 and December 31, 2016 , respectively.
Each non-wholly owned affiliate operating agreement provides the Company and/or the noncontrolling interests with contingent call or put redemption features used for the orderly transfer of noncontrolling equity interests between the affiliate noncontrolling interest owners and the Company at either a contractually predetermined fair value; multiple of earnings before interest, taxes, depreciation, and amortization (EBITDA); or fair value. The Company may liquidate these noncontrolling interests in cash, shares of the Company’s common stock, or other forms of consideration dependent on the operating agreement. These agreements are discussed in Part II. Item 8. “Financial Statements and Supplementary Data – Note 14: Noncontrolling Interests” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 .
Generally, these put and call redemption features refer to shareholder rights of both the Company and the noncontrolling interest owners of the Company’s majority-owned affiliate companies. The affiliate company noncontrolling interests generally take the form of limited liability company (LLC) units, profits interests, or common stock (collectively, the “noncontrolling equity interests”). In most circumstances, the put and call redemption features generally relate to the Company’s right and, in some cases, obligation to purchase and the noncontrolling equity interests’ right to sell their equity interests. There are various events that could cause the puts or calls to be exercised, such as a change in control, death, disability, retirement, resignation or termination. The puts and calls are generally to be exercised at the then fair value or a contractually agreed upon approximation thereof. The terms of these rights vary and are governed by the respective individual operating and legal documents.
The following table presents, by affiliate, the noncontrolling interests included as redeemable noncontrolling interests and noncontrolling interests in mezzanine and permanent equity, respectively, at the periods indicated:
 
September 30, 2017
 
December 31, 2016
 
(In thousands)
Anchor
$
9,644

 
$
10,934

BOS
7,330

 
6,782

DGHM (1)
3,700

 
3,417

Total
$
20,674

 
$
21,133

Redeemable noncontrolling interests
$
15,882

 
$
16,972

Noncontrolling interests
$
4,792

 
$
4,161

_____________________
(1)    Only includes redeemable noncontrolling interests.

40

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

The following tables present a rollforward of the Company’s redeemable noncontrolling interests and noncontrolling interests for the periods indicated:
 
Three months ended
 
Nine months ended
 
September 30, 2017
 
September 30, 2017
 
Redeemable noncontrolling interests
 
Noncontrolling interests
 
Redeemable noncontrolling interests
 
Noncontrolling interests
 
(In thousands)
Noncontrolling interests at beginning of period
$
17,216

 
$
4,375

 
$
16,972

 
$
4,161

Net income attributable to noncontrolling interests
802

 
272

 
2,385

 
805

Distributions
(869
)
 
(264
)
 
(2,414
)
 
(783
)
Purchases/ (sales) of ownership interests
103

 
85

 
235

 
85

Amortization of equity compensation
102

 
250

 
306

 
756

Adjustments to fair value
(1,472
)
 
74

 
(1,602
)
 
(232
)
Noncontrolling interests at end of period
$
15,882

 
$
4,792

 
$
15,882

 
$
4,792

 
Three months ended
 
Nine months ended
 
September 30, 2016
 
September 30, 2016
 
Redeemable noncontrolling interests
 
Noncontrolling interests
 
Redeemable noncontrolling interests
 
Noncontrolling interests
 
(In thousands)
Noncontrolling interests at beginning of period
$
15,843

 
$
3,379

 
$
18,088

 
$
3,393

Net income attributable to noncontrolling interests
821

 
289

 
2,308

 
702

Distributions
(809
)
 
(252
)
 
(2,213
)
 
(692
)
Purchases/ (sales) of ownership interests

 

 
(766
)
 
(18
)
Amortization of equity compensation
115

 
237

 
302

 
501

Adjustments to fair value
229

 
129

 
(1,520
)
 
(104
)
Noncontrolling interests at end of period
$
16,199

 
$
3,782

 
$
16,199

 
$
3,782



41

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

11.    Accumulated Other Comprehensive Income
The following table presents a summary of the amounts reclassified from accumulated other comprehensive income/ (loss) for the three and nine months ended September 30, 2017 and 2016 :
Description of component of accumulated other comprehensive income/ (loss)
 
Three months ended September 30,
 
Nine months ended September 30,
 
Affected line item in
Statement of Operations
 
2017
 
2016
 
2017
 
2016
 
 
 
(In thousands)
 
(In thousands)
 
 
Adjustment for realized gains/ (losses) on available-for-sale securities, net:
 
 
 
 
 
 
 
 
 
 
Pre-tax
 
$
230

 
$
273

 
$
486

 
$
519

 
Gain on sale of investments, net
Tax expense/ (benefit)
 
89

 
101

 
193

 
189

 
Income tax expense
Net
 
$
141

 
$
172

 
$
293

 
$
330

 
Net income attributable to the Company
Net realized gain/ (loss) on cash flow hedges:
 
 
 
 
 
 
 
 
 
 
Hedges related to deposits:
 
 
 
 
 
 
 
 
 
 
Pre-tax
 
$
(293
)
 
$
(405
)
 
$
(953
)
 
$
(1,319
)
 
Interest expense on deposits
Pre-tax
 
(2
)
 
(19
)
 
(3
)
 
26

 
Other income
Tax expense/ (benefit)
 
(123
)
 
(175
)
 
(398
)
 
(532
)
 
Income tax expense
Net
 
$
(172
)
 
$
(249
)
 
$
(558
)
 
$
(761
)
 
Net income attributable to the Company
Total reclassifications for the period, net of tax
 
$
(31
)
 
$
(77
)
 
$
(265
)
 
$
(431
)
 
 

12.    Restructuring
In the fourth quarter of 2014, the Company incurred restructuring charges related to the acquisition of Banyan Partners, LLC. The purpose of this restructuring was to realign the management structure within the Wealth Management and Trust segment. The total cost of the restructuring incurred in Q4 2014 was $0.7 million . In 2015, the Company incurred additional restructuring charges to further refine the management structure within the Wealth Management and Trust segment. The total cost of the restructuring charges in 2015 was $3.7 million .
In the first and second quarters of 2016, the Company incurred additional costs of $1.1 million and $0.9 million , respectively, in continued refinement of the management structure within the Wealth Management and Trust segment. The Company does not anticipate any additional restructuring costs related to this plan as of the date of this filing.
Restructuring expenses incurred since the plan of restructuring was first implemented in 2014 totaled $6.4 million , all within the Wealth Management and Trust segment.

42

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

The following table presents a summary of the restructuring activity for the three and nine months ended September 30, 2017 and 2016 :
 
Severance Charges
 
Total
 
(In thousands)
Accrued charges at December 31, 2016
$
1,977

 
$
1,977

Costs paid
(618
)
 
(618
)
Accrued charges at March 31, 2017
1,359

 
1,359

Costs paid
(335
)
 
(335
)
Accrued charges at June 30, 2017
1,024

 
1,024

Costs paid
(410
)
 
(410
)
Accrued charges at September 30, 2017
$
614

 
$
614

 
 
 
 
 
 
 
 
Accrued charges at December 31, 2015
$
3,305

 
$
3,305

Costs incurred
1,112

 
1,112

Costs paid
(849
)
 
(849
)
Accrued charges at March 31, 2016
3,568

 
3,568

Costs incurred
905

 
905

Costs paid
(1,214
)
 
(1,214
)
Accrued charges at June 30, 2016
3,259

 
3,259

Costs paid
(552
)
 
(552
)
Accrued charges at September 30, 2016
$
2,707

 
$
2,707


13.    Recent Accounting Pronouncements
In May 2014, the FASB issued ASU 2014-09,  Revenue from Contracts with Customers (Topic 606)  (“ASU 2014-09”). ASU 2014-09 replaces existing revenue recognition standards and expands the disclosure requirements for revenue agreements with customers. ASU 2014-09 has been subsequently amended by additional ASUs, including ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net) and ASU 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients, collectively, “ASU 2014-09 et al. . Under the new standard, a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration which the company expects to receive in exchange for those goods or services. ASU 2014-09 et al. does not apply to revenue associated with financial instruments such as loans and securities. Therefore, the Company’s net interest income will not be impacted by this new standard. The Company has assembled a project team to address the changes pursuant to ASU 2014-09 et al . The project team has completed the scope assessment. Approximately 61% of our revenue, including all of our interest income and a portion of our noninterest income, is out of scope of the guidance. The contracts that are in scope of the guidance are primarily related to service charges and fees on deposit accounts, wealth management and trust income, wealth advisory income, investment management income, and other service charges, commissions and fees. We are currently finalizing our review of these contracts and have not identified any material changes in the timing of revenue recognition. We plan to adopt ASU 2014-09 et al . using the modified retrospective transition method with a cumulative effect adjustment to opening retained earnings as of January 1, 2018. Although the Company does not anticipate any material impact of ASU 2014-09 et al. , the Company does expect additional financial statement disclosures and associated internal controls to be implemented along with the adoption of this ASU.
In February 2016, the FASB issued ASU 2016-02,  Leases (Topic 842) . This ASU update amends current lease accounting and requires all leases, other than short-term leases, to be reported on the balance sheet through the recognition of a right-of-use asset and a corresponding liability for future lease obligations. The amended guidance will be effective for fiscal years beginning after December 15, 2018, including interim periods within those annual periods and will require transition utilizing a modified retrospective approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Early adoption of this ASU is permitted although the Company does not plan to early adopt. The Company does not anticipate a material impact to revenue or operating expenses as a result of the adoption of

43

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

this ASU. The Company expects that this ASU will gross up the assets and liabilities on the balance sheet related to the lease assets and liabilities.
In March 2016, the FASB issued ASU 2016-09. This update is intended to simplify several aspects of the accounting for employee share-based plans such as income tax consequences, classification of awards as either liabilities or equity on the balance sheet, and classification on the statement of cash flows. The Company adopted this ASU on January 1, 2017. The adoption of this ASU has resulted in, and will continue to result in, fluctuations in the Company’s earnings due to changes in the Company’s stock price between issuance date and settlement date of employee share-based transactions. In addition, the Company anticipates that certain stock options will expire unexercised, due to being out of the money, and this ASU requires the previous tax benefits to be reversed. For the nine months ended September 30, 2017, the impact on the Company’s income tax expense related to the adoption of this ASU was a decrease of $0.3 million.
In June 2016, the FASB issued ASU 2016-13,  Financial Instruments (Topic 326)  (“ASU 2016-13”). This update is intended to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. This ASU will be effective for fiscal years beginning after December 15, 2019. Early adoption is available as of the fiscal year beginning after December 15, 2018. The Company does not plan on adopting early. The impact of this ASU on the Company’s consolidated financial statements will depend on factors at the time of adoption such as the balance and type of loans on the balance sheet, the Company’s loan loss history, and various qualitative factors.
In August 2016, the FASB issued ASU 2016-15,  Statement of Cash Flows (Topic 230) (“ASU 2016-15”). This update is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. This ASU is effective for fiscal years beginning after December 15, 2017, and interim periods within those years. Early adoption is permitted, provided that all of the amendments are adopted in the same period, however the Company does not plan to early adopt. The guidance requires application using a retrospective transition method. The Company does not expect that this ASU will have a significant impact on its consolidated financial statements.
In January 2017, the FASB issued ASU 2017-04. This update is the result of the first phase of a two phase project by the FASB to reduce the cost and complexity of the goodwill impairment test. The objective of Phase 1 of the project, which resulted in ASU 2017-04, is to simplify how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Step 2 measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. Instead, under the amendments in ASU 2017-04, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. Under the provisions of this update, an entity still has the option to perform the qualitative assessment, or Step 0 test, for a reporting unit to determine if the quantitative impairment test is necessary. This ASU will be effective for any annual or interim goodwill impairment tests in fiscal years beginning after December 15, 2019, with early adoption permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The Company elected to early adopt this ASU as of January 1, 2017. The adoption of this ASU could increase or decrease the amount of a goodwill impairment charge should any of the Company’s reporting units with goodwill fail a Step 1 test in the future, as compared to the amount of a goodwill impairment charge under the existing standards depending on the fair value of the reporting unit’s assets.
In March 2017, the FASB issued ASU 2017-08,  Receivables—Nonrefundable Fees and Other Costs (Subtopic 310-20), Premium Amortization on Purchased Callable Debt Securities (“ASU 2017-08”). This update amends the amortization period for certain purchased callable debt securities held at a premium. The amortization period for the premium on such securities is being shortened to the earliest call date. Under current GAAP, entities generally amortize the premium as an adjustment of yield over the contractual life of the instrument. ASU 2017-08 is effective for fiscal years beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted, including in an interim period. The guidance requires application using a modified retrospective transition method through a cumulative-effect adjustment to beginning retained earnings. The Company early adopted this ASU as of July 1, 2017, which had a minimal impact on the consolidated financial statements.


44

BOSTON PRIVATE FINANCIAL HOLDINGS, INC. AND SUBSIDIARIES
Notes to Unaudited Consolidated Financial Statements - (Continued)

In August 2017, the FASB issued ASU No. 2017-12, Targeted Improvements to Accounting for Hedging Activities (“ASU 2017-12”). The standard is intended to improve the transparency and understandability of information conveyed to financial statement users about an entity’s risk management activities by better aligning the entity’s financial reporting for hedging relationships with those risk management activities and to reduce the complexity of and simplify the application of hedge accounting by preparers. ASU No. 2017-12 is effective for interim and annual reporting periods beginning after December 15, 2018; early adoption is permitted. The Company plans to early adopt this ASU as of January 1, 2018. The Company currently has seven interest rate swaps that are designated for hedge accounting and the adoption is not expected to have a significant impact on the consolidated financial statements. This ASU will provide more flexibility in the Company’s risk management activities and we believe it will enhance the Company’s ability to employ risk management strategies, while improving the transparency and understanding of those strategies for financial statement users.


45


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
As of and for the three and nine months ended September 30, 2017
Certain statements contained in this Quarterly Report on Form 10-Q that are not historical facts may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties. These statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of the words “may,” “will,” “should,” “could,” “would,” “plan,” “potential,” “estimate,” “project,” “believe,” “intend,” “anticipate,” “expect,” “target” and similar expressions. These statements include, among others, statements regarding our strategy, effectiveness of our investment programs, evaluations of future interest rate trends and liquidity, expectations as to growth in assets, deposits and results of operations, receipt of regulatory approval for pending acquisitions, success of acquisitions, future operations, market position, financial position, and prospects, plans and objectives of management. You should not place undue reliance on our forward-looking statements. You should exercise caution in interpreting and relying on forward-looking statements because they are subject to significant risks, uncertainties and other factors which are, in some cases, beyond the Company’s control.
Forward-looking statements are based on the current assumptions and beliefs of management and are only expectations of future results. The Company’s actual results could differ materially from those projected in the forward-looking statements as a result of, among others, factors referenced herein under the section captioned “Risk Factors”; adverse conditions in the capital and debt markets and the impact of such conditions on the Company’s private banking, wealth management and trust, investment management, and wealth advisory activities; changes in interest rates; competitive pressures from other financial institutions; the effects of weakness in general economic conditions on a national basis or in the local markets in which the Company operates; changes in the value of securities and other assets; changes in loan default and charge-off rates; the adequacy of loan loss reserves; reductions in deposit levels necessitating increased borrowing to fund loans and investments; operational risks including, but not limited to, cybersecurity, fraud, and natural disasters; changes in government regulation; the risk that goodwill and intangibles recorded in the Company’s financial statements will become impaired; the risk that the Company’s deferred tax assets may not be realized; risks related to the identification and implementation of acquisitions, dispositions and restructurings; and changes in assumptions used in making such forward-looking statements, as well as the other risks and uncertainties detailed in the Company’s Annual Report on Form 10-K and updated in the Company’s Quarterly Reports on Form 10-Q and other filings submitted to the Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made. The Company does not undertake any obligation to update any forward-looking statement to reflect circumstances or events that occur after the date the forward-looking statements are made.


46


Executive Summary
Boston Private Financial Holdings, Inc. offers a wide range of wealth management and private banking services to high net worth individuals, families, businesses and select institutions through its four reportable segments: Private Banking, Wealth Management and Trust, Investment Management, and Wealth Advisory. This Executive Summary provides an overview of the most significant aspects of our operating segments and the Company’s operations in the third quarter of 2017 . Details of the matters addressed in this summary are provided elsewhere in this document and, in particular, in the sections immediately following.
 
As of and for the three months ended September 30,
 
 
 
 
 
2017
 
2016
 
$ Change
 
% Change
 
(In thousands, except per share data)
 
 
Total revenues
$
96,894

 
$
89,883

 
$
7,011

 
8
 %
Provision/ (credit) for loan losses
(432
)
 
(138
)
 
(294
)
 
nm

Total operating expense
69,346

 
61,670

 
7,676

 
12
 %
Net income from continuing operations
19,691

 
19,699

 
(8
)
 
 %
Net income attributable to noncontrolling interests
1,074

 
1,110

 
(36
)
 
(3
)%
Net income attributable to the Company
19,803

 
19,636

 
167

 
1
 %
Diluted earnings per share:
 
 
 
 
 
 
 
From continuing operations
$
0.21

 
$
0.21

 
$

 
 %
From discontinued operations
$
0.01

 
$
0.01

 
$

 
 %
Total attributable to common shareholders
$
0.22

 
$
0.22

 
$

 
 %
 
 
 
 
 
 
 
 
ASSETS UNDER MANAGEMENT AND ADVISORY:
 
 
 
 
 
 
 
Wealth Management and Trust
$
7,703,000

 
$
7,334,000

 
$
369,000

 
5
 %
Wealth Advisory
10,992,000

 
10,028,000

 
964,000

 
10
 %
Investment Managers
11,083,000

 
10,176,000

 
907,000

 
9
 %
Less: Inter-company Relationship
(11,000
)
 
(11,000
)
 

 
 %
Total Assets Under Management and Advisory
$
29,767,000

 
$
27,527,000

 
$
2,240,000

 
8
 %
_____________________
nm -    not meaningful
Net income attributable to the Company was $19.8 million for the three months ended September 30, 2017 and $19.6 million for the same period in 2016 . The Company recognized diluted earnings per share of $0.22 for each of the three month periods ended September 30, 2017 and 2016 .
Key items that affected the Company’s results in the third quarter of 2017 compared to the same period of 2016 include:
Net interest income increased 14% , to $56.6 million for the three months ended September 30, 2017 , compared to $49.9 million for the same period of 2016 . The increase for the three months is due to higher volume and yields on loans, partially offset by higher volumes and average rates paid on interest-bearing deposits and higher volume and average rates paid on the Company’s borrowings. The net interest margin (“NIM”) was 3.02% for the three months ended September 30, 2017 , an increase of fourteen basis points compared to the same period in 2016 .
Total fees and other income increased 1% to $40.3 million for the three months ended September 30, 2017 , compared to $40.0 million for the same period of 2016 . This increase was driven by a 7% increase in wealth management and trust fees, a 5% increase in investment management fees, and a 4% increase in wealth advisory fees, partially offset by decreases in swap fee income and market value adjustments on derivatives. Total fees and other income represents 42% of total revenue for the three months ended September 30, 2017 , compared to 45% of total revenue for the same period of 2016 .

47


Total operating expenses increased 12% to $69.3 million for the three months ended September 30, 2017 , compared to $61.7 million for the same period of 2016 . Increases in salaries and employee benefits, occupancy and equipment, professional fees, and marketing and business development expenses were partially offset by decreases in amortization of intangibles and contract services and data processing expenses.
The Company’s Private Banking segment reported net income attributable to the Company of $16.3 million in the third quarter of 2017 , compared to net income attributable to the Company of $17.4 million for the same period of 2016 . The $1.1 million , or 6% , decrease was a result of the increase in operating expenses, particularly salaries and employee benefits and occupancy and equipment expenses, and a decrease in banking fee income related to swap fees, partially offset by the increase in net interest income and the increase in the credit to the provision for loan losses.
The Company’s Wealth Management and Trust segment reported net income attributable to the Company of $0.1 million in the third quarter of 2017 , compared to a net loss attributable to the Company of $0.8 million for the same period of 2016 . During 2015 and 2016, employee turnover and the related loss of clients led to a negative impact on revenues and AUM. AUM dropped to $7.1 billion at the end of Q1 2016, from a high of $9.3 billion in AUM at the beginning of 2015. During 2016 and 2017, the segment took several actions to refine the cost structure of the business and stabilize the AUM base. The 2017 net income is attributed to continued refinement of the business’ cost structure combined with an increase in revenue levels year-over-year. Wealth management and trust fee income increased $0.8 million, or 7%, compared to the same period in 2016, while operating expenses decreased $0.6 million, or 5%, as compared to the same period in 2016. Fee-based revenue in the Wealth Management and Trust segment is determined based on beginning-of-quarter, end-of-month, or, for a small number of clients, end-of-quarter AUM data, depending on the custodian. Wealth Management and Trust AUM increased $0.4 billion , or 5% , to $7.7 billion at September 30, 2017 from $7.3 billion at September 30, 2016 . The increase in AUM is due to positive market action of $0.3 billion and net inflows of $0.1 billion for the twelve months ending September 30, 2017 .
The Company’s Investment Management segment reported net income attributable to the Company of $1.4 million in the third quarter of 2017 , compared to net income attributable to the Company of $1.3 million for the same period of 2016 . The 9% increase was due primarily to a 5% increase in investment management fee income, partially offset by a 5% increase in operating expenses, primarily in legal fees and salaries and employee benefits. Most fee-based revenue in the investment management segment is determined based on beginning-of-period AUM data. Investment Management AUM increased $0.9 billion , or 9% , to $11.1 billion at September 30, 2017 from $10.2 billion at September 30, 2016 , primarily due to positive market action of $1.3 billion, partially offset by net outflows of $0.4 billion for the twelve months ending September 30, 2017 .
The Company’s Wealth Advisory segment reported net income attributable to the Company of $2.0 million in the third quarter of 2017 , compared to net income attributable to the Company of $1.8 million for the same period of 2016 . The 9% increase was due to a 4% increase in wealth advisory fee income, partially offset by a 2% increase in operating expenses. The operating expense increase was primarily due to increased salaries and employee benefits expense, and occupancy and equipment expense, partially offset by decreased intangible amortization expense. Wealth Advisory AUM increased $1.0 billion , or 10% , to $11.0 billion at September 30, 2017 from $10.0 billion at September 30, 2016 , primarily due to positive market action of $0.9 billion and net inflows of $0.1 billion for the twelve months ending September 30, 2017 .

Critical Accounting Policies
Critical accounting policies reflect significant judgments and uncertainties, and could potentially result in materially different results under different assumptions and conditions. The Company believes that its most critical accounting policies upon which its financial condition depends, and which involve the most complex or subjective decisions or assessments are the allowance for loan and lease losses, the valuation of goodwill and intangible assets and analysis for impairment, and tax estimates. These policies are discussed in Part II. Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 . There have been no changes to these policies through the filing of this Quarterly Report on Form 10-Q.

Results of operations for the three and nine months ended September 30, 2017 versus September 30, 2016
Net Income. The Company recorded net income from continuing operations for the three and nine months ended September 30, 2017 of $19.7 million and $58.2 million , respectively, compared to $19.7 million and $52.7 million for the same respective periods in 2016 . Net income attributable to the Company, which includes income from both continuing and discontinued operations, for the three and nine months ended September 30, 2017 was $19.8 million and $58.9 million , respectively, compared to $19.6 million and $54.1 million for the same respective periods in 2016 .

48


The Company recognized diluted EPS attributable to common shareholders, which includes both continuing and discontinued operations, for the three and nine months ended September 30, 2017 of $0.22 per share and $0.66 per share, respectively, compared to $0.22 per share and $0.62 per share, respectively, for the same periods in 2016 .
Net income from continuing operations in both 2017 and 2016 was partially offset by charges that reduce income available to common shareholders. See Part I. Item 1. “Notes to Unaudited Consolidated Financial Statements - Note 2: Earnings Per Share” for further detail on these charges to income available to common shareholders.
The following discussions are based on the Company’s continuing operations, unless otherwise stated.
The following table presents selected financial highlights:
 
Three months ended September 30,
 
% Change
 
Nine months ended September 30,
 
% Change
 
2017
 
2016
 
 
2017
 
2016
 
 
(In thousands)
Net interest income
$
56,627

 
$
49,871

 
14
 %
 
$
167,414

 
$
148,919

 
12
 %
Fees and other income
40,267

 
40,012

 
1
 %
 
114,791

 
114,829

 
 %
Total revenue
96,894

 
89,883

 
8
 %
 
282,205

 
263,748

 
7
 %
Provision/ (credit) for loan losses
(432
)
 
(138
)
 
nm

 
(6,727
)
 
(5,806
)
 
16
 %
Operating expense
69,346

 
61,670

 
12
 %
 
205,947

 
193,110

 
7
 %
Income tax expense
8,289

 
8,652

 
(4
)%
 
24,805

 
23,716

 
5
 %
Net income from continuing operations
19,691

 
19,699

 
 %
 
58,180

 
52,728

 
10
 %
Net income from discontinued operations
1,186

 
1,047

 
13
 %
 
3,881

 
4,357

 
(11
)%
Less: Net income attributable to noncontrolling interests
1,074

 
1,110

 
(3
)%
 
3,190

 
3,010

 
6
 %
Net income attributable to the Company
$
19,803

 
$
19,636

 
1
 %
 
$
58,871

 
$
54,075

 
9
 %
Net interest income . Net interest income represents the difference between interest earned, primarily on loans and investments, and interest paid on funding sources, primarily deposits and borrowings. Interest rate spread is the difference between the average rate earned on total interest-earning assets and the average rate paid on total interest-bearing liabilities. Net Interest Margin (“NIM”) is calculated by taking annualized net interest income for the period, on a fully taxable-equivalent (“FTE”) basis, as a percentage of average interest-earning assets. The average rate earned on earning assets is the amount of annualized taxable equivalent interest income expressed as a percentage of average earning assets. The average rate paid on interest-bearing liabilities is equal to annualized interest expense as a percentage of average interest-bearing liabilities. When credit quality declines and loans are placed on nonaccrual status, NIM can decrease because the same assets are earning less income. Loans graded as substandard but still accruing interest income totaled $53.7 million at September 30, 2017 and could be placed on nonaccrual status if their credit quality declines further.
Net interest income for the three months ended September 30, 2017 was $56.6 million , an increase of $6.8 million , or 14% , compared to the same period in 2016 . For the nine months ended September 30, 2017 , net interest income was $167.4 million , an increase of $18.5 million , or 12% , compared to the same period in 2016 . The increase for the three months is due to higher volume and yields on loans and higher yields on cash and investments, partially offset by higher volume and average rates paid on the Company’s borrowings and interest-bearing deposits, and higher rates paid on the Company’s junior subordinated debentures. The increase for the nine months is due to higher volume and yields on loans and cash and investments, partially offset by higher volume and average rates paid on and interest-bearing deposits and the Company’s FHLB and other borrowings, and higher average rates paid on the Company’s junior subordinated debentures. The NIM was 3.02% for the three months ended September 30, 2017 , an increase of fourteen basis points compared to the same period in 2016 . For the nine months ended September 30, 2017 , the NIM was 3.01% , an increase of nine basis points compared to the same period in 2016 .
The following tables present the composition of the Company’s NIM on a FTE basis for the three and nine months ended September 30, 2017 and 2016 ; however, the discussion following these tables reflects non-FTE data.

49


 
Average Balance
 
Interest Income/Expense
 
Average Yield/Rate
 
As of and for the three months ended September 30,
AVERAGE BALANCE SHEET:
2017
 
2016
 
2017
 
2016
 
2017
 
2016
AVERAGE ASSETS
(In thousands)
 
 
 
 
Interest-Earning Assets:
 
 
 
 
 
 
 
 
 
 
 
Cash and Investments: (1)
 
 
 
 
 
 
 
 
 
 
 
Taxable investment securities
$
353,374

 
$
372,852

 
$
1,569

 
$
1,537

 
1.77
%
 
1.65
%
Non-taxable investment securities (2)
295,727

 
271,864

 
2,559

 
2,221

 
3.46
%
 
3.27
%
Mortgage-backed securities
631,052

 
629,748

 
3,267

 
3,079

 
2.07
%
 
1.96
%
Federal funds sold and other
146,285

 
152,892

 
916

 
469

 
2.47
%
 
1.20
%
Total Cash and Investments
1,426,438

 
1,427,356

 
8,311

 
7,306

 
2.33
%
 
2.05
%
Loans (3):
 
 
 
 
 
 
 
 
 
 
 
Commercial and Industrial (2)
994,388

 
1,065,787

 
10,001

 
10,626

 
3.94
%
 
3.90
%
Commercial Real Estate (2)
2,381,583

 
1,976,327

 
25,579

 
19,860

 
4.20
%
 
3.93
%
Construction and Land
113,562

 
117,183

 
1,415

 
1,263

 
4.88
%
 
4.22
%
Residential
2,567,044

 
2,300,392

 
20,423

 
17,812

 
3.18
%
 
3.10
%
Home Equity
106,744

 
122,505

 
1,128

 
1,105

 
4.19
%
 
3.59
%
Other Consumer
187,184

 
182,315

 
1,554

 
1,154

 
3.29
%
 
2.52
%
Total Loans
6,350,505

 
5,764,509

 
60,100

 
51,820

 
3.73
%
 
3.55
%
Total Earning Assets
7,776,943

 
7,191,865

 
68,411

 
59,126

 
3.48
%
 
3.25
%
Less: Allowance for Loan Losses
75,166

 
76,424

 
 
 
 
 
 
 
 
Cash and due From Banks (Non-interest Bearing)
42,031

 
39,301

 
 
 
 
 
 
 
 
Other Assets
455,820

 
445,517

 
 
 
 
 
 
 
 
TOTAL AVERAGE ASSETS
$
8,199,628

 
$
7,600,259

 
 
 
 
 
 
 
 
AVERAGE LIABILITIES, RNCI, AND SHAREHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
 
 
Interest-Bearing Liabilities:
 
 
 
 
 
 
 
 
 
 
 
Interest-Bearing Deposits (4):
 
 
 
 
 
 
 
 
 
 
 
NOW
$
630,282

 
$
551,085

 
$
189

 
$
120

 
0.12
%
 
0.09
%
Savings
71,900

 
76,999

 
16

 
25

 
0.09
%
 
0.13
%
Money Market
3,065,059

 
2,922,687

 
3,436

 
2,877

 
0.44
%
 
0.39
%
Certificates of Deposit
671,992

 
560,546

 
1,715

 
1,141

 
1.01
%
 
0.81
%
Total Interest Bearing Deposits
4,439,233

 
4,111,317

 
5,356

 
4,163

 
0.48
%
 
0.40
%
Junior Subordinated Debentures
106,363

 
106,363

 
761

 
591

 
2.80
%
 
2.17
%
FHLB Borrowings and Other Borrowings
736,035

 
624,528

 
2,768

 
1,978

 
1.47
%
 
1.24
%
Total Interest Bearing Liabilities
5,281,631

 
4,842,208

 
8,885

 
6,732

 
0.66
%
 
0.55
%
Non-interest Bearing Demand Deposits (4)
1,966,479

 
1,824,548

 
 
 
 
 
 
 
 
Payables and Other Liabilities
121,288

 
135,901

 
 
 
 
 
 
 
 
Total Average Liabilities
7,369,398

 
6,802,657

 
 
 
 
 
 
 
 
Redeemable Noncontrolling Interests
21,634

 
19,504

 
 
 
 
 
 
 
 
Average Shareholders’ Equity
808,596

 
778,098

 
 
 
 
 
 
 
 
TOTAL AVERAGE LIABILITIES, RNCI, AND SHAREHOLDERS’ EQUITY
$
8,199,628

 
$
7,600,259

 
 
 
 
 
 
 
 
Net Interest Income - on a FTE Basis
 
 
 
 
$
59,526

 
$
52,394

 
 
 
 
FTE Adjustment (2)
 
 
 
 
2,899

 
2,523

 
 
 
 
Net Interest Income (GAAP Basis)
 
 
 
 
$
56,627

 
$
49,871

 
 
 
 
Interest Rate Spread
 
 
 
 
 
 
 
 
2.82
%
 
2.70
%
Net Interest Margin
 
 
 
 
 
 
 
 
3.02
%
 
2.88
%



50



 
Average Balance
 
Interest Income/Expense
 
Average Yield/Rate
 
As of and for the nine months ended September 30,
AVERAGE BALANCE SHEET:
2017
 
2016
 
2017
 
2016
 
2017
 
2016
AVERAGE ASSETS
(In thousands)
 
 
 
 
Interest-Earning Assets:
 
 
 
 
 
 
 
 
 
 
 
Cash and Investments: (1)
 
 
 
 
 
 
 
 
 
 
 
Taxable investment securities
$
369,929

 
$
373,273

 
$
4,831

 
$
4,638

 
1.74
%
 
1.66
%
Non-taxable investment securities (2)
295,195

 
265,280

 
7,576

 
6,512

 
3.42
%
 
3.27
%
Mortgage-backed securities
652,159

 
594,461

 
10,266

 
9,126

 
2.10
%
 
2.05
%
Federal funds sold and other
169,114

 
160,114

 
2,347

 
1,381

 
1.55
%
 
1.14
%
Total Cash and Investments
1,486,397

 
1,393,128

 
25,020

 
21,657

 
2.21
%
 
2.07
%
Loans (3):
 
 
 
 
 
 
 
 
 
 
 
Commercial and Industrial (2)
988,449

 
1,072,051

 
29,077

 
32,358

 
3.88
%
 
3.97
%
Commercial Real Estate (2)
2,354,996

 
1,915,839

 
75,556

 
59,216

 
4.23
%
 
4.06
%
Construction and Land
115,629

 
147,548

 
4,036

 
4,367

 
4.60
%
 
3.89
%
Residential
2,494,151

 
2,262,262

 
58,988

 
52,555

 
3.15
%
 
3.10
%
Home Equity
111,423

 
121,849

 
3,302

 
3,260

 
3.96
%
 
3.57
%
Other Consumer
191,550

 
172,578

 
4,500

 
3,193

 
3.14
%
 
2.47
%
Total Loans
6,256,198

 
5,692,127

 
175,459

 
154,949

 
3.71
%
 
3.60
%
Total Earning Assets
7,742,595

 
7,085,255

 
200,479

 
176,606

 
3.43
%
 
3.30
%
Less: Allowance for Loan Losses
77,957

 
78,008

 
 
 
 
 
 
 
 
Cash and due From Banks (Non-interest Bearing)
42,006

 
39,869

 
 
 
 
 
 
 
 
Other Assets
436,373

 
432,005

 
 
 
 
 
 
 
 
TOTAL AVERAGE ASSETS
$
8,143,017

 
$
7,479,121

 
 
 
 
 
 
 
 
AVERAGE LIABILITIES, RNCI, AND SHAREHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
 
 
Interest-Bearing Liabilities:
 
 
 
 
 
 
 
 
 
 
 
Interest-Bearing Deposits (4):
 
 
 
 
 
 
 
 
 
 
 
NOW
$
616,054

 
$
549,429

 
$
472

 
$
311

 
0.10
%
 
0.08
%
Savings
72,831

 
75,958

 
49

 
71

 
0.09
%
 
0.13
%
Money Market
3,149,545

 
2,958,051

 
9,801

 
8,615

 
0.42
%
 
0.39
%
Certificates of Deposit
642,820

 
566,022

 
4,514

 
3,423

 
0.94
%
 
0.81
%
Total Interest-Bearing Deposits
4,481,250

 
4,149,460

 
14,836

 
12,420

 
0.44
%
 
0.40
%
Junior Subordinated Debentures
106,363

 
106,363

 
2,148

 
1,753

 
2.66
%
 
2.17
%
FHLB Borrowings and Other Borrowings
722,087

 
623,030

 
7,439

 
6,138

 
1.36
%
 
1.29
%
Total Interest-Bearing Liabilities
5,309,700

 
4,878,853

 
24,423

 
20,311

 
0.61
%
 
0.55
%
Non-interest Bearing Demand Deposits (4)
1,903,709

 
1,691,872

 
 
 
 
 
 
 
 
Payables and Other Liabilities
115,622

 
121,601

 
 
 
 
 
 
 
 
Total Average Liabilities
7,329,031

 
6,692,326

 
 
 
 
 
 
 
 
Redeemable Noncontrolling Interests
21,341

 
20,225

 
 
 
 
 
 
 
 
Average Shareholders’ Equity
792,645

 
766,570

 
 
 
 
 
 
 
 
TOTAL AVERAGE LIABILITIES, RNCI, AND SHAREHOLDERS’ EQUITY
$
8,143,017

 
$
7,479,121

 
 
 
 
 
 
 
 
Net Interest Income - on a FTE Basis
 
 
 
 
$
176,056

 
$
156,295

 
 
 
 
FTE Adjustment (2)
 
 
 
 
8,642

 
7,376

 
 
 
 
Net Interest Income (GAAP Basis)
 
 
 
 
$
167,414

 
$
148,919

 
 
 
 
Interest Rate Spread
 
 
 
 
 
 
 
 
2.82
%
 
2.75
%
Net Interest Margin
 
 
 
 
 
 
 
 
3.01
%
 
2.92
%

51


____________________

(1)
Investments classified as available-for-sale and held-to-maturity are shown in the average balance sheet at amortized cost.
(2)
Interest income on non-taxable investments and loans is presented on a FTE basis using statutory rates. The discussion following these tables reflects non-FTE data.
(3)
Includes loans held for sale and nonaccrual loans.
(4)
Includes deposits held for sale, if any.
Interest and dividend income . Total interest and dividend income for the three months ended September 30, 2017 was $65.5 million , an increase of $8.9 million , or 16% , compared to the same period in 2016 . Interest and dividend income for the nine months ended September 30, 2017 was $191.8 million , an increase of $22.6 million , or 13% , compared to the same period in 2016 . The increase for the three and nine months was primarily due to higher volume and yields on loans and higher yields on cash and investments as well as, for the nine month period, higher volume of cash and investments.
The Bank generally has interest income that is either recovered or reversed related to nonaccrual loans each quarter. Based on the net amount recovered or reversed, the impact on interest income and related yields can be either positive or negative. In addition, the Bank collects prepayment penalties on certain commercial loans that pay off prior to maturity which could also impact interest income and related yields positively. The amount and timing of prepayment penalties varies from quarter to quarter.
Interest income on commercial and industrial loans, on a non-FTE basis, for the three months ended September 30, 2017 was $8.7 million , a decrease of $0.1 million , or 1% , compared to the same period in 2016 , as a result of a 7% decrease in the average balance, partially offset by an 18 basis point increase in the average yield. For the nine months ended September 30, 2017 , commercial and industrial interest income was $25.3 million , a decrease of $2.0 million , or 7% , compared to the same period in 2016 , as a result of an 8% decrease in the average balance, partially offset by a three basis point increase in the average yield. The decreases in the average balances for the three and nine month periods are related to the reclassification in the fourth quarter of 2016 of tax-exempt multifamily loans into commercial real estate loans. The decreases in average balances for the three and nine month periods are also due to a number of factors including seasonal fluctuations of the commercial loan portfolio at the Bank. The increase in the average yield for the three and nine month periods is the result of market conditions and the fluctuations in the indicies to which the variable rate loans are tied.
Interest income on commercial real estate loans, on a non-FTE basis, for the three months ended September 30, 2017 was $24.8 million , an increase of $5.0 million , or 25% , compared to the same period in 2016 , as a result of a 21% increase in the average balance and a 15 basis point increase in the average yield. For the nine months ended September 30, 2017 , commercial real estate interest income was $73.4 million , an increase of $14.2 million , or 24% , compared to the same period in 2016 , as a result of a 23% increase in the average balance and a five basis point increase in the average yield. The increases in the average balances for the three and nine month periods are related to the reclassification in the fourth quarter of 2016 of certain tax-exempt multifamily loans into commercial real estate loans. The increases in average balances for the three and nine month periods are also related to the organic growth of the commercial real estate loan portfolio at the Bank. The changes in the average yields for the three and nine month periods are the result of market conditions as well as fluctuations in the indicies to which the variable rate loans are tied.
Interest income on construction and land loans for the three months ended September 30, 2017 was $1.4 million , an increase of $0.2 million , or 12% , compared to the same period in 2016 , as a result of a 66 basis point increase in the average yield, partially offset by a 3% decrease in the average balance. For the nine months ended September 30, 2017 , construction and land interest income was $4.0 million , a decrease of $0.3 million , or 8% , compared to the same period in 2016 , as a result of a 22% decrease in the average balance, partially offset by a 71 basis point increase in the average yield. The decreases in the average balances for the three and nine month periods are related to customer demand. The increases in the average yields for the three and nine month periods are the result of market conditions as well as fluctuations in the indicies to which the variable rate loans are tied.
Interest income on residential mortgage loans for the three months ended September 30, 2017 was $20.4 million , an increase of $2.6 million , or 15% , compared to the same period in 2016 , as a result of a 12% increase in the average balance and an eight basis point increase in the average yield. For the nine months ended September 30, 2017 , residential mortgage interest income was $59.0 million , an increase of $6.4 million , or 12% , compared to the same period in 2016 , as a result of a 10% increase in the average balance and a five basis point increase in the average yield. The increase in the average balances for the three and nine month periods is related to the organic growth of the residential loan portfolio at the Bank. The increases in the average yields for the three and nine month periods are the result of market conditions and adjustable rate mortgage (“ARM”) loans repricing to higher rates.

52


Interest income on home equity loans for the three months ended September 30, 2017 was $1.1 million , an increase of 2% compared to the same period in 2016 , as a result of a 60 basis point increase in the average yield, partially offset by a 13% decrease in the average balance. For the nine months ended September 30, 2017 , home equity interest income was $3.3 million , a slight increase of 1% compared to the same period in 2016 , as a result of a 39 basis point increase in the average yield offset by a 9% decrease in the average balance. The decrease in the average balance for the three and nine month periods is related to the timing of customer demand. The increase in the average yield for the three and nine month periods is the result of increases in the Prime rate.
Interest income on other consumer loans for the three months ended September 30, 2017 was $1.6 million , an increase of $0.4 million , or 35% , compared to the same period in 2016 , as a result of a 77 basis point increase in the average yield and a 3% increase in the average balance. For the nine months ended September 30, 2017 , other consumer interest income was $4.5 million , an increase of $1.3 million , or 41% , compared to the same period in 2016 , as a result of an 11% increase in the average balance and a 67 basis point increase in the average yield. The increase in the average yield for the three and nine month periods is primarily the result of increases in the Prime rate. The increase in the average balance for the three and nine month periods is primarily due to client demand.
Investment income, on a non-FTE basis, for the three months ended September 30, 2017 was $7.4 million , an increase of $0.9 million , or 14% , compared to the same period in 2016 , as a result of a 24 basis point increase in the average yield with a flat average balance. For the nine months ended September 30, 2017 , investment income was $22.4 million , an increase of $3.0 million , or 15% , compared to the same period in 2016 , as a result of a 7% increase in the average balance and a 12 basis point increase in the average yield. The increases in the average yields for the three and nine month periods are partially due to the increases in short-term interest rates. The increase in the average balance for the nine month period is primarily due to timing and volume of deposit balances as compared to the level of loans outstanding. Investment decisions are made based on anticipated liquidity, loan demand, and asset-liability management considerations.
Interest expense . Total interest expense for the three months ended September 30, 2017 was $8.9 million , an increase of $2.2 million , or 32% , compared to the same period in 2016 . For the nine months ended September 30, 2017 , total interest expense was $24.4 million , an increase of $4.1 million , or 20% , compared to the same period in 2016 .
Interest expense on interest-bearing deposits for the three months ended September 30, 2017 was $5.4 million , an increase of $1.2 million , or 29% , compared to the same period in 2016 , as a result of an eight basis point increase in the average rate paid, and an 8% increase in the average balance. For the nine months ended September 30, 2017 , interest expense on deposits was $14.8 million , an increase of $2.4 million , or 19% , compared to the same period in 2016 , as a result of an 8% increase in the average balance and a four basis point increase in the average rate paid.
Interest paid on non-deposit interest-bearing liabilities for the three months ended September 30, 2017 was $3.5 million , an increase of $1.0 million , or 37% , compared to the same period in 2016 , as a result of a 63 basis point increase in the average rate paid on FHLB borrowings and other borrowings, a 23 basis point increase in the average rate paid on junior subordinated debentures, and an 18% increase in the average balance of FHLB borrowings and other borrowings. For the nine months ended September 30, 2017 , interest paid on borrowings was $9.6 million , an increase of $1.7 million , or 21% , compared to the same period in 2016 , as a result of a 16% increase in the average balance of FHLB borrowings and other borrowings, a seven basis point increase in the average rate paid on FHLB borrowings and other borrowings, and a 49 basis point increase in the average rate paid on junior subordinated debentures. The increases for the three and nine month periods in the average rate paid on borrowings is due to the increases in benchmark interest rates, the mix and terms of borrowings, and the impact of derivatives.
Provision/ (credit) for loan losses. The Company recorded a credit to the provision for loan losses of $0.4 million for the three months ended September 30, 2017 , compared to a credit to the provision for loan losses of $0.1 million for the same period in 2016 . For the nine months ended September 30, 2017 , the Company recorded a credit to the provision for loan losses of $6.7 million , compared to a credit of $5.8 million for the same period in 2016 . The credits to the provision for loan losses for the three and nine months ended September 30, 2017 were the result of net recoveries and improved loss factors, partially offset by an increase in criticized loans and loan growth.
The provision/ (credit) for loan losses is determined as a result of the required level of the allowance for loan losses, estimated by management, which reflects the inherent risk of loss in the loan portfolio as of the balance sheet dates. The Company incorporates both quantitative and qualitative loss factors to determine the appropriate level of the allowance for loan losses. Quantitative loss factors are based on historical net charge-offs by loan portfolio. Qualitative factors are estimated by management and include trends in problem loans, economic and business conditions, strength of management, real estate collateral values, and underwriting standards. For further details, see “Loan Portfolio and Credit Quality” below.

53


Fees and other income. Total fees and other income for the three months ended September 30, 2017 was $40.3 million , an increase of $0.3 million , or 1% , compared to the same period in 2016 . For the nine months ended September 30, 2017 , total fees and other income was $114.8 million , flat as compared to the same period in 2016 . Factors affecting the increase in the three month period include higher fee income in the Wealth Management and Trust, Investment Management, and Wealth Advisory segments due to increases in AUM, partially offset by decreases in banking fee income related to swap fees and in other income related to fair market value adjustments on derivative agreements. Factors affecting the balances in the nine month periods include decreases in banking fee income related to swap fees, partially offset by increases in fee income in the Investment Management, Wealth Advisory, and Wealth Management and Trust segments due to increases in AUM.
Investment management fee income for the three months ended September 30, 2017 was $11.3 million , an increase of $0.6 million , or 5% , compared to the same period in 2016 . For the nine months ended September 30, 2017 , investment management fee income was $33.2 million , an increase of $1.2 million , or 4% , compared to the same period in 2016 . AUM as of September 30, 2017 managed or advised by the Investment Managers was $11.1 billion , an increase of $0.9 billion , or 9% , compared to 2016 . The increase is primarily due to positive market action of $1.3 billion, partially offset by net outflows of $0.4 billion for the twelve months ending September 30, 2017 .
Wealth advisory fee income for the three months ended September 30, 2017 was $13.3 million , an increase of $0.5 million , or 4% , compared to the same period in 2016 . For the nine months ended September 30, 2017 , wealth advisory fee income was $39.1 million , an increase of $1.1 million , or 3% , compared to the same period in 2016 . AUM managed or advised by the Wealth Advisors was $11.0 billion at September 30, 2017 , an increase of $1.0 billion , or 10% , compared to September 30, 2016 . The increase is due to positive market action of $0.9 billion and net inflows of $0.1 billion for the twelve months ending September 30, 2017 .
Wealth management and trust fee income for the three months ended September 30, 2017 was $11.6 million , an increase of $0.8 million , or 7% , compared to the same period in 2016 . For the nine months ended September 30, 2017 , wealth management and trust fee income was $33.6 million , an increase of $0.7 million , or 2% , compared to the same period in 2016 . AUM as of September 30, 2017 managed or advised by Boston Private Wealth was $7.7 billion , an increase of $0.4 billion , or 5% , compared to September 30, 2016 . The increase is due to positive market action of $0.3 billion and net inflows of $0.1 billion for the twelve months ending September 30, 2017 .
Other banking fee income for the three months ended September 30, 2017 was $2.7 million , a decrease of $0.7 million , or 21% , compared to the same period in 2016 . For the nine months ended September 30, 2017 , other banking fee income was $6.4 million , a decrease of $3.3 million , or 34% , compared to the same period in 2016 . The decrease for both the three and nine month periods is related to decreases in swap fee income due to elevated 2016 client demand for loan swap agreements. These decreases were partially offset in both the three and nine month periods by the increase in Bank Owned Life Insurance (“BOLI”) income, which is related to the additional $50.0 million investment in BOLI in the first quarter of 2017.
Other income for the three months ended September 30, 2017 was $1.0 million , a decrease of $0.7 million , or 43% , compared to the same period in 2016 . For the nine months ended September 30, 2017 , other income was $1.7 million , an increase of $1.0 million compared to the same period in 2016 . The decrease for the three month period and the increase for the nine month period were related to fluctuations in gains and losses on fair market value adjustments on derivative agreements in 2016 that did not recur in 2017.
Operating Expense. Total operating expense for the three months ended September 30, 2017 was $69.3 million , an increase of $7.7 million , or 12% , compared to the same period in 2016 . For the nine months ended September 30, 2017 , total operating expense was $205.9 million , an increase of $12.8 million , or 7% , compared to the same period in 2016 . The changes for the three month period ended September 30, 2017 are primarily due to increases in salaries and employee benefits, occupancy and equipment, professional services, marketing and business development, and other expenses, partially offset by decreases in contract services and data processing and FDIC insurance expenses. The changes for the nine month period ended September 30, 2017 are primarily due to increases in salaries and employee benefits, occupancy and equipment, professional services, other expenses, and marketing and business development, partially offset by decreases in contract services and data processing, FDIC insurance, and amortization of intangibles expenses. Additionally, the Company incurred no restructuring charges in the three or nine months ended September 30, 2017 and the three months ended September 30, 2016, and incurred restructuring charges of $2.0 million for the nine month period ended September 30, 2016.
Salaries and employee benefits expense, the largest component of operating expense, for the three months ended September 30, 2017 was $45.2 million , an increase of $4.2 million , or 10% , compared to the same period in 2016 . For the nine months ended September 30, 2017 , salaries and employee benefits was $134.5 million , an increase of $10.4 million , or 8% , compared to the same period in 2016 . The increase for the three and nine month periods is primarily due to higher variable and performance based compensation, commissions and sales incentives, and stock compensation. Although the Company incurred

54


severance expenses in the nine months ended September 30, 2016, the majority of the costs were categorized as restructuring expense, whereas there was severance expense categorized as salaries and employee benefits expense in the nine months ended September 30, 2017.
Occupancy and equipment expense for the three months ended September 30, 2017 was $11.3 million , an increase of $1.8 million , or 19% , compared to the same period in 2016 . For the nine months ended September 30, 2017 , occupancy and equipment expense was $32.7 million , an increase of $3.7 million , or 13% , compared to the same period in 2016 . The increase for the three and nine month periods is primarily due to an increase in telecommunications and technology expense and an increase in rent expense due to new office locations.
Professional services expense for the three months ended September 30, 2017 was $3.3 million , an increase of $1.0 million , or 44% , compared to the same period in 2016 . For the nine months ended September 30, 2017 , professional services expense was $9.7 million , an increase of $0.9 million , or 10% , compared to the same period in 2016 . The increase for the three and nine month periods is primarily due to increases in recruitment and consulting expense, partially offset by decreases in legal expense related to loan workouts.
In 2017, the Bank began working on an initiative to upgrade its information technology. This initiative required the Bank to hire additional employees with expertise in information technology. Recruiters were generally used in the placement of these professionals. The Bank has utilized consultants and temporary employees to assist with the project in addition to the new hires. Generally the expenditures in the preliminary project stage were expensed as incurred. Other expenditures related to the application development stage have been capitalized. The capitalized expenditures will be depreciated over the useful life of the asset when the asset is placed in service. The Bank anticipates that the capitalized assets will be placed in service beginning in late 2017 through early 2019.
Marketing and business development expense for the three months ended September 30, 2017 was $2.2 million , an increase of $0.6 million , or 37% , compared to the same period in 2016 . For the nine months ended September 30, 2017 , marketing and business development expense was $5.8 million , an increase of $0.2 million , or 4% , compared to the same period in 2016 . The three month increase is primarily related to an increase in marketing expense in the Private Banking and Wealth Advisory segments. The nine month increase is primarily related to the timing of marketing programs in the Private Banking segment.
Contract services and data processing expense for the three months ended September 30, 2017 was $1.6 million , a decrease of $0.3 million , or 14% , compared to the same period in 2016 . For the nine months ended September 30, 2017 , contract services and data processing expense was $4.8 million , a decrease of $0.5 million , or 9% , compared to the same period in 2016 . The decreases for the three and nine month periods are primarily due to a decrease in custody and recordkeeping expenses.
Income Tax Expense. Income tax expense for continuing operations for the nine months ended September 30, 2017 was $24.8 million . The effective tax rate for continuing operations for the nine months ended September 30, 2017 was 29.9% , compared to an effective tax rate of 31.0% for the same period in 2016 . See Part I. Item 1. “Notes to Unaudited Consolidated Financial Statements - Note 9: Income Taxes” for further detail.


55



Financial Condition

Condensed Consolidated Balance Sheets and Discussion
 
September 30,
2017
 
December 31, 2016
 
Increase/
(decrease)
 
%
Change
 
(In thousands)
Assets:
 
 
 
 
 
 
 
Total cash and investments
$
1,446,071

 
$
1,507,845

 
$
(61,774
)
 
(4
)%
Loans held for sale
1,957

 
3,464

 
(1,507
)
 
(44
)%
Total loans
6,413,201

 
6,114,354

 
298,847

 
5
 %
Less: Allowance for loan losses
74,873

 
78,077

 
(3,204
)
 
(4
)%
Net loans
6,338,328

 
6,036,277

 
302,051

 
5
 %
Goodwill and intangible assets, net
165,001

 
169,279

 
(4,278
)
 
(3
)%
Total other assets
318,041

 
253,609

 
64,432

 
25
 %
Total assets
$
8,269,398

 
$
7,970,474

 
$
298,924

 
4
 %
Liabilities and Equity:
 
 
 
 
 
 
 
Deposits
$
6,262,347

 
$
6,085,146

 
$
177,201

 
3
 %
Total borrowings
1,049,039

 
980,192

 
68,847

 
7
 %
Total other liabilities
127,069

 
119,683

 
7,386

 
6
 %
Total liabilities
7,438,455

 
7,185,021

 
253,434

 
4
 %
Redeemable Noncontrolling Interests (“RNCI”)
15,882

 
16,972

 
(1,090
)
 
(6
)%
Total shareholders’ equity
815,061

 
768,481

 
46,580

 
6
 %
Total liabilities, RNCI and shareholders’ equity
$
8,269,398

 
$
7,970,474

 
$
298,924

 
4
 %
_____________________
nm     not meaningful
Total Assets. Total assets increased $0.3 billion to $8.3 billion at September 30, 2017 from $8.0 billion at December 31, 2016 . This increase was primarily due to the increase in loans.
Cash and Investments. Total cash and investments (consisting of cash and cash equivalents, investment securities, and stock in the FHLB and Federal Reserve Bank) decreased $61.8 million , or 4% , to $1.4 billion , or 17% of total assets at September 30, 2017 from $1.5 billion , or 19% of total assets at December 31, 2016 . The decrease was due to the $74.3 million , or 6% , decrease in available-for-sale securities, and the $9.0 million , or 10% decrease in held-to-maturity securities, partially offset by the $17.6 million , or 40% , increase in stock in the FHLB and Federal Reserve Bank and the $3.9 million , or 4% , increase in cash and cash equivalents. The changes in cash and investments were the net result of short-term fluctuations in liquidity due to changes in levels of deposits, borrowings and loans outstanding. Additionally, on July 28, 2017, Boston Private Bank & Trust Company became a member of the Federal Reserve System, which required the purchase of stock in the Federal Reserve Bank of Boston.
The majority of the investments held by the Company are held by the Bank. The Bank’s investment policy requires management to maintain a portfolio of securities which will provide liquidity necessary to facilitate funding of loans, to cover deposit fluctuations, and to mitigate the Bank’s overall balance sheet exposure to interest rate risk, while at the same time earning a satisfactory return on the funds invested. The securities in which the Bank may invest are subject to regulation and are generally limited to securities that are considered “investment grade.”
Investment maturities, calls, principal payments, and sales of securities, net of purchases, provided $242.8 million of cash proceeds during the nine months ended September 30, 2017 . The timing of sales and reinvestments is based on various factors, including management’s evaluation of interest rate trends, the credit risk of municipal securities and the Company’s liquidity. The Company’s available-for-sale investment portfolio carried a total of $6.9 million of unrealized gains and $13.7 million of unrealized losses at September 30, 2017 , compared to $4.6 million of unrealized gains and $23.7 million of unrealized losses at December 31, 2016 .

56



No impairment losses were recognized through earnings related to investment securities during the nine months ended September 30, 2017 and 2016 . The total amount of unrealized losses was primarily due to changes in interest rates since the securities were purchased.
Additionally, at September 30, 2017 and December 31, 2016 , the Company held $84.1 million and $93.1 million , respectively, of held-to-maturity securities at amortized cost. All of the held-to-maturity securities were mortgage-backed securities guaranteed by U.S. government agencies or government-sponsored entities, or U.S. Treasury securities.
See Part I. Item 1. “Notes to Unaudited Consolidated Financial Statements - Note 4: Investments” for further details of the Company’s investment securities.
Loans held for sale. Loans held for sale decreased $1.5 million , or 44% , to $2.0 million at September 30, 2017 from $3.5 million at December 31, 2016 . The balance of loans held for sale usually relates to the timing and volume of residential loans originated for sale and the ultimate sale transaction which is typically executed within a short time following the loan origination. From time to time, the Company may also sell loans that have been held in the loan portfolio. The sale of such loans may improve the Bank’s liquidity and capital position or may provide the Bank additional flexibility for more profitable and strategic future lending opportunities.
Goodwill and intangible assets, net. Goodwill and intangible assets decreased $4.3 million , or 3% , to $165.0 million at September 30, 2017 from $169.3 million at December 31, 2016 . The decrease was due to amortization of intangible assets.
Goodwill and indefinite-lived intangible assets such as trade names are subject to annual impairment tests, or more frequently, if there is indication of impairment, based on guidance in ASC 350, Intangibles-Goodwill and Other . Long-lived intangible assets such as advisory contracts are tested for recoverability whenever events or changes in circumstances indicate that the carrying amount of the asset or asset group may not be recoverable in accordance with ASC 360, Property, Plant, and Equipment (“ASC 360”).
Management performed its annual goodwill and indefinite-lived intangible asset impairment testing during the fourth quarter of 2016 for applicable reporting units. The 2016 goodwill impairment testing indicated that Boston Private Wealth failed Step 1 and the resulting Step 2 test indicated goodwill impairment of $9.5 million. The estimated fair value for all other applicable reporting units exceeded the carrying value in 2016, and as a result no other impairment was evident. There was no additional testing required for long-lived intangible assets in 2016.
The estimated fair value of Boston Private Wealth as a result of the fourth quarter 2016 impairment testing was $68.0 million as compared to a carrying value of $76.9 million, resulting in a deficit of $8.9 million, or 11.6%. Even though the Company recorded a goodwill impairment charge for Boston Private Wealth in 2016, there could be additional goodwill impairment in the future should Boston Private Wealth’s actual results not meet projections. In addition to financial results, other inputs to the valuation, such as the discount rate and market assumptions, could negatively affect the estimated fair value of Boston Private Wealth in the future. The Company has concluded that no interim goodwill impairment triggering event has occurred and no interim goodwill impairment testing was necessary at September 30, 2017. The Company will again be performing its annual goodwill impairment testing in the fourth quarter.
The estimated fair value of Anchor as a result of the fourth quarter 2016 impairment testing was $87.0 million as compared to a carrying value of $81.6 million, an excess of $5.4 million, or 6.6%. Due to the narrow margin between the fair value and the carrying value of Anchor, Anchor will continue to be at risk for potential goodwill impairment. The Company has concluded that no interim goodwill impairment triggering event occurred and no interim goodwill impairment testing was necessary at September 30, 2017. The Company will again be performing its annual goodwill impairment testing in the fourth quarter.
Total other assets. Total other assets, as presented in the table above, consists of the following line items from the consolidated balance sheet: other real estate owned (“OREO”) (if any), premises and equipment, fees receivable, accrued interest receivable, deferred income taxes, net, and other assets. Total other assets increased $64.4 million , or 25% , to $318.0 million at September 30, 2017 as compared to $253.6 million at December 31, 2016 . The increase was the result of increases in other assets partially offset by a decrease in deferred income taxes, net, OREO, and fees receivable.
OREO decreased $1.7 million to zero at September 30, 2017 from $1.7 million at December 31, 2016 . In 2017, the one property held in OREO at December 31, 2016 was sold for a small loss.
Deferred income taxes, net, decreased $9.4 million , or 17% , to $46.1 million at September 30, 2017 from $55.5 million at December 31, 2016 . The decrease was primarily due to the current year tax effect of other comprehensive income. At September 30, 2017 , no valuation allowance on the net deferred tax asset was required due primarily to the expectation of

57



future taxable income as well as the availability of current and historical taxable income. Our use of these deferred tax benefits may depend on a number of factors including future changes in laws or regulations relating to tax credits, tax deductions, and net operating losses. A decrease in tax rates would require us to revalue the net deferred tax assets lower with a corresponding income tax expense.
Other assets, which consist primarily of BOLI, prepaid expenses, investment in partnerships, the fair value of interest rate derivatives, and other receivables, increased $70.3 million , or 54% , to $201.0 million at September 30, 2017 from $130.8 million at December 31, 2016 . The increase was primarily due to an additional $50.0 million investment in BOLI policies, an increase in income taxes receivable and the purchase of additional cost method investments.
Deposits. Deposits increased $177.2 million , or 3% , to $6.3 billion , at September 30, 2017 from $6.1 billion at December 31, 2016 . Deposits are the principal source of the Bank’s funds for use in lending, investments, and liquidity. Certificates of deposits represented approximately 11% and 10% of total deposits at September 30, 2017 and December 31, 2016 , respectively. Deposit levels can fluctuate from quarter to quarter as a result of large short-term transactions by commercial clients. Seasonality can also affect the deposit balances.
The following table presents the composition of the Company’s deposits at September 30, 2017 and December 31, 2016 :
 
September 30, 2017
 
December 31, 2016
 
Balance
 
as a % of total
 
Balance
 
as a % of total
 
(In thousands)
Demand deposits (noninterest-bearing)
$
1,850,833

 
30
%
 
$
1,753,648

 
29
%
NOW (1)
636,013

 
10
%
 
578,657

 
9
%
Savings
74,333

 
1
%
 
74,162

 
1
%
Money market (1)
3,009,779

 
48
%
 
3,102,048

 
51
%
Certificates of deposit under $100,000 (1)
265,402

 
4
%
 
236,001

 
4
%
Certificates of deposit of $100,000 or greater
425,987

 
7
%
 
340,630

 
6
%
Total deposits
$
6,262,347

 
100
%
 
$
6,085,146

 
100
%
_____________________
(1)
Includes brokered deposits of $562.5 million $738.3 million at September 30, 2017 and December 31, 2016 , respectively.
Borrowings. Total borrowings (consisting of securities sold under agreements to repurchase, federal funds purchased (if any), FHLB borrowings, and junior subordinated debentures) increased $68.8 million , or 7% , to $1.0 billion at September 30, 2017 from $1.0 billion at December 31, 2016 .
FHLB borrowings increased $78.6 million , or 11% , to $812.8 million at September 30, 2017 from $734.2 million at December 31, 2016 . The increase was primarily due to loan growth in excess of deposit growth in 2017. FHLB borrowings are generally used to provide additional funding for loan growth when it is in excess of deposit growth and to manage interest rate risk, but can also be used as an additional source of liquidity for the Bank.
From time to time, the Company purchases federal funds from the FHLB and other banking institutions to supplement its liquidity position. At September 30, 2017 , the Company had $70.0 million federal funds purchased outstanding. The Company had $80.0 million in federal funds purchased outstanding at December 31, 2016 .
Repurchase agreements increased $0.3 million to $59.9 million at September 30, 2017 from $59.6 million at December 31, 2016 . Repurchase agreements are generally linked to commercial demand deposit accounts with an overnight sweep feature.
Total other liabilities. Total other liabilities, which consist primarily of accrued interest, accrued bonus, the fair value of interest rate derivatives, and other accrued expenses, increased $7.4 million , or 6% , to $127.1 million at September 30, 2017 from $119.7 million at December 31, 2016 . The increase was primarily due to additional landlord allowances and deferred rent, partially offset by the payment in the first quarter of 2017 of accrued variable compensation, bonuses and employee benefits that had been accrued for at December 31, 2016.


58



Loan Portfolio and Credit Quality
Loans. Total portfolio loans increased $298.8 million , or 5% , to $6.4 billion , or 78% of total assets, at September 30, 2017 , from $6.1 billion , or 77% of total assets, at December 31, 2016 . Increases were recorded in residential loans of $220.9 million, or 9%; commercial real estate loans of $60.9 million, or 3%; commercial tax exempt loans of $32.7 million, or 8%; construction and land loans of $13.4 million, or 13%; and commercial and industrial loans of $6.9 million, or 1%, partially offset by decreases in consumer and other loans of $24.4 million, or 12%; and home equity loans of $11.6 million, or 10%.
The Bank specializes in lending to individuals, real estate investors, and middle market businesses, including corporations, partnerships, associations and nonprofit organizations. Loans made by the Bank to individuals may include residential mortgage loans and mortgage loans on investment or vacation properties, unsecured and secured personal lines of credit, home equity loans, and overdraft protection. Loans made by the Bank to businesses include commercial and mortgage loans, revolving lines of credit, working capital loans, equipment financing, community lending programs, and construction and land loans. The types and sizes of loans the Bank originates are limited by regulatory requirements.
The Bank’s loans are affected by the economic and real estate markets in which they are located. Generally, commercial real estate, construction, and land loans are affected more than residential loans in an economic downturn.
In August of 2017, parts of Texas experienced widespread damage and flooding from Hurricane Harvey. In September of 2017, parts of Florida and the Caribbean experienced widespread damage and flooding from Hurricane Irma. Additionally, in September and October of 2017, parts of northern California experienced damage resulting from several widespread wildfires. Surveys of the Bank’s borrowers and collateral located within these areas indicated that most customers experienced only minor damage to the Bank’s underlying collateral which, to date, has been covered by property insurance. However, the Bank continues to assess the extent of the damage and the insurance coverage in place. In addition, the ongoing businesses of customers in these impacted areas could be interrupted which could adversely impact their ability to repay their loans. The Bank is continuing to communicate with borrowers in the affected areas and is evaluating any financial impact.
The Bank’s commercial real estate loan portfolio, the largest portfolio segment after residential, includes loans secured by the following types of collateral at September 30, 2017 : $706.4 million secured by multifamily and residential investment property; $618.8 million secured by retail property; $543.1 million secured by office and medical property; $186.4 million secured by manufacturing, industrial, and warehouse property; $145.3 million secured by hospitality property; and $163.2 million secured by other property. The Bank’s commercial real estate loan portfolio as of December 31, 2016 included loans secured by the following types of collateral: $674.2 million secured by multifamily and residential investment property; $660.7 million secured by retail property; $466.8 million secured by office and medical property; $195.9 million secured by manufacturing, industrial, and warehouse property; $116.0 million secured by hospitality property; and $188.6 million secured by other property.

59



Geographic concentration. The following table presents the Company’s outstanding loan balance concentrations at the dates indicated based on the location of the regional offices to which they are attributed.
 
As of September 30, 2017
 
New England
 
San Francisco Bay Area
 
Southern California
 
Total
 
Amount
 
Percent
 
Amount
 
Percent
 
Amount
 
Percent
 
Amount
 
Percent
 
(In thousands)
Commercial and industrial
$
503,322

 
8
%
 
$
50,686

 
1
%
 
$
64,248

 
1
%
 
$
618,256

 
9
%
Commercial tax exempt
320,172

 
5
%
 
99,540

 
2
%
 
11,638

 
%
 
431,350

 
7
%
Commercial real estate
988,788

 
15
%
 
698,148

 
11
%
 
676,223

 
11
%
 
2,363,159

 
37
%
Construction and land
61,635

 
1
%
 
20,893

 
%
 
35,763

 
1
%
 
118,291

 
2
%
Residential
1,558,587

 
24
%
 
510,956

 
8
%
 
531,245

 
8
%
 
2,600,788

 
40
%
Home equity
72,149

 
1
%
 
26,052

 
1
%
 
9,026

 
%
 
107,227

 
2
%
Consumer and other
150,309

 
2
%
 
15,302

 
%
 
8,519

 
%
 
174,130

 
3
%
Total loans (1)
$
3,654,962

 
56
%
 
$
1,421,577

 
23
%
 
$
1,336,662

 
21
%
 
$
6,413,201

 
100
%
 
As of December 31, 2016
 
New England
 
San Francisco Bay Area
 
Southern California
 
Total
 
Amount
 
Percent
 
Amount
 
Percent
 
Amount
 
Percent
 
Amount
 
Percent
 
(In thousands)
Commercial and industrial
$
493,451

 
8
%
 
$
50,578

 
1
%
 
$
67,341

 
1
%
 
$
611,370

 
10
%
Commercial tax exempt
317,691

 
5
%
 
69,064

 
1
%
 
11,849

 
%
 
398,604

 
6
%
Commercial real estate
1,012,284

 
17
%
 
637,042

 
10
%
 
652,918

 
11
%
 
2,302,244

 
38
%
Construction and land
47,434

 
1
%
 
29,629

 
1
%
 
27,776

 
%
 
104,839

 
2
%
Residential
1,456,592

 
24
%
 
473,102

 
8
%
 
450,167

 
7
%
 
2,379,861

 
39
%
Home equity
87,280

 
2
%
 
25,129

 
%
 
6,408

 
%
 
118,817

 
2
%
Consumer and other
186,680

 
3
%
 
7,517

 
%
 
4,422

 
%
 
198,619

 
3
%
Total loans (1)
$
3,601,412

 
59
%
 
$
1,292,061

 
21
%
 
$
1,220,881

 
20
%
 
$
6,114,354

 
100
%
________________________
(1)
Regional percentage totals may not reconcile due to rounding.
Allowance for loan losses . The allowance for loan losses is reported as a reduction of outstanding loan balances and totaled $74.9 million and $78.1 million as of September 30, 2017 and December 31, 2016 , respectively.
The allowance for loan losses as of September 30, 2017 decreased $3.2 million from December 31, 2016 due to a decline in the loss factors, partially offset by the mix in the loan portfolio, change in the volume and type of criticized loans and loan growth in certain portfolio segments. The allowance for loan losses as a percentage of total loans decreased 11 basis points to 1.17% as of September 30, 2017 from 1.28% as of December 31, 2016 . The decrease in the ratio of allowance for loan losses to total loans is due to a decline in the loss factors, a combination of the mix in the loan portfolio, and the change in the volume and type of criticized loans. See Part I. Item 1. “Notes to Unaudited Consolidated Financial Statements - Note 7: Allowance for Loan Losses” for an analysis of the Company’s allowance for loan losses.
An analysis of the risk in the loan portfolio as well as management judgment is used to determine the estimated appropriate amount of the allowance for loan losses. The Company’s allowance for loan losses is comprised of three primary components (general reserves, allocated reserves on non-impaired special mention and substandard loans, and allocated reserves on impaired loans). See Part II. Item 8. “Notes to Unaudited Consolidated Financial Statements - Note 6: Allowance for Loan Losses” and the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 for further information.

60



The following table presents a summary of loans charged-off, net of recoveries, by geography for the periods indicated. The geography assigned to the data is based on the location of the regional offices to which the loans are attributed.
 
Three months ended September 30,
 
Nine months ended September 30,
 
2017
 
2016
 
2017
 
2016
 
(In thousands)
Net loans (charged-off)/ recovered:
 
 
 
 
 
 
 
New England
$
73

 
$
1,704

 
$
819

 
$
834

San Francisco Bay Area
206

 
318

 
3,097

 
4,309

Southern California
17

 
32

 
(393
)
 
(168
)
Total net loans (charged-off)/ recovered
$
296

 
$
2,054

 
$
3,523

 
$
4,975

Net recoveries of $0.3 million were recorded in the third quarter of 2017 , compared to $2.1 million of net recoveries for the same period of 2016 . The $3.5 million in net recoveries recorded in the first nine months of 2017 related primarily to commercial real estate loans.
Despite the current year net recoveries on previously charged-off commercial loans (which include construction and land loans, commercial real estate, and commercial and industrial loans), the Company believes that commercial loans represent the greatest risk of loss due to the size and nature of these loans and the related collateral. Local economic and business conditions in the markets where our offices are located have a significant impact on our commercial loan customers and their ability to service their loans.
Nonperforming assets. The Company’s nonperforming assets include nonaccrual loans and OREO, if any. OREO, if any, consists of real estate acquired through foreclosure proceedings and real estate acquired through acceptance of deeds in lieu of foreclosure. As of September 30, 2017 , nonperforming assets totaled $13.6 million, or 0.16% of total assets, a decrease of $5.4 million, or 28%, compared to $19.0 million , or 0.24% of total assets, as of December 31, 2016 .
The Bank’s policy is to discontinue the accrual of interest on a loan when the collectability of principal or interest in accordance with the contractual terms of the loan agreement is in doubt. Despite a loan having a current payment status, if the Bank has reason to believe it may not collect all principal and interest on the loan in accordance with the related contractual terms, the Bank will generally discontinue the accrual of interest income and will apply any future interest payments received to principal. Of the $13.6 million of loans on nonaccrual status as of September 30, 2017 , $6.3 million, or 46%, had a current payment status, $0.5 million, or 4%, were 30-89 days past due, and $6.8 million, or 50% , were 90 days or more past due. Of the $17.3 million of loans on nonaccrual status as of December 31, 2016, $5.1 million, or 29%, had a current payment status, $2.2 million, or 13%, were 30-89 days past due, and $10.0 million, or 58%, were 90 days or more past due.
The Bank continues to evaluate the underlying collateral of each nonperforming loan and pursue the collection of interest and principal. Where appropriate, the Bank obtains updated appraisals on collateral. Reductions in fair values of the collateral for nonaccrual loans, if they are collateral dependent, could result in additional future provision for loan losses depending on the timing and severity of the decline. See Part I. Item 1. “Financial Statements and Supplementary Data - Note 6: Loans Receivable” for further information on nonperforming loans.
The Bank’s policy for returning a loan to accrual status requires the loan to be brought current and for the client to show a history of making timely payments (generally six consecutive months). For nonaccruing troubled debt restructured loans (“TDRs”), a return to accrual status generally requires timely payments for a period of six months in accordance with restructured terms, along with meeting other criteria.
Delinquencies. The past due status of a loan is determined in accordance with its contractual repayment terms. All loan types are reported past due when one scheduled payment is due and unpaid for 30 days or more. Loans 30-89 days past due decreased $9.8 million, or 65%, to $5.3 million as of September 30, 2017 from $15.1 million as of December 31, 2016 . Loan delinquencies can be attributed to many factors, such as continuing weakness in, or deteriorating, economic conditions in the region the collateral is located, the loss of a tenant or lower lease rates for commercial borrowers, renewal and administrative issues, or the loss of income for consumers and the resulting liquidity impacts on the borrowers. Further deterioration in the credit condition of these delinquent loans could lead to the loans going to nonaccrual status and/or being downgraded. Downgrades would generally result in additional provision for loan losses. Past due loans may be included with accruing substandard loans.

61



In certain instances, although very infrequently, loans that have become 90 days or more past due may remain on accrual status if the value of the collateral securing the loan is sufficient to cover principal and interest and the loan is in the process of collection. There were no loans 90 days or more past due, but still accruing, respectively, as of September 30, 2017 and December 31, 2016 .
Impaired Loans. When management determines that it is probable that the Bank will not collect all principal and interest on a loan in accordance with the original loan terms, the loan is considered impaired. Certain impaired loans may continue to accrue interest based on factors such as the restructuring terms, if any, the historical payment performance, the value of collateral, and the financial condition of the borrower. Impaired commercial loans and impaired construction loans are typically, in accordance with ASC 310, individually evaluated for impairment. Large groups of smaller-balance homogeneous loans may be collectively evaluated for impairment. Such groups of loans may include, but are not limited to, residential loans, home equity loans, and consumer loans. However, if the terms of any of such loans are modified in a troubled debt restructuring, then such loans would be individually evaluated for impairment in the allowance for loan and lease losses.
Loans that are individually evaluated for impairment require an analysis to determine the amount of impairment, if any. For collateral dependent loans, impairment would be indicated as a result of the carrying value of the loan exceeding the estimated collateral value, less costs to sell, or, for loans not considered to be collateral dependent, the net present value of the projected cash flow, discounted at the loan’s contractual effective interest rate. Generally, when a collateral dependent loan becomes impaired, an updated appraisal of the collateral, if appropriate, is obtained. If the impaired loan has not been upgraded to a performing status within a reasonable amount of time, the Bank will continue to obtain updated appraisals, as deemed necessary, especially during periods of declining property values. Normally, shortfalls in the analysis of collateral dependent loans would result in the impairment amount being charged-off to the allowance for loan losses. Shortfalls on cash flow dependent loans may be carried as specific allocations to the general reserve unless a known loss is determined to have occurred, in which case such known loss is charged-off. Based on the impairment analysis, the provision could be higher or lower than the amount of provision associated with a loan prior to its classification as impaired. See Part II. Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 for detail on the Company’s treatment of impaired loans in the allowance for loan losses.
Impaired loans individually evaluated for impairment in the allowance for loan losses totaled $21.6 million as of September 30, 2017 , a decrease of $4.4 million, or 17%, compared to $26.0 million as of December 31, 2016 . As of September 30, 2017 , $8.7 million of the individually evaluated impaired loans had $0.8 million in specific reserve allocations. The remaining $12.9 million of individually evaluated impaired loans did not have specific reserve allocations due to the adequacy of collateral, prior charge-offs taken, interest collected and applied to principal, or a combination of these items. As of December 31, 2016 , $11.4 million of individually evaluated impaired loans had $1.1 million in specific reserve allocations, and the remaining $14.6 million of individually evaluated impaired loans did not have specific reserve allocations.
The Bank may, under certain circumstances, restructure loans as a concession to borrowers who are experiencing financial difficulty. Such loans are classified as TDRs and are included in impaired loans. TDRs typically result from the Bank’s loss mitigation activities which, among other things, could include rate reductions, payment extensions, and/or principal forgiveness. As of September 30, 2017 and December 31, 2016 , TDRs totaled $14.7 million and $18.1 million , respectively. As of September 30, 2017 , $11.5 million of the $14.7 million in TDRs were on accrual status. As of December 31, 2016 , $12.4 million of the $18.1 million in TDRs were on accrual status.
Potential Problem Loans. Loans that evidence weakness or potential weakness related to repayment history, the borrower’s financial condition, or other factors are reviewed by the Bank’s management to determine if the loan should be adversely classified. Delinquent loans may or may not be adversely classified depending upon management’s judgment with respect to each individual loan. The Bank classifies certain loans as “substandard,” “doubtful,” or “loss” based on criteria consistent with guidelines provided by banking regulators. Potential problem loans consist of accruing substandard loans where known information about possible credit problems of the related borrowers causes management to have doubts as to the ability of such borrowers to comply with the present loan repayment terms and which may result in classification of such loans as nonperforming at some time in the future. Management cannot predict the extent to which economic conditions may worsen or other factors which may impact borrowers and the potential problem loans. Triggering events for loan downgrades include updated appraisal information, inability of borrowers to cover debt service payments, loss of tenants or notification by the tenant of non-renewal of lease, inability of borrowers to sell completed construction projects, and the inability of borrowers to sell properties. Accordingly, there can be no assurance that other loans will not become 90 days or more past due, be placed on nonaccrual, be restructured, or require increased allowance coverage and provision for loan losses.

62



As of September 30, 2017 , the Bank has identified $53.7 million in potential problem loans, a decrease of $10.0 million, or 16%, compared to $63.7 million as of December 31, 2016 . This decrease was primarily due to one CRE loan for $9.2 million which was paid off in April 2017. Numerous factors impact the level of potential problem loans including economic conditions and real estate values. These factors affect the borrower’s liquidity and, in some cases, the borrower’s ability to comply with loan covenants such as debt service coverage. When there is a loss of a major tenant in a commercial real estate building, the appraised value of the building generally declines. Loans may be downgraded when this occurs as a result of the additional risk to the borrower in obtaining a new tenant in a timely manner and negotiating a lease with similar or better terms than the previous tenant. In many cases, these loans are still current and paying as agreed, although future performance may be impacted.
The following table presents a rollforward of nonaccrual loans for the three and nine months ended September 30, 2017 and 2016 :
 
As of and for the three months ended September 30,
 
As of and for the nine months ended September 30,
2017
 
2016
 
2017
 
2016
(In thousands)
Nonaccrual loans, beginning of period
$
16,176

 
$
19,188

 
$
17,315

 
$
26,571

Transfers in to nonaccrual status
578

 
2,430

 
8,294

 
7,566

Transfers out to OREO

 

 

 
(1,944
)
Transfers out to accrual status
(1,146
)
 
(581
)
 
(2,686
)
 
(1,855
)
Charge-offs
(38
)
 
(337
)
 
(496
)
 
(3,102
)
Paid off/ paid down
(1,947
)
 
(4,209
)
 
(8,804
)
 
(10,745
)
Nonaccrual loans, end of period
$
13,623

 
$
16,491

 
$
13,623

 
$
16,491


The following table presents a summary of credit quality by geography, based on the location of the regional offices:
 
September 30,
2017
 
December 31, 2016
 
(In thousands)
Nonaccrual loans:
 
 
 
New England
$
7,380

 
$
10,081

San Francisco Bay Area
1,494

 
2,989

Southern California
4,749

 
4,245

Total nonaccrual loans
$
13,623

 
$
17,315

Loans 30-89 days past due and accruing:
 
 
 
New England
$
4,664

 
$
10,311

San Francisco Bay Area
430

 
591

Southern California
198

 
4,235

Total loans 30-89 days past due
$
5,292

 
$
15,137

Accruing substandard loans:
 
 
 
New England
$
8,196

 
$
10,972

San Francisco Bay Area
11,622

 
15,890

Southern California
33,923

 
36,809

Total accruing substandard loans
$
53,741

 
$
63,671



63



The following table presents a summary of credit quality by loan type. The loan type assigned to the credit quality data is based on the purpose of the loan.
 
September 30, 2017
 
December 31, 2016
 
(In thousands)
Nonaccrual loans:
 
 
 
Commercial and industrial
$
968

 
$
572

Commercial real estate
2,601

 
4,583

Construction and land
206

 
179

Residential
8,765

 
10,908

Home equity
1,062

 
1,072

Consumer and other
21

 
1

Total nonaccrual loans
$
13,623

 
$
17,315

Loans 30-89 days past due and accruing:
 
 
 
Commercial and industrial
$
959

 
$
1,619

Commercial real estate
907

 
3,096

Construction and land
413

 

Residential
226

 
4,182

Home equity
2,202

 
245

Consumer and other
585

 
5,995

Total loans 30-89 days past due
$
5,292

 
$
15,137

Accruing substandard loans:
 
 
 
Commercial and industrial
$
8,138

 
$
9,277

Commercial real estate
37,306

 
49,696

Construction and land
6,688

 
3,297

Residential
1,358

 
1,399

Home equity

 

Consumer and other
251

 
2

Total accruing substandard loans
$
53,741

 
$
63,671


Liquidity
Liquidity is defined as the Company’s ability to generate adequate cash to meet its needs for day-to-day operations and material long and short-term commitments. Liquidity risk is the risk of potential loss if the Company were unable to meet its funding requirements at a reasonable cost. The Company manages its liquidity based on demand, commitments, specific events and uncertainties to meet current and future financial obligations of a short-term nature. The Company’s objective in managing liquidity is to respond to the needs of depositors and borrowers as well as earnings enhancement opportunities in a changing marketplace.
At September 30, 2017 , the Company’s cash and cash equivalents amounted to $110.4 million . The Holding Company’s cash and cash equivalents amounted to $63.0 million at September 30, 2017 . Management believes that the Holding Company and its affiliates, including the Bank, have adequate liquidity to meet their commitments for the foreseeable future.

64



Management is responsible for establishing and monitoring liquidity targets as well as strategies to meet these targets. At September 30, 2017 consolidated cash and cash equivalents and available-for-sale securities, less securities pledged against current borrowings and derivatives, amounted to $1.2 billion, or 15% of total assets, compared to $1.3 billion, or 16% of total assets at December 31, 2016 . Future loan growth may depend upon the Company’s ability to continue to grow its core deposit levels. In addition, the Company has access to available borrowings through the FHLB totaling $1.0 billion at September 30, 2017 , compared to $0.9 billion at December 31, 2016 . Combined, this liquidity totals $2.2 billion, or 27% of assets and 36% of total deposits, as of September 30, 2017 , compared to $2.2 billion, or 28% of assets and 37% of total deposits, at December 31, 2016 .
The Bank has various internal policies and guidelines regarding liquidity, both on- and off-balance sheet, loans to assets ratio, and limits on the use of wholesale funds. These policies and/or guidelines require certain minimum or maximum balances or ratios be maintained at all times. In light of the provisions in the Bank’s internal liquidity policies and guidelines, the Bank will carefully manage the amount and timing of future loan growth along with its relevant liquidity policies and balance sheet guidelines.
Holding Company Liquidity. The Company and some of the Company’s majority-owned affiliates hold put and call options that would require the Company to purchase (and the noncontrolling interest owners of the majority-owned affiliates to sell) the remaining noncontrolling interests in these companies at either a contractually predetermined fair value, a multiple of EBITDA, or fair value, as determined by the respective agreements. At September 30, 2017 , the estimated maximum redemption value for these affiliates related to outstanding put options was $15.9 million , all of which could be redeemed within the next 12 months, under certain circumstances, and is classified on the consolidated balance sheets as redeemable noncontrolling interests. These put and call options are discussed in detail in Part II. Item 8. “Financial Statements and Supplementary Data - Note 14: Noncontrolling Interests” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 .
The Holding Company’s primary sources of funds are dividends from its affiliates and access to the capital and debt markets. The Holding Company recognized $3.9 million in net income from discontinued operations during the nine months ended September 30, 2017 related to a revenue sharing agreement with Westfield Capital Management Company, LLC (“Westfield”). This revenue sharing agreement is in effect through December 2017, and the terms are discussed in detail in Part II. Item 8. “Financial Statements and Supplementary Data - Note 3: Acquisitions, Asset Sales, and Divestitures” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 . Other than the revenue sharing agreement with Westfield, divestitures are not current ongoing sources of funds for the Holding Company. After the December 2017 payment under the revenue sharing agreement is received in 2018, the Company will not receive additional net income from Westfield. Dividends from the Bank are limited by various regulatory requirements relating to capital adequacy and retained earnings. See Part II. Item 5. “Market for Registrant’s Common Equity, Related Stockholders Matters, and Issuers Purchases of Equity Securities” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 for further details.
The Bank pays dividends to the Holding Company, subject to the approval of the Bank’s board of directors, depending on its profitability and asset growth. If regulatory agencies were to require banks to increase their capital ratios, or impose other restrictions, it may limit the ability of the Bank to pay dividends to the Holding Company and/or limit the amount that the Bank could grow.
Although the Bank’s capital currently exceeds regulatory requirements for capital, the Holding Company could downstream additional capital to increase the rate that the Bank could grow. Depending upon the amount of capital downstreamed by the Holding Company, the approval of the Holding Company’s board of directors may be required prior to the payment, if any.
The Company is required to pay interest quarterly on its junior subordinated debentures. The estimated cash outlay for the remaining three months of 2017 for the interest payments is approximately $1.6 million based on the debt outstanding at September 30, 2017 and estimated LIBOR.
The Company presently plans to pay cash dividends on its common stock on a quarterly basis dependent upon a number of factors such as profitability, Holding Company liquidity, and the Company’s capital levels. However, the ultimate declaration of dividends by the board of directors of the Company will depend on consideration of, among other things, recent financial trends and internal forecasts, regulatory limitations, alternative uses of capital deployment, general economic conditions, and regulatory changes to capital requirements. Based on the current quarterly dividend rate of $0.11 per share, as announced by the Company on January 18, 2017, and estimated shares outstanding, the Company estimates that the amount to be paid out for dividends to common shareholders in the remaining three months of 2017 will be approximately $9.1 million. The estimated dividend payments in 2017 could increase or decrease if the Company’s board of directors votes to increase or decrease, respectively, the current dividend rate, and/or the number of shares outstanding changes significantly.

65



Based on the shares of stock outstanding of 6.95% Non-Cumulative Perpetual Preferred Stock, Series D, and the dividend rate, the Company expects to pay $0.9 million in cash dividends on preferred stock for the remaining three months of 2017 . Although the rate of interest is set in the terms of the preferred stock, the quarterly preferred stock dividend payments are subject to approval by the Company’s board of directors.
In the first quarter of 2016, the Company’s board of directors approved, and received regulatory non-objection for, a share repurchase program of up to $20 million of the Company’s outstanding common shares. Under the program, shares may be repurchased from time to time in the open market for a two-year period. As of September 30, 2017 , there remains $10.7 million available to be repurchased. The amount and timing of additional repurchases, if any, will be based on the Company’s continuous evaluation of the program.
Bank Liquidity. The Bank has established various borrowing arrangements to provide additional sources of liquidity and funding. Management believes that the Bank currently has adequate liquidity available to respond to current demands. The Bank is a member of the FHLB of Boston, and as such, has access to short- and long-term borrowings from that institution. The FHLB can change the advance amounts that banks can utilize based on a bank’s current financial condition as obtained from publicly available data such as FDIC Call Reports. Decreases in the amount of FHLB borrowings available to the Bank would lower its liquidity and possibly limit the Bank’s ability to grow in the short-term. Management believes that the Bank has adequate liquidity to meet its commitments for the foreseeable future.
In addition to the above liquidity, the Bank has access to the Federal Reserve discount window facility, which can provide short-term liquidity as “lender of last resort,” brokered deposits, and federal funds lines. The use of non-core funding sources, including brokered deposits and borrowings, by the Bank may be limited by regulatory agencies. Generally, the regulatory agencies prefer that banks rely on core-funding sources for liquidity.
From time to time, the Bank purchases federal funds from the FHLB and other banking institutions to supplement its liquidity position. At September 30, 2017 , the Bank had unused federal fund lines of credit totaling $495.0 million with correspondent institutions to provide it with immediate access to overnight borrowings, compared to $485.0 million at December 31, 2016 . At September 30, 2017 , the Bank had $70.0 million of outstanding borrowings under the federal fund lines with these correspondent institutions and had $80.0 million of outstanding borrowings under the federal fund lines at December 31, 2016 . Certain liquidity sources, such as federal funds lines, may be withdrawn by the correspondent bank at any time especially in the event of financial deterioration of the institution.
The Bank has also negotiated brokered deposit agreements with several institutions that have nationwide distribution capabilities. At September 30, 2017 , the Bank had $562.5 million of brokered deposits outstanding under these agreements, compared to $738.3 million at December 31, 2016 .
If the Bank is no longer able to utilize the FHLB for borrowing, collateral currently used for FHLB borrowings could be transferred to other facilities such as the Federal Reserve’s discount window. In addition, the Bank could increase its usage of brokered deposits. Other borrowing arrangements may have higher rates than the FHLB would typically charge.

Capital Resources
Total shareholders’ equity at September 30, 2017 was $815.1 million , compared to $768.5 million at December 31, 2016 , an increase of $46.6 million , or 6% . The increase in shareholders’ equity was primarily the result of net income, the change in other comprehensive income/(loss), amortization of stock compensation, and the conversion of stock warrants, partially offset by dividends paid.
The Company currently has one class of warrants to purchase common stock outstanding. These warrants were initially issued to the U.S. Department of the Treasury (the “TARP warrants”). As of September 30, 2017, 1,832,755 warrants were outstanding, before adjusting for dividends paid on the Company’s common stock in excess of $0.01 per share. The TARP warrants expire in November 2018.
As a bank holding company, the Company is subject to various regulatory capital requirements administered by federal agencies. Failure to meet minimum capital requirements can result in certain mandatory, and possibly additional discretionary, actions by regulators that, if undertaken, could have a material effect on the Company’s financial statements. For example, under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Bank, which is a wholly-owned subsidiary of the Company, must meet specific capital guidelines that involve quantitative measures of the Bank’s assets and certain off-balance sheet items as calculated under regulatory guidelines. The Bank’s capital and classifications are also subject to qualitative judgments by the regulators about components, risk weightings, and other factors.

66


Similarly, the Company is also subject to capital requirements administered by the Federal Reserve with respect to certain non-banking activities, including adjustments in connection with off-balance sheet items.
Effective January 1, 2015, the Company and the Bank adopted the BASEL III regulatory capital framework. Under BASEL III, the Company and the Bank were required to implement a new risk-weighted capital measure, common equity tier 1 (“CETI”), as well as a phased in capital conservation buffer. In addition, capital requirements for all banking organizations were increased. In order to avoid limitations on distributions, including dividend payments and certain discretionary bonus payments to executive officers, a capital conservation buffer must be held above the minimum risk-based capital requirements. The new rules are phased-in through 2019. The Bank and Company were in compliance with all of the requirements of the capital conservation buffer as of September 30, 2017.
To be categorized as “well capitalized,” the Company and the Bank must maintain specified minimum capital ratios. In addition, the Company and the Bank cannot be subject to any written agreement, order or capital directive or prompt corrective action to be considered “well capitalized.” Both the Company and the Bank maintained capital at levels that would be considered “well capitalized” as of September 30, 2017 under the applicable regulations.
As of September 30, 2017 , quantitative measures established by regulation to ensure capital adequacy required us to maintain minimum ratios of CETI, Tier 1, and total capital (as defined in the regulations) to risk-weighted assets (as defined in the regulations) and of Tier 1 capital (as defined in the regulations) to average assets (as defined in the regulations).
The following tables present the Company’s and the Bank’s amounts of regulatory capital and related ratios as of September 30, 2017 and December 31, 2016. Also presented are the minimum requirements established by the Federal Reserve and the FDIC as of those dates for the Company and the Bank, respectively, to meet applicable capital requirements and the requirements of the FDIC as of those dates for the Bank to be considered “well capitalized” under the FDIC’s prompt corrective action provisions. On July 28, 2017, Boston Private Bank became a member of the Federal Reserve System. The Federal Reserve and the Massachusetts Division of Banks may impose higher capital ratios than those listed below based upon the results of regulatory exams. The Bank was categorized as “well capitalized” under the FDIC’s prompt corrective action provisions as of September 30, 2017 and December 31, 2016.
 
Actual
 
For capital adequacy purposes (at least)
 
To be well capitalized under prompt corrective action provisions (at least)
 
Basel III minimum capital ratio with capital conservation buffer (1)
 
Amount
 
Ratio
 
Amount
 
Ratio
 
Amount
 
Ratio
 
Ratio
 
(In thousands)
 
 
As of September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
 
Common equity tier 1 risk-based capital
 
 
 
 
 
 
 
 
 
 
 
 
 
Company
$
607,822

 
10.42
%
 
$
262,420

 
4.5
%
 
n/a

 
n/a
 
7.0
%
Boston Private Bank
695,945

 
11.98

 
261,314

 
4.5

 
$
377,453

 
6.5
%
 
7.0

Tier 1 risk-based capital
 
 
 
 
 
 
 
 
 
 
 
 
 
Company
757,505

 
12.99

 
349,893

 
6.0

 
n/a

 
n/a
 
8.5

Boston Private Bank
695,945

 
11.98

 
348,418

 
6.0

 
464,558

 
8.0

 
8.5

Total risk-based capital
 
 
 
 
 
 
 
 
 
 
 
 
 
Company
830,719

 
14.25

 
466,525

 
8.0

 
n/a

 
n/a
 
10.5

Boston Private Bank
768,577

 
13.24

 
464,558

 
8.0

 
580,697

 
10.0

 
10.5

Tier 1 leverage capital
 
 
 
 
 
 
 
 
 
 
 
 
 
Company
757,505

 
9.42

 
321,760

 
4.0

 
n/a

 
n/a
 
4.0

Boston Private Bank
695,945

 
8.71

 
319,778

 
4.0

 
399,722

 
5.0

 
4.0

 
 
 
 
 
 
 
 
 
 
 
 
 
 

67


 
Actual
 
For capital adequacy purposes (at least)
 
To be well capitalized under prompt corrective action provisions (at least)
 
Basel III minimum capital ratio with capital conservation buffer (1)
 
Amount
 
Ratio
 
Amount
 
Ratio
 
Amount
 
Ratio
 
Ratio
 
(In thousands)
 
 
As of December 31, 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
Common equity tier 1 risk-based capital
 
 
 
 
 
 
 
 
 
 
 
 
 
Company
$
571,663

 
10.00
%
 
$
257,222

 
4.5
%
 
n/a

 
n/a
 
7.0%
Boston Private Bank
661,991

 
11.64

 
256,030

 
4.5

 
$
369,822

 
6.5
%
 
7.0
Tier 1 risk-based capital
 
 
 
 
 
 
 
 
 
 
 
 
 
Company
722,674

 
12.64

 
342,962

 
6.0

 
n/a

 
n/a
 
8.5
Boston Private Bank
661,991

 
11.64

 
341,374

 
6.0

 
455,165

 
8.0

 
8.5
Total risk-based capital
 
 
 
 
 
 
 
 
 
 
 
 
 
Company
794,584

 
13.90

 
457,283

 
8.0

 
n/a

 
n/a
 
10.5
Boston Private Bank
733,214

 
12.89

 
455,165

 
8.0

 
568,956

 
10.0

 
10.5
Tier 1 leverage capital
 
 
 
 
 
 
 
 
 
 
 
 
 
Company
722,674

 
9.42

 
306,848

 
4.0

 
n/a

 
n/a
 
4.0
Boston Private Bank
661,991

 
8.70

 
304,510

 
4.0

 
380,637

 
5.0

 
4.0
_____________________
n/a    not applicable
(1)
Required capital ratios under the Basel III capital rules with the fully phased-in capital conservation buffer added to the minimum risk-based capital ratios. The fully phased-in ratios are effective for 2019, with lower requirements during the transition years 2016 through 2018.
Bank regulatory authorities restrict the Bank from lending or advancing funds to, or investing in the securities of, the Company. Further, these authorities restrict the amounts available for the payment of dividends by the Bank to the Company.
The Company has sponsored the creation of two statutory trusts for the sole purpose of issuing trust preferred securities and investing the proceeds in junior subordinated debentures of the Company. In accordance with ASC 810-10-55, Consolidation - Overall - Implementation Guidance and Illustrations - Variable Interest Entities , these statutory trusts created by the Company are not consolidated into the Company’s financial statements; however, the Company reflects the amounts of junior subordinated debentures payable to the preferred stockholders of statutory trusts as debt in its financial statements. As of both September 30, 2017 and December 31, 2016 , all $100.0 million of the net balance of these trust preferred securities qualified as Tier 1 capital.

Recent Accounting Pronouncements
See Part I. Item 1. “Notes to Unaudited Consolidated Financial Statements - Note 13: Recent Accounting Pronouncements” for a description of upcoming changes to accounting principles generally accepted in the United States that may impact the Company.

Item 3.     Quantitative and Qualitative Disclosures about Market Risk
There have been no material changes in the Interest Rate Sensitivity and Market Risk as described in Part II. Item 7A. “Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Sensitivity and Market Risk” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.

Item 4.     Controls and Procedures
(a) Evaluation of disclosure controls and procedures.
As required by Rule 13a-15 under the Exchange Act, the Company has evaluated, with the participation of management, including the Chief Executive Officer and Chief Financial Officer, as of the end of the period covered by this

68



report, the effectiveness of the design and operation of its disclosure controls and procedures. In designing and evaluating the Company’s disclosure controls and procedures, the Company and its management recognize that any controls and procedures, no matter how well designed and operated, can provide only a reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating and implementing possible controls and procedures.
Based on such evaluation, except for the exclusion noted in the preceding paragraph, the Chief Executive Officer and Chief Financial Officer have concluded that such disclosure controls and procedures were effective as of September 30, 2017 in ensuring that material information required to be disclosed by the Company, including its consolidated subsidiaries, was made known to the certifying officers by others within the Company and its consolidated subsidiaries in the reports that it files or submits under the Exchange Act and is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms. On a quarterly basis, the Company evaluates the disclosure controls and procedures, and may from time to time make changes aimed at enhancing their effectiveness and to ensure that the Company’s systems evolve with its business.
(b) Change in internal controls over financial reporting.
There have been no changes in the Company’s internal controls over financial reporting that occurred during the quarter ended September 30, 2017 , that have materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.


69



PART II. Other Information

Item 1.     Legal Proceedings
The Company is involved in various legal proceedings. In the opinion of management, final disposition of these proceedings will not have a material adverse effect on the financial condition or results of operations of the Company.

Item 1A.     Risk Factors
Before deciding to invest in us or deciding to maintain or increase your investment, you should carefully consider the risks described in Part I. Item 1A. “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2016 as filed with the SEC. There have been no material changes to these risk factors since the filing of that report, except as discussed in the following paragraphs.
The Company is amending one of the risk factors in its Annual Report on Form 10-K to reflect the fact that, on July 28, 2017, the Bank became a member of the Federal Reserve Bank of Boston.
Our banking business is highly regulated, which could limit or restrict our activities, and changes in banking laws and regulations could have a material adverse effect on our business.
We are subject to regulation and supervision by the Federal Reserve, and the Bank is subject to regulation and supervision by the Commissioner and the Federal Reserve. Federal and state laws and regulations govern numerous matters affecting us, including changes in the ownership or control of banks and bank holding companies; maintenance of adequate capital and the financial condition of a financial institution; permissible types, amounts and terms of extensions of credit and investments; permissible non-banking activities; the level of reserves against deposits and restrictions on dividend payments. The Federal Reserve and the Commissioner have the power to issue cease and desist orders to prevent or remedy unsafe or unsound practices or violations of law by banks subject to their regulation, and the Federal Reserve possesses similar powers with respect to bank holding companies. These and other restrictions limit the manner in which we and the Bank may conduct business and obtain financing.
The laws, rules, regulations and supervisory guidance and policies applicable to us are subject to regular modification and change. These changes could adversely and materially impact us. Such changes could subject us to additional costs, including costs of compliance, limit the types of financial services and products we may offer, and/or increase the ability of non-banks to offer competing financial services and products, among other things. Failure to comply with laws, regulations, policies, or supervisory guidance could result in enforcement and other legal actions by federal or state authorities, including criminal and civil penalties, the loss of FDIC insurance, revocation of a banking charter, other sanctions by regulatory agencies, civil money penalties, and/or reputational damage, which could have a material adverse effect on our business, financial condition, and results of operations. 

Item 2.     Unregistered Sales of Equity Securities and Use of Proceeds
There were no unregistered sales of equity securities of the Company in the third quarter of 2017 .
The Company received a notice of non-objection from the Federal Reserve for a share repurchase program of up to $20 million of the Company’s outstanding common shares. Under the program, shares may be repurchased from time to time in the open market for a two-year period. The Company’s board of directors approved the program on January 27, 2016. There were no repurchases of equity securities of the Company in the third quarter of 2017 . The Company has authorization to repurchase $10,661,737 of shares based on the remaining amount in the current repurchase program.
 
 
 
 
 
 
 
 

70



Item 3.     Defaults Upon Senior Securities
None.

Item 4.     Mine Safety Disclosures
Not applicable.

Item 5.     Other Information
None.

Item 6.     Exhibits
(a) Exhibits
Exhibit No.
 
Description
 
Incorporated by Reference
 
Filed or
Furnished
with this
10-Q
Form
 
SEC Filing
Date
 
Exhibit
Number
 
10.1
 
 
 
 
 
 
 
 
Filed
10.2
 
 
 
 
 
 
 
 
Filed
10.3
 
 
 
 
 
 
 
 
Filed
10.4
 
 
 
 
 
 
 
 
Filed
10.5
 
 
 
 
 
 
 
 
Filed
31.1
 
 
 
 
 
 
 
 
Filed
31.2
 
 
 
 
 
 
 
 
Filed
32.1
 
 
 
 
 
 
 
 
Furnished
32.2
 
 
 
 
 
 
 
 
Furnished
101.INS
 
XBRL Instance Document
 
 
 
 
 
 
 
Filed
101.SCH
 
XBRL Taxonomy Extension Schema Document
 
 
 
 
 
 
 
Filed
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
 
 
 
 
Filed
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
 
 
 
 
 
 
 
Filed
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
 
 
 
 
 
 
 
Filed
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
 
 
 
 
 
Filed


71




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
B OSTON  P RIVATE  F INANCIAL  H OLDINGS , I NC .
 
 
 
/s/ C LAYTON  G. D EUTSCH
November 7, 2017
Clayton G. Deutsch
 
Chief Executive Officer
 
 
 
/s/ D AVID  J. K AYE
November 7, 2017
David J. Kaye
 
Executive Vice President, Chief Financial
and Administrative Officer


72


Exhibit 10.1

FORM OF

PERFORMANCE
RESTRICTED STOCK UNIT AWARD AGREEMENT
UNDER THE BOSTON PRIVATE FINANCIAL HOLDINGS, INC.
AMENDED AND RESTATED
2009 STOCK OPTION AND INCENTIVE PLAN

Name of Grantee:
Clayton G. Deutsch
 
 
No. of Restricted Stock Units:
 
 
 
Grant Date:
 

Pursuant to the Boston Private Financial Holdings, Inc. Amended and Restated 2009 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), Boston Private Financial Holdings, Inc. (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $1.00 per share (the “Stock”) of the Company

By accepting this Award, the Grantee hereby affirms his agreement to the terms and conditions of his Employment Agreement with the Company that addresses confidentiality of Company information and post-employment restrictions on competition and solicitation of employees and customers or clients and should be reviewed carefully by the Grantee. If this Award is not so accepted within 60 days of the Grant Date, the Grantee shall forfeit the Award in its entirety (regardless of whether vested or unvested).

1. Restrictions on Transfer of Award . This Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of by the Grantee and any shares of Stock issuable with respect to the Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of until (i) the Restricted Stock Units have vested as provided in Paragraph 2 of this Agreement and (ii) shares of Stock have been issued to the Grantee in accordance with the terms of the Plan and this Agreement.






2. Vesting of Restricted Stock Units . The Grantee shall have no rights to this Award unless he or she shall have accepted the Award electronically through the Company’s Stock Plan Administration System. The restrictions and conditions in this Agreement shall lapse and the Restricted Stock Units shall vest on _________ (the “Vesting Date”) based on the Company’s performance during the period beginning on ___________ and ending on _____________ (the “Measurement Period”). The Restricted Stock Units shall vest if, and only to the extent that, the Company achieves the performance targets described on Schedule A , hereto. The number of shares of Restricted Stock Units set forth above (the “Target Award”) represents the number of shares of Restricted Stock Units that will vest if the Company achieves target levels of performance, and the actual number of shares of Restricted Stock Units that may vest could be lower than the Target Award and could be zero. To the extent that the Company’s performance during the Measurement Period exceeds the target performance metrics described on Schedule A , the Grantee may be eligible to receive an award of a number of shares of Restricted Stock Units in addition to the Target Award, calculated pursuant to such schedule. The Grantee shall forfeit any portion of the Target Award that does not vest on the Vesting Date.

3. Termination of Employment . Except as otherwise provided in this Paragraph 3, if the Grantee’s employment with the Company and its subsidiaries is voluntarily or involuntarily terminated for any reason prior to the Vesting Date, all Restricted Stock Units shall immediately and automatically be forfeited. Notwithstanding the foregoing, if the Grantee’s employment with the Company and its subsidiaries is terminated (a) (i) due to Grantee’s disability (as determined in accordance with Section 3(b) of that certain Employment Agreement, dated June 7, 2010, by and between the Company and Grantee (the “Employment Agreement”)), (ii) due to Grantee’s Retirement, or (iii) by the Company without Cause (as defined below), the Grantee shall be eligible to vest, on the Vesting Date, with respect to a pro-rated portion of the Final Award that the Grantee would have received had the Grantee’s employment not terminated prior to the Vesting Date, calculated based on (A) the number of days from the Grant Date through the date the Grantee’s termination of employment divided by (B) the number of days from the Grant Date through the Vesting Date, if, and only to the extent that, the Company achieves the performance targets described on Schedule A , or (b) due to Grantee’s death, the Restricted Stock Units shall vest with respect to a pro-rated portion of the Target Award, calculated based on (A) the number of days from the Grant Date through the date the Grantee’s termination of employment divided by (B) the number of days from the Grant Date through the Vesting Date. The Administrator’s determination of the reason for termination of the Grantee’s employment shall be conclusive and binding on the Grantee and his or her representatives or legatees.






“Cause” shall mean: (i) conduct by Grantee constituting a material act of misconduct in connection with the performance of his duties, including, without limitation, misappropriation of funds or property of the Company or any of its subsidiaries or affiliates other than the occasional, customary and de minimis use of Company property for personal purposes; (ii) the commission by Grantee of any felony or a misdemeanor involving moral turpitude, deceit, dishonesty or fraud, or any conduct by Grantee that would reasonably be expected to result in material injury or reputational harm to the Company or any of its subsidiaries and affiliates if he were retained in his position; (iii) continued neglect of his duties hereunder by Grantee (other than by reason of Grantee’s disability, as determined in accordance with Section 3(b) of the Employment Agreement) which has continued for more than 30 days following written notice of such neglect from the Board of Directors of the Company; (iv) a breach by Grantee of any of the provisions contained in Section 7 of the Employment Agreement which, to the extent curable, has not been cured within 30 days following written notice of such violation or breach; (v) a material violation by Grantee of the Company’s written employment policies or material breach of the Employment Agreement which, to the extent curable, has not been cured within 30 days following written notice of such violation or breach, or (vi) failure to cooperate with a bona fide internal investigation or an investigation by regulatory or law enforcement authorities, after being instructed by the Company to cooperate, or the willful destruction or failure to preserve documents or other materials known to be relevant to such investigation or the inducement of others to fail to cooperate or to produce documents or other materials in connection with such investigation.

4. Change of Control . Notwithstanding the provisions of Paragraph 3 above, or the provisions of any agreement between the Grantee and Company or any subsidiary that is in effect as of the date hereof, in the event of a Change of Control or Sale Event prior to the end of the Measurement Period, (i) if, in connection with such Change of Control or Sale Event, this Award is not assumed or continued by the successor entity in such Change of Control or Sale Event or substituted with a new award of such successor (in accordance with Section 3(c) of the Plan), the Restricted Stock Units shall automatically become vested with respect to a pro-rated portion of the Target Award calculated based on (a) the number of days from the Grant Date through the effective date of such Change of Control or Sale Event divided by (b) the number of days from the Grant Date through the Vesting Date, and (ii) if this Award is assumed or continued by the successor entity in such Change of Control or Sale Event or substituted with a new award of such successor subject to the provisions of the Plan, the Restricted Stock Units shall vest in accordance with Paragraphs 2 and 3 and Schedule A of this Agreement (as applicable), subject, in each case, to the terms of the Plan and to any applicable adjustments to the performance metrics set forth on





Schedule A in connection with such Change of Control or Sale Event that may be made in the sole discretion of the Administrator and the parties to such Change of Control or Sale Event.

5. Issuance of Shares of Stock . As soon as practicable following each Vesting Date (but in no event later than thirty days after the Vesting Date occurs), the Company shall (i) issue to the Grantee the number of shares of Stock equal to the aggregate number of Restricted Stock Units that have vested pursuant to Paragraphs 2 or 3 of this Agreement on such date and the Grantee shall thereafter have all the rights of a stockholder of the Company with respect to such shares, and (ii) pay in cash to the Grantee an amount equal to the product of (x) the amount of dividends payable per share of Stock since the Grant Date and (y) the number of Restricted Stock Units that have vested pursuant to Paragraph 2 of this Agreement on such date.

6. Incorporation of Plan . Notwithstanding anything herein to the contrary, this Agreement shall be subject to and governed by all the terms and conditions of the Plan, including the powers of the Administrator set forth in Section 2(b) of the Plan. Capitalized terms in this Agreement shall have the meaning specified in the Plan, unless a different meaning is specified herein.

7. Tax Withholding . The Grantee shall, not later than the date as of which the receipt of this Award becomes a taxable event for Federal income tax purposes, pay to the Company or make arrangements satisfactory to the Administrator for payment of any Federal, state, and local taxes required by law to be withheld on account of such taxable event. The Grantee may elect to have, and the Company shall have the authority to cause, the required minimum tax withholding obligation satisfied, in whole or in part, by authorizing the Company to withhold from shares of Stock to be issued or released by the transfer agent a number of shares of Stock with an aggregate Fair Market Value that would satisfy the withholding amount due.

8. Section 409A of the Code . This Agreement shall be interpreted in such a manner that all provisions relating to the settlement of the Award are exempt from the requirements of Section 409A of the Code as “short-term deferrals” as described in Section 409A of the Code.

9. No Obligation to Continue Employment . Neither the Company nor any subsidiary is obligated by or as a result of the Plan or this Agreement to continue the Grantee in employment and neither the Plan nor this Agreement shall interfere in any way with the right of the Company or any subsidiary to terminate the employment of the Grantee at any time.






10. Clawback . This Award and any Restricted Stock Units granted hereunder (and any gains thereon) shall be subject to recovery or “clawback” by the Company if and to the extent that the vesting of such Restricted Stock Units was determined or calculated based on materially inaccurate financial statements or any other material inaccurate performance metric criteria. If the Company or its subsidiaries terminate the Grantee’s service relationship due to the Grantee’s gross negligence or willful misconduct (whether or not such actions also constitute Cause hereunder) which conduct, directly or indirectly results in the Company preparing an accounting restatement, and/or, if the Grantee breaches any provision of the Employment Agreement any Restricted Stock Units granted hereunder, whether or not vested, (and any gains thereon) shall be subject to forfeiture, recovery and “clawback.”

11. Data Privacy Consent . In order to administer the Plan and this Agreement and to implement or structure future equity grants, the Company, its subsidiaries and affiliates and certain agents thereof (together, the “Relevant Companies”) may process any and all personal or professional data, including but not limited to Social Security or other identification number, home address and telephone number, date of birth and other information that is necessary or desirable for the administration of the Plan and/or this Agreement (the “Relevant Information”). By entering into this Agreement, the Grantee (i) authorizes the Company to collect, process, register and transfer to the Relevant Companies all Relevant Information; (ii) waives any privacy rights the Grantee may have with respect to the Relevant Information; (iii) authorizes the Relevant Companies to store and transmit such information in electronic form; and (iv) authorizes the transfer of the Relevant Information to any jurisdiction in which the Relevant Companies consider appropriate. The Grantee shall have access to, and the right to change, the Relevant Information. Relevant Information will only be used in accordance with applicable law.

12. Notices . Notices hereunder shall be mailed or delivered to the Company at its principal place of business and shall be mailed or delivered to the Grantee at the address on file with the Company or, in either case, at such other address as one party may subsequently furnish to the other party in writing.





 
 
 
BOSTON PRIVATE FINANCIAL
HOLDINGS, INC.
 
 
By:
 
 
Title:
The foregoing Agreement is hereby accepted and the terms and conditions thereof hereby agreed to by the undersigned. Electronic acceptance of this Agreement pursuant to the Company’s instructions to the Grantee (including through an online acceptance process) is acceptable.
 
 
 
 
 
Dated:
 
 
 
 
 
 
Grantee’s Signature
 
 
 
 
 
 
 
Grantee’s name:







SCHEDULE A
PERFORMANCE TARGETS






Exhibit 10.2

FORM OF

RESTRICTED STOCK UNIT AWARD AGREEMENT
UNDER THE BOSTON PRIVATE FINANCIAL HOLDINGS, INC.
AMENDED AND RESTATED
2009 STOCK OPTION AND INCENTIVE PLAN

Name of Grantee:
Clayton G. Deutsch
 
 
No. of Restricted Stock Units:
 
 
 
Grant Date:
 

Pursuant to the Boston Private Financial Holdings, Inc. Amended and Restated 2009 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), Boston Private Financial Holdings, Inc. (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $1.00 per share (the “Stock”) of the Company.
By accepting this Award, the Grantee hereby affirms his agreement to the terms and conditions of his Employment Agreement with the Company that addresses confidentiality of Company information and post-employment restrictions on competition and solicitation of employees and customers or clients and should be reviewed carefully by the Grantee. If this Award is not so accepted within 60 days of the Grant Date, the Grantee shall forfeit the Award in its entirety (regardless of whether vested or unvested).
1. Restrictions on Transfer of Award . This Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of by the Grantee, and any shares of Stock issuable with respect to the Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of until (i) the Restricted Stock Units have vested as provided in Paragraph 2 of this Agreement and (ii) shares of Stock have been issued to the Grantee in accordance with the terms of the Plan and this Agreement.

2. Vesting of Restricted Stock Units . The Grantee shall have no rights to this Award unless he or she shall have accepted the Award electronically through the Company’s Stock Plan Administration System. The restrictions and conditions in this Agreement shall lapse on the Vesting Date or Dates specified in the following schedule so long as the Grantee remains an employee of the Company or a Subsidiary on such Dates. If a series of Vesting Dates is specified, then the restrictions and conditions in Paragraph 1 shall lapse only with respect to the number of Restricted Stock Units specified as vested on such date.





Number of
Restricted Stock Units Vested
Vesting Date
_____________ (100%)
_____________, 20__

3. Termination of Employment . Except as otherwise provided in this Paragraph 3, if the Grantee’s employment with the Company and its subsidiaries is voluntarily or involuntarily terminated for any reason prior to the Vesting Date, all Restricted Stock Units shall immediately and automatically be forfeited. Notwithstanding the foregoing, if the Grantee’s employment with the Company and its subsidiaries is terminated (a) due to the Grantee’s disability (as determined in accordance with Section 3(b) of that certain Employment Agreement, dated June 7, 2010, by and between the Company and Grantee (the “Employment Agreement”)) or death, all Restricted Stock Units shall automatically become fully vested, subject to the provisions of the Plan, as of the date of the Grantee’s termination of employment, or (b) (i) due to Grantee’s Retirement or (ii) by the Company without Cause (as defined below), the Grantee shall be eligible to vest, with respect to a pro-rated portion of this Award, calculated based on (A) the number of days from the Grant Date through the date of the Grantee’s termination of employment, divided by (B) the number of days from the Grant Date through the Vesting Date; provided, however, that if the Grantee is terminated by the Company without Cause within the 24-month period following a Change of Control or Sale Event, all Restricted Stock Units shall automatically become fully vested, subject to the provisions of the Plan, as of the date of the Grantee’s termination of employment. The Administrator’s determination of the reason for termination of the Grantee’s employment shall be conclusive and binding on the Grantee and his or her representatives or legatees.

“Cause” shall mean: (i) conduct by Grantee constituting a material act of misconduct in connection with the performance of his duties, including, without limitation, misappropriation of funds or property of the Company or any of its subsidiaries or affiliates other than the occasional, customary and de minimis use of Company property for personal purposes; (ii) the commission by Grantee of any felony or a misdemeanor involving moral turpitude, deceit, dishonesty or fraud, or any conduct by Grantee that would reasonably be expected to result in material injury or reputational harm to the Company or any of its subsidiaries and affiliates if he were retained in his position; (iii) continued neglect of his duties hereunder by Grantee (other than by reason of Grantee’s disability, as determined in accordance with Section 3(b) of the Employment Agreement) which has continued for more than 30 days following written notice of such neglect from the Board of Directors of the Company; (iv) a breach by Grantee of any of the provisions contained in Section 7 of the Employment Agreement which, to the extent curable, has not been cured within 30 days following written notice of such violation or breach; (v) a material violation by Grantee of the Company’s written employment policies or material breach of the Employment Agreement which, to the extent curable, has not been cured within 30 days following written notice of such violation or breach, or (vi) failure to cooperate with a bona fide internal investigation or an investigation by regulatory or law enforcement authorities, after being instructed by the Company to cooperate, or the willful destruction or failure to preserve documents or other materials known to be relevant to such investigation or the inducement of others to fail to cooperate or to produce documents or other materials in connection with such investigation.

4. Change of Control . Notwithstanding the provisions of Paragraph 3 above, or the provisions of any agreement between the Grantee and Company or any subsidiary that is in effect as of the date hereof, in the event of a Change of Control or Sale Event prior to the Vesting Date, (i) if, in connection with such Change of Control or Sale Event, this Award is not assumed or continued by the successor entity in such Change of Control or Sale Event or substituted with a new award of such successor (in accordance with the Plan), the Restricted Stock Units shall automatically become fully vested, subject to the provisions of the Plan, as of the effective time of such Change of Control or Sale Event, and (ii) if this





Award is assumed or continued by the successor entity in such Change of Control or Sale Event or substituted with a new award of such successor subject to the provisions of the Plan, the Restricted Stock Units shall vest in accordance with Paragraphs 2 and 3 of this Agreement (as applicable), subject, in each case, to the terms of the Plan.

5. Issuance of Shares of Stock . As soon as practicable following each Vesting Date (but in no event later than thirty days after the Vesting Date), the Company shall (i) issue to the Grantee the number of shares of Stock equal to the aggregate number of Restricted Stock Units that have vested pursuant to Paragraphs 2 or 3 of this Agreement on such date and the Grantee shall thereafter have all the rights of a stockholder of the Company with respect to such shares, and (ii) pay in cash to the Grantee an amount equal to the product of (x) the amount of dividends payable per share of Stock since the Grant Date and (y) the number of Restricted Stock Units that have vested pursuant to Paragraph 2 of this Agreement on such date.

6. Incorporation of Plan . Notwithstanding anything herein to the contrary, this Agreement shall be subject to and governed by all the terms and conditions of the Plan, including the powers of the Administrator set forth in Section 2(b) of the Plan. Capitalized terms in this Agreement shall have the meaning specified in the Plan, unless a different meaning is specified herein.

7. Tax Withholding . The Grantee shall, not later than the date as of which the receipt of this Award becomes a taxable event for Federal income tax purposes, pay to the Company or make arrangements satisfactory to the Administrator for payment of any Federal, state, and local taxes required by law to be withheld on account of such taxable event. The Grantee may elect to have, and the Company shall have the authority to cause, the required minimum tax withholding obligation satisfied, in whole or in part, by authorizing the Company to withhold from shares of Stock to be issued or released by the transfer agent a number of shares of Stock with an aggregate Fair Market Value that would satisfy the withholding amount due.

8. Section 409A of the Code. This Agreement shall be interpreted in such a manner that all provisions relating to the settlement of the Award are exempt from the requirements of Section 409A of the Code as “short-term deferrals” as described in Section 409A of the Code.

9. No Obligation to Continue Employment . Neither the Company nor any subsidiary is obligated by or as a result of the Plan or this Agreement to continue the Grantee in employment and neither the Plan nor this Agreement shall interfere in any way with the right of the Company or any subsidiary to terminate the employment of the Grantee at any time.

10. Clawback . This Award and any Restricted Stock Units granted hereunder (and any gains thereon) shall be subject to recovery or “clawback” by the Company if and to the extent that the vesting of such Restricted Stock Units was determined or calculated based on materially inaccurate financial statements or any other material inaccurate performance metric criteria. If the Company or its subsidiaries terminate the Grantee’s service relationship due to the Grantee’s gross negligence or willful misconduct (whether or not such actions also constitute Cause hereunder), which conduct, directly or indirectly results in the Company preparing an accounting restatement, and/or if the Grantee breaches any provision of the Employment Agreement, any Restricted Stock Units granted hereunder, whether or not vested, (and any gains thereon) shall be subject to forfeiture, recovery and “clawback.”

11. Data Privacy Consent . In order to administer the Plan and this Agreement and to implement or structure future equity grants, the Company, its subsidiaries and affiliates and certain agents





thereof (together, the “Relevant Companies”) may process any and all personal or professional data, including but not limited to Social Security or other identification number, home address and telephone number, date of birth and other information that is necessary or desirable for the administration of the Plan and/or this Agreement (the “Relevant Information”). By entering into this Agreement, the Grantee (i) authorizes the Company to collect, process, register and transfer to the Relevant Companies all Relevant Information; (ii) waives any privacy rights the Grantee may have with respect to the Relevant Information; (iii) authorizes the Relevant Companies to store and transmit such information in electronic form; and (iv) authorizes the transfer of the Relevant Information to any jurisdiction in which the Relevant Companies consider appropriate. The Grantee shall have access to, and the right to change, the Relevant Information. Relevant Information will only be used in accordance with applicable law.

12. Notices . Notices hereunder shall be mailed or delivered to the Company at its principal place of business and shall be mailed or delivered to the Grantee at the address on file with the Company or, in either case, at such other address as one party may subsequently furnish to the other party in writing.







BOSTON PRIVATE FINANCIAL
HOLDINGS, INC.
By: _________________________________________         
Title:

The foregoing Agreement is hereby accepted and the terms and conditions thereof hereby agreed to by the undersigned. Electronic acceptance of this Agreement pursuant to the Company’s instructions to the Grantee (including through an online acceptance process) is acceptable.

Dated:     _______________________________        _________________________________________________        
Grantee’s Signature

Grantee’s name and address:
_________________________________________
_________________________________________
_________________________________________
        


        
        
        





Exhibit 10.3

FORM OF

PERFORMANCE
RESTRICTED STOCK UNIT AWARD AGREEMENT
UNDER THE BOSTON PRIVATE FINANCIAL HOLDINGS, INC.
AMENDED AND RESTATED
2009 STOCK OPTION AND INCENTIVE PLAN

Name of Grantee:
 
 
 
No. of Restricted Stock Units:
 
 
 
Grant Date:
 

Pursuant to the Boston Private Financial Holdings, Inc. Amended and Restated 2009 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), Boston Private Financial Holdings, Inc. (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $1.00 per share (the “Stock”) of the Company
By accepting this Award, the Grantee confirms the Grantee’s agreement to all of the terms and conditions of any agreement between the Grantee and the Company or any of its subsidiaries that addresses confidentiality obligations and/or post-employment restrictions on solicitation of employees and customers or clients. If the Grantee is not a party to any such agreement, by accepting this Award, the Grantee agrees to the terms and conditions of the Non-Solicitation and Confidentiality Agreement attached as Exhibit I , hereto (the “Non-Solicitation Agreement”). The Non-Solicitation Agreement addresses confidentiality of Company information, post-employment restrictions on solicitation of employees and customers or clients and other similar matters and should be reviewed carefully by the Grantee. If this Award is not so accepted within 60 days of the Grant Date, the Grantee shall forfeit the Award in its entirety (regardless of whether vested or unvested).
1. Restrictions on Transfer of Award . This Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of by the Grantee and any shares of Stock issuable with respect to the Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of until (i) the Restricted Stock Units have vested as provided in Paragraph 2 of this Agreement and (ii) shares of Stock have been issued to the Grantee in accordance with the terms of the Plan and this Agreement.
2. Vesting of Restricted Stock Units . The Grantee shall have no rights to this Award unless he or she shall have accepted the Award electronically through the Company’s Stock Plan Administration System. The restrictions and conditions in this Agreement shall lapse and the Restricted Stock Units shall vest on _________ (the “Vesting Date”) based on the Company’s performance during the period beginning on __________ and ending on __________ (the “Measurement Period”). The Restricted Stock Units shall vest if, and only to the extent that, the Company achieves the performance targets described on





Schedule A , hereto. The number of shares of Restricted Stock Units set forth above (the “Target Award”) represents the number of shares of Restricted Stock Units that will vest if the Company achieves target levels of performance, and the actual number of shares of Restricted Stock Units that may vest could be lower than the Target Award and could be zero. To the extent that the Company’s performance during the Measurement Period exceeds the target performance metrics described on Schedule A , the Grantee may be eligible to receive an award of a number of shares of Restricted Stock Units in addition to the Target Award, calculated pursuant to such schedule. The Grantee shall forfeit any portion of the Target Award that does not vest on the Vesting Date.
3. Termination of Employment . Except as otherwise provided in this Paragraph 3, if the Grantee’s employment with the Company and its subsidiaries is voluntarily or involuntarily terminated for any reason prior to the Vesting Date, all Restricted Stock Units shall immediately and automatically be forfeited. Notwithstanding the foregoing, if the Grantee’s employment with the Company and its subsidiaries is terminated (a) (i) due to Grantee’s disability (as determined by the Administrator), (ii) due to Grantee’s Retirement, or (iii) by the Company without Cause (as defined below), the Grantee shall be eligible to vest, on the Vesting Date, with respect to a pro-rated portion of the Final Award that the Grantee would have received had the Grantee’s employment not terminated prior to the Vesting Date, calculated based on (A) the number of days from the Grant Date through the date the Grantee’s termination of employment divided by (B) the number of days from the Grant Date through the Vesting Date, if, and only to the extent that, the Company achieves the performance targets described on Schedule A , or (b) due to Grantee’s death, the Restricted Stock Units shall vest with respect to a pro-rated portion of the Target Award, calculated based on (A) the number of days from the Grant Date through the date the Grantee’s termination of employment divided by (B) the number of days from the Grant Date through the Vesting Date. The Administrator’s determination of the reason for termination of the Grantee’s employment shall be conclusive and binding on the Grantee and his or her representatives or legatees.
“Cause” means a termination of the Grantee’s employment as a result of (i) conviction of the Grantee of, or plea of guilty or nolo contendere by the Grantee to, a felony, or (ii) dishonest acts against the Company or any of its subsidiaries, or (iii) misconduct which is likely to cause financial loss to the Company or any of its subsidiaries or to cause damage to the business reputation of the Company or any of its subsidiaries, or (iv) willful or repeated misconduct or gross neglect constituting bad faith in performing the Grantee’s duties with the Company, or (v) breach of fiduciary duty involving personal profit to the Grantee. For purposes of clause (iv), no act, or failure to act, on the Grantee’s part shall be deemed “willful” unless done, or omitted to be done, by the Grantee without reasonable belief that the Grantee’s act, or failure to act, was in the best interest of the Company and any of its subsidiaries. In the event the Grantee is a party to an employment agreement with the Company or any subsidiary that contains a different definition of “cause,” the definition set forth in such other agreement shall be applicable to the Grantee for purposes of this Agreement and not this definition.
4. Change of Control . Notwithstanding the provisions of Paragraph 3 above, or the provisions of any agreement between the Grantee and Company or any subsidiary that is in effect as of the date hereof, in the event of a Change of Control or Sale Event prior to the end of the Measurement Period, (i) if, in connection with such Change of Control or Sale Event, this Award is not assumed or continued by the successor entity in such Change of Control or Sale Event or substituted with a new award of such successor (in accordance with Section 3(c) of the Plan), the Restricted Stock Units shall automatically become vested with respect to a pro-rated portion of the Target Award calculated based on (a) the number of days from the Grant Date through the effective date of such Change of Control or Sale Event divided by (b) the number of days from the Grant Date through the Vesting Date, and (ii) if this Award is assumed or continued by the successor entity in such Change of Control or Sale Event or substituted with a new





award of such successor subject to the provisions of the Plan, the Restricted Stock Units shall vest in accordance with Paragraphs 2 and 3 and Schedule A of this Agreement (as applicable), subject, in each case, to the terms of the Plan and to any applicable adjustments to the performance metrics set forth on Schedule A in connection with such Change of Control or Sale Event that may be made in the sole discretion of the Administrator and the parties to such Change of Control or Sale Event.

5. Issuance of Shares of Stock . As soon as practicable following each Vesting Date (but in no event later than thirty days after the Vesting Date occurs), the Company shall (i) issue to the Grantee the number of shares of Stock equal to the aggregate number of Restricted Stock Units that have vested pursuant to Paragraphs 2 or 3 of this Agreement on such date and the Grantee shall thereafter have all the rights of a stockholder of the Company with respect to such shares, and (ii) pay in cash to the Grantee an amount equal to the product of (x) the amount of dividends payable per share of Stock since the Grant Date and (y) the number of Restricted Stock Units that have vested pursuant to Paragraph 2 of this Agreement on such date.

6. Incorporation of Plan . Notwithstanding anything herein to the contrary, this Agreement shall be subject to and governed by all the terms and conditions of the Plan, including the powers of the Administrator set forth in Section 2(b) of the Plan. Capitalized terms in this Agreement shall have the meaning specified in the Plan, unless a different meaning is specified herein.

7. Tax Withholding . The Grantee shall, not later than the date as of which the receipt of this Award becomes a taxable event for Federal income tax purposes, pay to the Company or make arrangements satisfactory to the Administrator for payment of any Federal, state, and local taxes required by law to be withheld on account of such taxable event. The Grantee may elect to have, and the Company shall have the authority to cause, the required minimum tax withholding obligation satisfied, in whole or in part, by authorizing the Company to withhold from shares of Stock to be issued or released by the transfer agent a number of shares of Stock with an aggregate Fair Market Value that would satisfy the withholding amount due.

8. Section 409A of the Code . This Agreement shall be interpreted in such a manner that all provisions relating to the settlement of the Award are exempt from the requirements of Section 409A of the Code as “short-term deferrals” as described in Section 409A of the Code.

9. No Obligation to Continue Employment . Neither the Company nor any subsidiary is obligated by or as a result of the Plan or this Agreement to continue the Grantee in employment and neither the Plan nor this Agreement shall interfere in any way with the right of the Company or any subsidiary to terminate the employment of the Grantee at any time.

10. Clawback . This Award and any Restricted Stock Units granted hereunder (and any gains thereon) shall be subject to recovery or “clawback” by the Company if and to the extent that the vesting of such Restricted Stock Units was determined or calculated based on materially inaccurate financial statements or any other material inaccurate performance metric criteria. If the Company or its subsidiaries terminate the Grantee’s service relationship due to the Grantee’s gross negligence or willful misconduct (whether or not such actions also constitute Cause hereunder) which conduct, directly or indirectly results in the Company preparing an accounting restatement, and/or, if the Grantee breaches any provision of the Non-Solicitation Agreement (or, if applicable, such other agreement referenced in Paragraph 1, above) any Restricted Stock Units granted hereunder, whether or not vested, (and any gains thereon) shall be subject to forfeiture, recovery and “clawback.”






11. Data Privacy Consent . In order to administer the Plan and this Agreement and to implement or structure future equity grants, the Company, its subsidiaries and affiliates and certain agents thereof (together, the “Relevant Companies”) may process any and all personal or professional data, including but not limited to Social Security or other identification number, home address and telephone number, date of birth and other information that is necessary or desirable for the administration of the Plan and/or this Agreement (the “Relevant Information”). By entering into this Agreement, the Grantee (i) authorizes the Company to collect, process, register and transfer to the Relevant Companies all Relevant Information; (ii) waives any privacy rights the Grantee may have with respect to the Relevant Information; (iii) authorizes the Relevant Companies to store and transmit such information in electronic form; and (iv) authorizes the transfer of the Relevant Information to any jurisdiction in which the Relevant Companies consider appropriate. The Grantee shall have access to, and the right to change, the Relevant Information. Relevant Information will only be used in accordance with applicable law.

12. Notices . Notices hereunder shall be mailed or delivered to the Company at its principal place of business and shall be mailed or delivered to the Grantee at the address on file with the Company or, in either case, at such other address as one party may subsequently furnish to the other party in writing.






 
 
 
BOSTON PRIVATE FINANCIAL
HOLDINGS, INC.
 
 
By:
 
 
Title:
The foregoing Agreement is hereby accepted and the terms and conditions thereof hereby agreed to by the undersigned. Electronic acceptance of this Agreement pursuant to the Company’s instructions to the Grantee (including through an online acceptance process) is acceptable.
 
 
 
 
 
Dated:
 
 
 
 
 
 
Grantee’s Signature
 
 
 
 
 
 
 
Grantee’s name:







EXHIBIT I (A): NON-SOLICITATION AND
CONFIDENTIALITY AGREEMENT FOR NON-CALIFORNIA RESIDENTS

I acknowledge that I enter into this Non-Solicitation and Confidentiality Agreement (the “Agreement”) in connection with an award of restricted stock, restricted stock units or a grant of a stock option (together, an “Award”) that is made on or about the date of the proposal of this Agreement, pursuant to the Boston Private Financial Holdings, Inc. Amended and Restated 2009 Stock Option and Incentive Plan or any subsequent stock option and/or restricted stock plan of Boston Private Financial Holdings, Inc. (together, the “Plan”) and that I shall forfeit the Award (whether vested or unvested) if I do not execute this Non-Solicitation and Confidentiality Agreement (the “Agreement”) within 60 days of the grant date of the Award.
For purposes of this Agreement, the “Company” refers to Boston Private Financial Holdings, Inc. (“BPFH”) and any and all of its wholly or partially owned subsidiaries.
In consideration for my eligibility for any Award, I hereby agree as follows:
1. Confidential Information . During my employment with the Company and at all times thereafter, I shall keep secret and retain in strictest confidence, and shall not disclose or use, other than in the proper performance of my responsibilities for the Company, any Confidential Information. “Confidential Information” means any information, whether or not in writing, concerning the Company’s business or activities that the Company has not released to the general public. I acknowledge that all Confidential Information is the property of the Company. I understand that the term “Confidential Information” includes, but is not limited to financial statements, business plans, document templates, term sheets, policies and procedures, proprietary training materials, personnel, board materials and minutes, operations, customer and client lists and identities, potential customers and clients, vendor lists and agreements, employees, servicing methods, strategies and strategic planning materials, analyses, profit margins and other proprietary information in connection with the Company; provided , however, that Confidential Information shall not include any information which is generally known to the public or becomes known in the industry through no wrongful act on my part. Confidential Information also includes information received in confidence by the Company from its customers, clients or other third parties.
2. Return of Confidential Information and Other Property . I shall deliver to the Company all copies of Confidential Information and other Company property (which includes but is not limited to any documents, notes or other work product connected with or derived from my services to or affiliation with the Company, whether in electronic or paper form) in my possession or control upon the earlier of a request by the Company or termination of my employment.





  





3. Non-Solicitation/Non-Accept .
(a) During my employment with the Company, and for the period ending on the first anniversary of the effective date of my termination of employment with the Company, I shall not directly or indirectly:
(i) solicit or accept for employment with another employer or employ any person then, or within the prior six (6) months, employed by the Company, or request, influence or advise any person who at the time of such communication is employed by the Company to leave such employment; or
(ii) influence or advise any business that is or may be competitive with the business of the Company to employ any person who is employed by the Company; or
(iii) solicit or accept any customer or client of the Company to do business with any person or entity other than the Company or request, induce or advise any customer or client of the Company to withdraw, curtail, diminish or cease his, her or its business with the Company.
(iv) For purposes of Section 3(a), I understand and acknowledge the following for purposes of this Agreement:
(v) A business is or may be “competitive” with the Company if such business is engaged in banking, investment management, financial planning, trust administration or other related financial services;
(vi) to “employ” means to perform services as a common law employer or as an independent contractor for the Company or another person or entity;
(vii) if I advise others concerning the process of encouraging a person to become employed or a customer to do business, I will be considered to have solicited such person or customer regardless of whether I directly engage in solicitation of the person;
(viii) I shall be considered to “accept for employment” or “employ” any person who becomes employed by another employer if:
(A) I advise any bank or other business with which I am affiliated to consider such person for employment,
(B) I participate in any way in the consideration of any such person for employment, or
(C) such person becomes employed in a position in which I supervise such person;
(ix) I shall be considered to “accept” a customer or client if I perform services for such customer or client;
(x) a “customer or client of the Company” means any person or entity who or which did business with the Company during my employment with the Company; provided that, if my employment with the Company is limited exclusively to Boston Private Bank & Trust Company and its predecessors (the “Bank”), a “customer or client of the Company” shall be





limited to any person or entity who or which did business with the Bank during my employment with the Bank. for purposes of the post-employment restrictions in this Section 3.
(b) I hereby acknowledge the necessity of the protection provided to the Company under this Agreement. I have carefully considered the nature and scope of such protection. The Company and I hereby agree that the unique nature of the business of the Company and the nature of my services for the Company require the protection specified in this Agreement. The consideration described in this Agreement is sufficient and adequate to compensate me for agreeing to the restrictions contained herein. I acknowledge that I can continue to actively pursue my career and earn sufficient compensation without breaching any of the foregoing restrictions. The period of the post-employment restrictions in this Agreement is expressly represented and agreed to be fair, reasonable and necessary.
4. Other Obligations . I represent and warrant to the Company that I am not under any contract, agreement or restrictive covenant, and have not previously executed any documents whatsoever with any other person, firm, association, or corporation, that will, in any manner, prevent me from performing any of the job duties and responsibilities that may be assigned to me from time to time by the Company. I also represent and warrant that I will not bring and have not brought with me to the Company and that I will not use in the course and scope of my employment with the Company any confidential, proprietary and/or trade secret materials, documents or information that I obtained from a former employer or other individual or entity, without the express written authorization of the pertinent former employer or other individual or entity. I further represent and warrant that, during my employment with the Company, I will not breach any obligation or duty to maintain confidential and not to disclose or use that I may owe to any former employer or other individual or entity, and I agree to fulfill and comply with any and all such obligations and duties during my employment by the Company.
5. Notice to Future Employers and of Future Employment .
(a) I agree that during my employment with the Company and for the period of one (1) year following the termination of my employment with the Company for any reason, I will inform each prospective new employer I may have, prior to accepting employment, of the existence of this Agreement, and I shall provide each prospective employer with a copy of this Agreement.
(b) I also agree that during my employment with the Company and for the period of one (1) year following the termination of my employment with the Company for any reason, I shall notify the Company in writing of any subsequent engagement, occupation or employment, whether as owner, employee, officer, director, agent, consultant, independent contractor or the like, and my duties and responsibilities with respect to any such position.
6. Enforcement and Remedies . I hereby acknowledge that upon my breach of any of the covenants contained in this Agreement, the Company will suffer irreparable harm for which the remedy at law will be inadequate, and that an injunction may be entered against me by any court having jurisdiction, restraining me from breaching any of the provisions of this Agreement or continuing the breach of any such provisions, without the necessity of posting a bond. Resort to such equitable relief shall not be construed to be a waiver by the Company of any other rights or remedies that the Company may have to recover damages or other relief. In addition, if the Company prevails in an action to enforce this Agreement, I shall compensate the Company for its reasonable attorneys’ fees and related expenses incurred in enforcing this Agreement.
7. At-Will Employment . It is my understanding that the Company or I may terminate my employment at any time, with or without cause; provided that if I have entered into or in the future enter





into a separate written and fully executed employment agreement that expressly provides for employment on other than an at-will basis, my employment status pursuant to such agreement shall supersede the foregoing acknowledgment of at-will employment.
8. Amendment or Modification . This Agreement may not be changed or amended except in writing signed by myself and the Company.
9. Severability . All provisions, terms, conditions, paragraphs, agreements and covenants (“Provisions”) contained in this Agreement are severable and, in the event any one of them shall be held to be invalid, this Agreement shall be interpreted as if such Provision was not contained herein, and such determination shall not otherwise affect the validity of any other Provision.
10. Survival and Assignment by the Company . The Company may assign the rights given to it in this Agreement, and this Agreement shall survive any sale of assets, merger, consolidation, or other change in corporate structure. I understand that my obligations under this Agreement will continue in accordance with its express terms regardless of any changes in my title, position, duties, salary, compensation or benefits or other terms and conditions of employment or any transfer between Company entities and that no such changes shall constitute a termination of my employment. I also acknowledge that provisions of this Agreement shall continue in effect following the termination of my employment as specified above. Notwithstanding the foregoing, if my employment terminates without Cause upon or following a Change of Control or a Sale Event, my obligations under Section 3 (“Non-Solicitation/Non-Accept”) shall no longer be in effect. For purposes of this Agreement, (i) a termination without “Cause” shall have the same meaning as a Job Elimination, as that term is defined in the BPFH Severance Pay Plan as in effect on the date of this Agreement; and (ii) the terms “Change of Control” and “Sale Event” shall have the same meanings as set forth in the Plan.
11. Waiver . The waiver by the Company of any breach of any provision of this Agreement shall not be construed as a waiver of any subsequent breach of such provision or the breach of any other provision contained in this Agreement.
12. Governing Law . This Agreement shall be construed in accordance with and governed by the substantive laws of the Commonwealth of Massachusetts without regard to conflict of law provisions.
13. Knowledge of Rights and Duties . I have carefully reviewed and completely read all of the provisions of this Agreement and understand my rights, duties, obligations and responsibilities under this Agreement. I acknowledge that I am knowingly and voluntarily entering into this Agreement.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date shown below.

___________________________________________         Martha T. Higgins, Executive Vice President     
EMPLOYEE (Print Name)
FOR THE COMPANY (Print name, title & employer)

____________________________________     ___________________________________________                            
Signature                          Signature


DATE: ______________________________





EXHIBIT I (B): NON-SOLICITATION AND
CONFIDENTIALITY AGREEMENT (FOR CALIFORNIA RESIDENTS ONLY)

I acknowledge that I enter into this Non-Solicitation and Confidentiality Agreement (the “Agreement”) in connection with an award of restricted stock, restricted stock units or a grant of a stock option (together, an “Award”) that is made on or about the date of the proposal of this Agreement, pursuant to the Boston Private Financial Holdings, Inc. Amended and Restated 2009 Stock Option and Incentive Plan or any subsequent stock option and/or restricted stock plan of Boston Private Financial Holdings, Inc. (together, the “Plan”) and that I shall forfeit the Award (whether vested or unvested) if I do not execute this Non-Solicitation and Confidentiality Agreement (the “Agreement”) within 60 days of the grant date of the Award.
For purposes of this Agreement, the “Company” refers to Boston Private Financial Holdings, Inc. (“BPFH”) and any and all of its wholly or partially owned subsidiaries.
In consideration for my eligibility for any Award, I hereby agree as follows:
1. Confidential Information . During my employment with the Company and at all times thereafter, I shall keep secret and retain in strictest confidence, and shall not disclose or use, other than in the proper performance of my responsibilities for the Company, any Confidential Information. “Confidential Information” means any information, whether or not in writing, concerning the Company’s business or activities that the Company has not released to the general public. I acknowledge that all Confidential Information is the property of the Company. I understand that the term “Confidential Information” includes, but is not limited to financial statements, business plans, document templates, term sheets, policies and procedures, proprietary training materials, personnel, board materials and minutes, operations, customer and client lists and identities, potential customers and clients, vendor lists and agreements, employees, servicing methods, strategies and strategic planning materials, analyses, profit margins and other proprietary information in connection with the Company; provided , however, that Confidential Information shall not include any information which is generally known to the public or becomes known in the industry through no wrongful act on my part. Confidential Information also includes information received in confidence by the Company from its customers, clients or other third parties.
2. Return of Confidential Information and Other Property . I shall deliver to the Company all copies of Confidential Information and other Company property (which includes but is not limited to any documents, notes or other work product connected with or derived from my services to or affiliation with the Company, whether in electronic or paper form) in my possession or control upon the earlier of a request by the Company or termination of my employment.
3. Non-Solicitation . During my employment with the Company, and for the period ending on the first anniversary of the effective date of my termination of employment with the Company, I shall not, directly or indirectly, solicit any person then, or within the prior six (6) months, employed by the Company, or request, influence or advise any person who at the time of such communication is employed by the Company to leave such employment.
4. Other Obligations . I represent and warrant to the Company that I am not under any contract, agreement or restrictive covenant, and have not previously executed any documents whatsoever with any other person, firm, association, or corporation, that will, in any manner, prevent me from performing any of the job duties and responsibilities that may be assigned to me from time to time by the





Company. I also represent and warrant that I will not bring and have not brought with me to the Company and that I will not use in the course and scope of my employment with the Company any confidential, proprietary and/or trade secret materials, documents or information that I obtained from a former employer or other individual or entity, without the express written authorization of the pertinent former employer or other individual or entity. I further represent and warrant that, during my employment with the Company, I will not breach any obligation or duty to maintain confidential and not to disclose or use that I may owe to any former employer or other individual or entity, and I agree to fulfill and comply with any and all such obligations and duties during my employment by the Company.
5. Notice to Future Employers . I agree that during my employment with the Company and for the period of one (1) year following the termination of my employment with the Company for any reason, I will inform each prospective new employer I may have, prior to accepting employment, of the existence of this Agreement, and I shall provide each prospective employer with a copy of this Agreement. I also agree that the Company has the right to independently contact any potential or actual future employer of mine to notify the future employer of my obligations under this Agreement and provide such future employer with a copy of this Agreement.
6. Enforcement and Remedies . I hereby acknowledge that upon my breach of any of the covenants contained in this Agreement, the Company will suffer irreparable harm for which the remedy at law will be inadequate, and that an injunction may be entered against me by any court having jurisdiction, restraining me from breaching any of the provisions of this Agreement or continuing the breach of any such provisions, without the necessity of posting a bond. Resort to such equitable relief shall not be construed to be a waiver by the Company of any other rights or remedies that the Company may have to recover damages or other relief. In addition, if the Company prevails in an action to enforce this Agreement, I shall compensate the Company for its reasonable attorneys’ fees and related expenses incurred in enforcing this Agreement.
7. At-Will Employment . It is my understanding that the Company or I may terminate my employment at any time, with or without cause; provided that if I have entered into or in the future enter into a separate written and fully executed employment agreement that expressly provides for employment on other than an at-will basis, my employment status pursuant to such agreement shall supersede the foregoing acknowledgment of at-will employment.
8. Amendment or Modification . This Agreement may not be changed or amended except in writing signed by myself and the Company.
9. Severability . All provisions, terms, conditions, paragraphs, agreements and covenants (“Provisions”) contained in this Agreement are severable and, in the event any one of them shall be held to be invalid, this Agreement shall be interpreted as if such Provision was not contained herein, and such determination shall not otherwise affect the validity of any other Provision.
10. Survival and Assignment by the Company . The Company may assign the rights given to it in this Agreement, and this Agreement shall survive any sale of assets, merger, consolidation, or other change in corporate structure. I understand that my obligations under this Agreement will continue in accordance with its express terms regardless of any changes in my title, position, duties, salary, compensation or benefits or other terms and conditions of employment or any transfer between Company entities and that no such changes shall constitute a termination of my employment. I also acknowledge that provisions of this Agreement shall continue in effect following the termination of my employment as specified above. I also acknowledge that provisions of this Agreement shall continue in effect following the termination of my employment as specified above. Notwithstanding the foregoing, if my employment





terminates without Cause upon or following a Change of Control or a Sale Event, my obligations under Section 3 (“Non-Solicitation”) shall no longer be in effect. For purposes of this Agreement, (i) a termination without “Cause” shall have the same meaning as a Job Elimination, as that term is defined in the BPFH Severance Pay Plan as in effect on the date of this Agreement; and (ii) the terms “Change of Control” and “Sale Event” shall have the same meanings as set forth in the Plan.
11. Waiver . The waiver by the Company of any breach of any provision of this Agreement shall not be construed as a waiver of any subsequent breach of such provision or the breach of any other provision contained in this Agreement.
12. Governing Law . This Agreement shall be construed in accordance with and governed by the substantive laws of the State of California without regard to conflict of law provisions.
13. Knowledge of Rights and Duties . I have carefully reviewed and completely read all of the provisions of this Agreement and understand my rights, duties, obligations and responsibilities under this Agreement. I acknowledge that I am knowingly and voluntarily entering into this Agreement.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date shown below.

___________________________________________         Martha T. Higgins, Executive Vice President     
EMPLOYEE (Print Name)
FOR THE COMPANY (Print name, title & employer)

____________________________________     ___________________________________________                            
Signature                          Signature


DATE: ______________________________








SCHEDULE A
PERFORMANCE TARGETS






Exhibit 10.4

FORM OF
RESTRICTED STOCK UNIT AWARD AGREEMENT
UNDER THE BOSTON PRIVATE FINANCIAL HOLDINGS, INC.
AMENDED AND RESTATED
2009 STOCK OPTION AND INCENTIVE PLAN

Name of Grantee:
 
 
 
No. of Restricted Stock Units:
 
 
 
Grant Date:
 
Pursuant to the Boston Private Financial Holdings, Inc. Amended and Restated 2009 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), Boston Private Financial Holdings, Inc. (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $1.00 per share (the “Stock”) of the Company.
By accepting this Award, the Grantee confirms the Grantee’s agreement to all of the terms and conditions of any agreement between the Grantee and the Company or any of its subsidiaries that addresses confidentiality obligations and/or post-employment restrictions on solicitation of employees and customers or clients. If the Grantee is not a party to any such agreement, by accepting this Award, the Grantee agrees to the terms and conditions of the Non-Solicitation and Confidentiality Agreement attached as Exhibit I , hereto (the “Non-Solicitation Agreement”). The Non-Solicitation Agreement addresses confidentiality of Company information, post-employment restrictions on solicitation of employees and customers or clients and other similar matters and should be reviewed carefully by the Grantee. If this Award is not so accepted within 60 days of the Grant Date, the Grantee shall forfeit the Award in its entirety (regardless of whether vested or unvested).
1. Restrictions on Transfer of Award . This Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of by the Grantee, and any shares of Stock issuable with respect to the Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of until (i) the Restricted Stock Units have vested as provided in Paragraph 2 of this Agreement and (ii) shares of Stock have been issued to the Grantee in accordance with the terms of the Plan and this Agreement.

2. Vesting of Restricted Stock Units . The Grantee shall have no rights to this Award unless he or she shall have accepted the Award electronically through the Company’s Stock Plan Administration System. The restrictions and conditions in this Agreement shall lapse on the Vesting Date or Dates specified in the following schedule so long as the Grantee remains an employee of the Company or a Subsidiary on such Dates. If a series of Vesting Dates is specified, then the restrictions and conditions in Paragraph 1 shall lapse only with respect to the number of Restricted Stock Units specified as vested on such date.





Number of
Restricted Stock Units Vested
Vesting Date
_____________ (100%)
___________, 20__

3. Termination of Employment . Except as otherwise provided in this Paragraph 3, if the Grantee’s employment with the Company and its subsidiaries is voluntarily or involuntarily terminated for any reason prior to the Vesting Date, all Restricted Stock Units shall immediately and automatically be forfeited. Notwithstanding the foregoing, if the Grantee’s employment with the Company and its subsidiaries is terminated (a) due to the Grantee’s disability (as determined by the Administrator) or death, all Restricted Stock Units shall automatically become fully vested, subject to the provisions of the Plan, as of the date of the Grantee’s termination of employment, or (b) (i) due to Grantee’s Retirement or (ii) by the Company without Cause (as defined below), the Grantee shall be eligible to vest, with respect to a pro-rated portion of this Award, calculated based on (A) the number of days from the Grant Date through the date of the Grantee’s termination of employment, divided by (B) the number of days from the Grant Date through the Vesting Date; provided, however, that if the Grantee is terminated by the Company without Cause within the 24-month period following a Change of Control or Sale Event, all Restricted Stock Units shall automatically become fully vested, subject to the provisions of the Plan, as of the date of the Grantee’s termination of employment. The Administrator’s determination of the reason for termination of the Grantee’s employment shall be conclusive and binding on the Grantee and his or her representatives or legatees.

“Cause” means a termination of Grantee’s employment as a result of (i) conviction of the Grantee of, or plea of guilty or nolo contendere by the Grantee to, a felony, or (ii) dishonest acts against the Company or any of its subsidiaries, or (iii) misconduct which is likely to cause financial loss to the Company or any of its subsidiaries or to cause damage to the business reputation of the Company or any of its subsidiaries, or (iv) willful or repeated misconduct or gross neglect constituting bad faith in performing the Grantee’s duties with the Company, or (v) breach of fiduciary duty involving personal profit to the Grantee. For purposes of clause (iv), no act, or failure to act, on the Grantee’s part shall be deemed “willful” unless done, or omitted to be done, by the Grantee without reasonable belief that the Grantee’s act, or failure to act, was in the best interest of the Company and any of its subsidiaries. In the event the Grantee is a party to an employment agreement with the Company or any subsidiary that contains a different definition of “cause,” the definition set forth in such other agreement shall be applicable to the Grantee for purposes of this Agreement and not this definition.
4. Change of Control . Notwithstanding the provisions of Paragraph 3 above, or the provisions of any agreement between the Grantee and Company or any subsidiary that is in effect as of the date hereof, in the event of a Change of Control or Sale Event prior to the Vesting Date, (i) if, in connection with such Change of Control or Sale Event, this Award is not assumed or continued by the successor entity in such Change of Control or Sale Event or substituted with a new award of such successor (in accordance with the Plan), the Restricted Stock Units shall automatically become fully vested, subject to the provisions of the Plan, as of the effective time of such Change of Control or Sale Event, and (ii) if this Award is assumed or continued by the successor entity in such Change of Control or Sale Event or substituted with a new award of such successor subject to the provisions of the Plan, the Restricted Stock Units shall vest in accordance with Paragraphs 2 and 3 of this Agreement (as applicable), subject, in each case, to the terms of the Plan.

5. Issuance of Shares of Stock . As soon as practicable following each Vesting Date (but in no event later than thirty days after the Vesting Date), the Company shall (i) issue to the Grantee the number of shares of Stock equal to the aggregate number of Restricted Stock Units that have vested pursuant to





Paragraphs 2 or 3 of this Agreement on such date and the Grantee shall thereafter have all the rights of a stockholder of the Company with respect to such shares, and (ii) pay in cash to the Grantee an amount equal to the product of (x) the amount of dividends payable per share of Stock since the Grant Date and (y) the number of Restricted Stock Units that have vested pursuant to Paragraph 2 of this Agreement on such date.

6. Incorporation of Plan . Notwithstanding anything herein to the contrary, this Agreement shall be subject to and governed by all the terms and conditions of the Plan, including the powers of the Administrator set forth in Section 2(b) of the Plan. Capitalized terms in this Agreement shall have the meaning specified in the Plan, unless a different meaning is specified herein.

7. Tax Withholding . The Grantee shall, not later than the date as of which the receipt of this Award becomes a taxable event for Federal income tax purposes, pay to the Company or make arrangements satisfactory to the Administrator for payment of any Federal, state, and local taxes required by law to be withheld on account of such taxable event. The Grantee may elect to have, and the Company shall have the authority to cause, the required minimum tax withholding obligation satisfied, in whole or in part, by authorizing the Company to withhold from shares of Stock to be issued or released by the transfer agent a number of shares of Stock with an aggregate Fair Market Value that would satisfy the withholding amount due.

8. Section 409A of the Code. This Agreement shall be interpreted in such a manner that all provisions relating to the settlement of the Award are exempt from the requirements of Section 409A of the Code as “short-term deferrals” as described in Section 409A of the Code.

9. No Obligation to Continue Employment . Neither the Company nor any subsidiary is obligated by or as a result of the Plan or this Agreement to continue the Grantee in employment and neither the Plan nor this Agreement shall interfere in any way with the right of the Company or any subsidiary to terminate the employment of the Grantee at any time.

10. Clawback . This Award and any Restricted Stock Units granted hereunder (and any gains thereon) shall be subject to recovery or “clawback” by the Company if and to the extent that the vesting of such Restricted Stock Units was determined or calculated based on materially inaccurate financial statements or any other material inaccurate performance metric criteria. If the Company or its subsidiaries terminate the Grantee’s service relationship due to the Grantee’s gross negligence or willful misconduct (whether or not such actions also constitute Cause hereunder), which conduct, directly or indirectly results in the Company preparing an accounting restatement, and/or if the Grantee breaches any provision of the Non-Solicitation Agreement (or, if applicable, such other agreement referenced in Paragraph 1 above), any Restricted Stock Units granted hereunder, whether or not vested, (and any gains thereon) shall be subject to forfeiture, recovery and “clawback.”

11. Data Privacy Consent . In order to administer the Plan and this Agreement and to implement or structure future equity grants, the Company, its subsidiaries and affiliates and certain agents thereof (together, the “Relevant Companies”) may process any and all personal or professional data, including but not limited to Social Security or other identification number, home address and telephone number, date of birth and other information that is necessary or desirable for the administration of the Plan and/or this Agreement (the “Relevant Information”). By entering into this Agreement, the Grantee (i) authorizes the Company to collect, process, register and transfer to the Relevant Companies all Relevant Information; (ii) waives any privacy rights the Grantee may have with respect to the Relevant Information; (iii) authorizes the Relevant Companies to store and transmit such information in electronic





form; and (iv) authorizes the transfer of the Relevant Information to any jurisdiction in which the Relevant Companies consider appropriate. The Grantee shall have access to, and the right to change, the Relevant Information. Relevant Information will only be used in accordance with applicable law.

12. Notices . Notices hereunder shall be mailed or delivered to the Company at its principal place of business and shall be mailed or delivered to the Grantee at the address on file with the Company or, in either case, at such other address as one party may subsequently furnish to the other party in writing.

BOSTON PRIVATE FINANCIAL
HOLDINGS, INC.
By: _________________________________________         
Title:

The foregoing Agreement is hereby accepted and the terms and conditions thereof hereby agreed to by the undersigned. Electronic acceptance of this Agreement pursuant to the Company’s instructions to the Grantee (including through an online acceptance process) is acceptable.



Dated: ______________________             __________________________________________________        
Grantee’s Signature

Grantee’s name and address:
___________________________________________
___________________________________________
___________________________________________


    
    
    






EXHIBIT I (A): NON-SOLICITATION AND
CONFIDENTIALITY AGREEMENT FOR NON-CALIFORNIA RESIDENTS

I acknowledge that I enter into this Non-Solicitation and Confidentiality Agreement (the “Agreement”) in connection with an award of restricted stock, restricted stock units or a grant of a stock option (together, an “Award”) that is made on or about the date of the proposal of this Agreement, pursuant to the Boston Private Financial Holdings, Inc. Amended and Restated 2009 Stock Option and Incentive Plan or any subsequent stock option and/or restricted stock plan of Boston Private Financial Holdings, Inc. (together, the “Plan”) and that I shall forfeit the Award (whether vested or unvested) if I do not execute this Non-Solicitation and Confidentiality Agreement (the “Agreement”) within 60 days of the grant date of the Award.
For purposes of this Agreement, the “Company” refers to Boston Private Financial Holdings, Inc. (“BPFH”) and any and all of its wholly or partially owned subsidiaries.
In consideration for my eligibility for any Award, I hereby agree as follows:
1. Confidential Information . During my employment with the Company and at all times thereafter, I shall keep secret and retain in strictest confidence, and shall not disclose or use, other than in the proper performance of my responsibilities for the Company, any Confidential Information. “Confidential Information” means any information, whether or not in writing, concerning the Company’s business or activities that the Company has not released to the general public. I acknowledge that all Confidential Information is the property of the Company. I understand that the term “Confidential Information” includes, but is not limited to financial statements, business plans, document templates, term sheets, policies and procedures, proprietary training materials, personnel, board materials and minutes, operations, customer and client lists and identities, potential customers and clients, vendor lists and agreements, employees, servicing methods, strategies and strategic planning materials, analyses, profit margins and other proprietary information in connection with the Company; provided , however, that Confidential Information shall not include any information which is generally known to the public or becomes known in the industry through no wrongful act on my part. Confidential Information also includes information received in confidence by the Company from its customers, clients or other third parties.

2. Return of Confidential Information and Other Property . I shall deliver to the Company all copies of Confidential Information and other Company property (which includes but is not limited to any documents, notes or other work product connected with or derived from my services to or affiliation with the Company, whether in electronic or paper form) in my possession or control upon the earlier of a request by the Company or termination of my employment.

3. Non-Solicitation/Non-Accept .

(a) During my employment with the Company, and for the period ending on the first anniversary of the effective date of my termination of employment with the Company, I shall not directly or indirectly:

(i) solicit or accept for employment with another employer or employ any person then, or within the prior six (6) months, employed by the Company, or request, influence or advise any person who at the time of such communication is employed by the Company to leave such employment; or






(ii) influence or advise any business that is or may be competitive with the business of the Company to employ any person who is employed by the Company; or

(iii) solicit or accept any customer or client of the Company to do business with any person or entity other than the Company or request, induce or advise any customer or client of the Company to withdraw, curtail, diminish or cease his, her or its business with the Company.

(iv) For purposes of Section 3(a), I understand and acknowledge the following for purposes of this Agreement:
(A) A business is or may be “competitive” with the Company if such business is engaged in banking, investment management, financial planning, trust administration or other related financial services;
(B) to “employ” means to perform services as a common law employer or as an independent contractor for the Company or another person or entity;
(C) if I advise others concerning the process of encouraging a person to become employed or a customer to do business, I will be considered to have solicited such person or customer regardless of whether I directly engage in solicitation of the person;
(D) I shall be considered to “accept for employment” or “employ” any person who becomes employed by another employer if:
(1) I advise any bank or other business with which I am affiliated to consider such person for employment,
(2) I participate in any way in the consideration of any such person for employment, or
(3) such person becomes employed in a position in which I supervise such person;
(E) I shall be considered to “accept” a customer or client if I perform services for such customer or client;
(F) a “customer or client of the Company” means any person or entity who or which did business with the Company during my employment with the Company; provided that, if my employment with the Company is limited exclusively to Boston Private Bank & Trust Company and its predecessors (the “Bank”), a “customer or client of the Company” shall be limited to any person or entity who or which did business with the Bank during my employment with the Bank. for purposes of the post-employment restrictions in this Section 3.
(b) I hereby acknowledge the necessity of the protection provided to the Company under this Agreement. I have carefully considered the nature and scope of such protection. The Company and I hereby agree that the unique nature of the business of the Company and the nature of my services for the Company require the protection specified in this Agreement. The consideration described in this Agreement is sufficient and adequate to compensate me for agreeing to the restrictions contained herein. I acknowledge that I can continue to actively pursue my career and earn sufficient compensation without





breaching any of the foregoing restrictions. The period of the post-employment restrictions in this Agreement is expressly represented and agreed to be fair, reasonable and necessary.

4. Other Obligations . I represent and warrant to the Company that I am not under any contract, agreement or restrictive covenant, and have not previously executed any documents whatsoever with any other person, firm, association, or corporation, that will, in any manner, prevent me from performing any of the job duties and responsibilities that may be assigned to me from time to time by the Company. I also represent and warrant that I will not bring and have not brought with me to the Company and that I will not use in the course and scope of my employment with the Company any confidential, proprietary and/or trade secret materials, documents or information that I obtained from a former employer or other individual or entity, without the express written authorization of the pertinent former employer or other individual or entity. I further represent and warrant that, during my employment with the Company, I will not breach any obligation or duty to maintain confidential and not to disclose or use that I may owe to any former employer or other individual or entity, and I agree to fulfill and comply with any and all such obligations and duties during my employment by the Company.

5. Notice to Future Employers and of Future Employment .

(a) I agree that during my employment with the Company and for the period of one (1) year following the termination of my employment with the Company for any reason, I will inform each prospective new employer I may have, prior to accepting employment, of the existence of this Agreement, and I shall provide each prospective employer with a copy of this Agreement.
  
(b) I also agree that during my employment with the Company and for the period of one (1) year following the termination of my employment with the Company for any reason, I shall notify the Company in writing of any subsequent engagement, occupation or employment, whether as owner, employee, officer, director, agent, consultant, independent contractor or the like, and my duties and responsibilities with respect to any such position.

6. Enforcement and Remedies . I hereby acknowledge that upon my breach of any of the covenants contained in this Agreement, the Company will suffer irreparable harm for which the remedy at law will be inadequate, and that an injunction may be entered against me by any court having jurisdiction, restraining me from breaching any of the provisions of this Agreement or continuing the breach of any such provisions, without the necessity of posting a bond. Resort to such equitable relief shall not be construed to be a waiver by the Company of any other rights or remedies that the Company may have to recover damages or other relief. In addition, if the Company prevails in an action to enforce this Agreement, I shall compensate the Company for its reasonable attorneys’ fees and related expenses incurred in enforcing this Agreement.

7. At-Will Employment . It is my understanding that the Company or I may terminate my employment at any time, with or without cause; provided that if I have entered into or in the future enter into a separate written and fully executed employment agreement that expressly provides for employment on other than an at-will basis, my employment status pursuant to such agreement shall supersede the foregoing acknowledgment of at-will employment.

8. Amendment or Modification . This Agreement may not be changed or amended except in writing signed by myself and the Company.






9. Severability . All provisions, terms, conditions, paragraphs, agreements and covenants (“Provisions”) contained in this Agreement are severable and, in the event any one of them shall be held to be invalid, this Agreement shall be interpreted as if such Provision was not contained herein, and such determination shall not otherwise affect the validity of any other Provision.
  
10. Survival and Assignment by the Company . The Company may assign the rights given to it in this Agreement, and this Agreement shall survive any sale of assets, merger, consolidation, or other change in corporate structure. I understand that my obligations under this Agreement will continue in accordance with its express terms regardless of any changes in my title, position, duties, salary, compensation or benefits or other terms and conditions of employment or any transfer between Company entities and that no such changes shall constitute a termination of my employment. I also acknowledge that provisions of this Agreement shall continue in effect following the termination of my employment as specified above. Notwithstanding the foregoing, if my employment terminates without Cause upon or following a Change of Control or a Sale Event, my obligations under Section 3 (“Non-Solicitation/Non-Accept”) shall no longer be in effect. For purposes of this Agreement, (i) a termination without “Cause” shall have the same meaning as a Job Elimination, as that term is defined in the BPFH Severance Pay Plan as in effect on the date of this Agreement; and (ii) the terms “Change of Control” and “Sale Event” shall have the same meanings as set forth in the Plan.

11. Waiver . The waiver by the Company of any breach of any provision of this Agreement shall not be construed as a waiver of any subsequent breach of such provision or the breach of any other provision contained in this Agreement.

12. Governing Law . This Agreement shall be construed in accordance with and governed by the substantive laws of the Commonwealth of Massachusetts without regard to conflict of law provisions.
  
13. Knowledge of Rights and Duties . I have carefully reviewed and completely read all of the provisions of this Agreement and understand my rights, duties, obligations and responsibilities under this Agreement. I acknowledge that I am knowingly and voluntarily entering into this Agreement.

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date shown below.

___________________________________________         Martha T. Higgins, Executive Vice President     
EMPLOYEE (Print Name)
FOR THE COMPANY (Print name, title & employer)

____________________________________     ___________________________________________                            
Signature                          Signature


DATE: ______________________________







EXHIBIT I (B): NON-SOLICITATION AND
CONFIDENTIALITY AGREEMENT (FOR CALIFORNIA RESIDENTS ONLY)

I acknowledge that I enter into this Non-Solicitation and Confidentiality Agreement (the “Agreement”) in connection with an award of restricted stock, restricted stock units or a grant of a stock option (together, an “Award”) that is made on or about the date of the proposal of this Agreement, pursuant to the Boston Private Financial Holdings, Inc. Amended and Restated 2009 Stock Option and Incentive Plan or any subsequent stock option and/or restricted stock plan of Boston Private Financial Holdings, Inc. (together, the “Plan”) and that I shall forfeit the Award (whether vested or unvested) if I do not execute this Non-Solicitation and Confidentiality Agreement (the “Agreement”) within 60 days of the grant date of the Award.
For purposes of this Agreement, the “Company” refers to Boston Private Financial Holdings, Inc. (“BPFH”) and any and all of its wholly or partially owned subsidiaries.
In consideration for my eligibility for any Award, I hereby agree as follows:
1. Confidential Information . During my employment with the Company and at all times thereafter, I shall keep secret and retain in strictest confidence, and shall not disclose or use, other than in the proper performance of my responsibilities for the Company, any Confidential Information. “Confidential Information” means any information, whether or not in writing, concerning the Company’s business or activities that the Company has not released to the general public. I acknowledge that all Confidential Information is the property of the Company. I understand that the term “Confidential Information” includes, but is not limited to financial statements, business plans, document templates, term sheets, policies and procedures, proprietary training materials, personnel, board materials and minutes, operations, customer and client lists and identities, potential customers and clients, vendor lists and agreements, employees, servicing methods, strategies and strategic planning materials, analyses, profit margins and other proprietary information in connection with the Company; provided , however, that Confidential Information shall not include any information which is generally known to the public or becomes known in the industry through no wrongful act on my part. Confidential Information also includes information received in confidence by the Company from its customers, clients or other third parties.
2. Return of Confidential Information and Other Property . I shall deliver to the Company all copies of Confidential Information and other Company property (which includes but is not limited to any documents, notes or other work product connected with or derived from my services to or affiliation with the Company, whether in electronic or paper form) in my possession or control upon the earlier of a request by the Company or termination of my employment.
3. Non-Solicitation . During my employment with the Company, and for the period ending on the first anniversary of the effective date of my termination of employment with the Company, I shall not, directly or indirectly, solicit any person then, or within the prior six (6) months, employed by the Company, or request, influence or advise any person who at the time of such communication is employed by the Company to leave such employment.
4. Other Obligations . I represent and warrant to the Company that I am not under any contract, agreement or restrictive covenant, and have not previously executed any documents whatsoever with any other person, firm, association, or corporation, that will, in any manner, prevent me from performing any of the job duties and responsibilities that may be assigned to me from time to time by the





Company. I also represent and warrant that I will not bring and have not brought with me to the Company and that I will not use in the course and scope of my employment with the Company any confidential, proprietary and/or trade secret materials, documents or information that I obtained from a former employer or other individual or entity, without the express written authorization of the pertinent former employer or other individual or entity. I further represent and warrant that, during my employment with the Company, I will not breach any obligation or duty to maintain confidential and not to disclose or use that I may owe to any former employer or other individual or entity, and I agree to fulfill and comply with any and all such obligations and duties during my employment by the Company.
5. Notice to Future Employers . I agree that during my employment with the Company and for the period of one (1) year following the termination of my employment with the Company for any reason, I will inform each prospective new employer I may have, prior to accepting employment, of the existence of this Agreement, and I shall provide each prospective employer with a copy of this Agreement. I also agree that the Company has the right to independently contact any potential or actual future employer of mine to notify the future employer of my obligations under this Agreement and provide such future employer with a copy of this Agreement.
6. Enforcement and Remedies . I hereby acknowledge that upon my breach of any of the covenants contained in this Agreement, the Company will suffer irreparable harm for which the remedy at law will be inadequate, and that an injunction may be entered against me by any court having jurisdiction, restraining me from breaching any of the provisions of this Agreement or continuing the breach of any such provisions, without the necessity of posting a bond. Resort to such equitable relief shall not be construed to be a waiver by the Company of any other rights or remedies that the Company may have to recover damages or other relief. In addition, if the Company prevails in an action to enforce this Agreement, I shall compensate the Company for its reasonable attorneys’ fees and related expenses incurred in enforcing this Agreement.
7. At-Will Employment . It is my understanding that the Company or I may terminate my employment at any time, with or without cause; provided that if I have entered into or in the future enter into a separate written and fully executed employment agreement that expressly provides for employment on other than an at-will basis, my employment status pursuant to such agreement shall supersede the foregoing acknowledgment of at-will employment.
8. Amendment or Modification . This Agreement may not be changed or amended except in writing signed by myself and the Company.
9. Severability . All provisions, terms, conditions, paragraphs, agreements and covenants (“Provisions”) contained in this Agreement are severable and, in the event any one of them shall be held to be invalid, this Agreement shall be interpreted as if such Provision was not contained herein, and such determination shall not otherwise affect the validity of any other Provision.
10. Survival and Assignment by the Company . The Company may assign the rights given to it in this Agreement, and this Agreement shall survive any sale of assets, merger, consolidation, or other change in corporate structure. I understand that my obligations under this Agreement will continue in accordance with its express terms regardless of any changes in my title, position, duties, salary, compensation or benefits or other terms and conditions of employment or any transfer between Company entities and that no such changes shall constitute a termination of my employment. I also acknowledge that provisions of this Agreement shall continue in effect following the termination of my employment as specified above. I also acknowledge that provisions of this Agreement shall continue in effect following the termination of my employment as specified above. Notwithstanding the foregoing, if my employment





terminates without Cause upon or following a Change of Control or a Sale Event, my obligations under Section 3 (“Non-Solicitation”) shall no longer be in effect. For purposes of this Agreement, (i) a termination without “Cause” shall have the same meaning as a Job Elimination, as that term is defined in the BPFH Severance Pay Plan as in effect on the date of this Agreement; and (ii) the terms “Change of Control” and “Sale Event” shall have the same meanings as set forth in the Plan.
11. Waiver . The waiver by the Company of any breach of any provision of this Agreement shall not be construed as a waiver of any subsequent breach of such provision or the breach of any other provision contained in this Agreement.
12. Governing Law . This Agreement shall be construed in accordance with and governed by the substantive laws of the State of California without regard to conflict of law provisions.
13. Knowledge of Rights and Duties . I have carefully reviewed and completely read all of the provisions of this Agreement and understand my rights, duties, obligations and responsibilities under this Agreement. I acknowledge that I am knowingly and voluntarily entering into this Agreement.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date shown below.

___________________________________          Martha T. Higgins, Executive Vice President
EMPLOYEE (Print Name)
FOR THE COMPANY (Print name, title & employer)

___________________________________          ____________________________________
Signature                          Signature


DATE:_____________________________




Exhibit 10.5

FORM OF

RESTRICTED STOCK UNIT AWARD AGREEMENT
UNDER THE BOSTON PRIVATE FINANCIAL HOLDINGS, INC.
2010 INDUCEMENT STOCK PLAN

Name of Grantee:
 
 
 
No. of Restricted Stock Units:
 
 
 
Grant Date:
 
Pursuant to the Boston Private Financial Holdings, Inc. 2010 Inducement Stock Plan as amended through the date hereof (the “Plan”), Boston Private Financial Holdings, Inc. (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $1.00 per share (the “Stock”) of the Company.
By accepting this Award, the Grantee confirms the Grantee’s agreement to all of the terms and conditions of any agreement between the Grantee and the Company or any of its subsidiaries that addresses confidentiality obligations and/or post-employment restrictions on solicitation of employees and customers or clients. If the Grantee is not a party to any such agreement, by accepting this Award, the Grantee agrees to the terms and conditions of the Non-Solicitation and Confidentiality Agreement attached as Exhibit I , hereto (the “Non-Solicitation Agreement”). The Non-Solicitation Agreement addresses confidentiality of Company information, post-employment restrictions on solicitation of employees and customers or clients and other similar matters and should be reviewed carefully by the Grantee. If this Award is not so accepted within 60 days of the Grant Date, the Grantee shall forfeit the Award in its entirety (regardless of whether vested or unvested).
1. Restrictions on Transfer of Award . This Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of by the Grantee, and any shares of Stock issuable with respect to the Award may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of until (i) the Restricted Stock Units have vested as provided in Paragraph 2 of this Agreement and (ii) shares of Stock have been issued to the Grantee in accordance with the terms of the Plan and this Agreement.
2. Vesting of Restricted Stock Units . The Grantee shall have no rights to this Award unless he or she shall have accepted the Award electronically through the Company’s Stock Plan Administration System. The restrictions and conditions in this Agreement shall lapse on the Vesting Date or Dates specified in the following schedule so long as the Grantee remains an employee of the Company or a Subsidiary on such Dates. If a series of Vesting Dates is specified, then the restrictions and conditions in Paragraph 1 shall lapse only with respect to the number of Restricted Stock Units specified as vested on such date.





Number of
Restricted Stock Units Vested
Vesting Date
_____________ (100%)
_______________, 20__
3. Termination of Employment . Except as otherwise provided in this Paragraph 3, if the Grantee’s employment with the Company and its subsidiaries is voluntarily or involuntarily terminated for any reason prior to the Vesting Date, all Restricted Stock Units shall immediately and automatically be forfeited. Notwithstanding the foregoing, if the Grantee’s employment with the Company and its subsidiaries is terminated (a) due to the Grantee’s disability (as determined by the Administrator) or death, all Restricted Stock Units shall automatically become fully vested, subject to the provisions of the Plan, as of the date of the Grantee’s termination of employment, or (b) (i) due to Grantee’s Retirement or (ii) by the Company without Cause (as defined below) the Grantee shall be eligible to vest with respect to a pro-rated portion of the Award, calculated based on (A) the number of days from the Grant Date through the date of the Grantee’s termination of employment, divided by (B) the number of days from the Grant Date through the Vesting Date; provided, however, that if the Grantee is terminated by the Company without Cause within the 24-month period following a Change of Control or Sale Event, all Restricted Stock Units shall automatically become fully vested, subject to the provisions of the Plan, as of the date of the Grantee’s termination of employment. The Administrator’s determination of the reason for termination of the Grantee’s employment shall be conclusive and binding on the Grantee and his or her representatives or legatees.
“Cause” means a termination of Grantee’s employment as a result of (i) conviction of the Grantee of, or plea of guilty or nolo contendere by the Grantee to, a felony, or (ii) dishonest acts against the Company or any of its subsidiaries, or (iii) misconduct which is likely to cause financial loss to the Company or any of its subsidiaries or to cause damage to the business reputation of the Company or any of its subsidiaries, or (iv) willful or repeated misconduct or gross neglect constituting bad faith in performing the Grantee’s duties with the Company, or (v) breach of fiduciary duty involving personal profit to the Grantee. For purposes of clause (iv), no act, or failure to act, on the Grantee’s part shall be deemed “willful” unless done, or omitted to be done, by the Grantee without reasonable belief that the Grantee’s act, or failure to act, was in the best interest of the Company and any of its subsidiaries. In the event the Grantee is a party to an employment agreement with the Company or any subsidiary that contains a different definition of “cause,” the definition set forth in such other agreement shall be applicable to the Grantee for purposes of this Agreement and not this definition.
4. Change of Control . Notwithstanding the provisions of Paragraph 3 above, or the provisions of any agreement between the Grantee and Company or any subsidiary that is in effect as of the date hereof, in the event of a Change of Control or Sale Event prior to the Vesting Date, (i) if, in connection with such Change of Control or Sale Event, this Award is not assumed or continued by the successor entity in such Change of Control or Sale Event or substituted with a new award of such successor (in accordance with the Plan), the Restricted Stock Units shall automatically become fully vested, subject to the provisions of the Plan, as of the effective time of such Change of Control or Sale Event, and (ii) if this Award is assumed or continued by the successor entity in such Change of Control or Sale Event or substituted with a new award of such successor subject to the provisions of the Plan, the Restricted Stock Units shall vest in accordance with Paragraphs 2 and 3 of this Agreement (as applicable), subject, in each case, to the terms of the Plan.
5. Issuance of Shares of Stock . As soon as practicable following each Vesting Date (but in no event later than thirty days after the Vesting Date), the Company shall (i) issue to the Grantee the number of shares of Stock equal to the aggregate number of Restricted Stock Units that have vested pursuant to





Paragraphs 2 and 3 of this Agreement on such date and the Grantee shall thereafter have all the rights of a stockholder of the Company with respect to such shares, and (ii) pay in cash to the Grantee an amount equal to the product of (x) the amount of dividends payable per share of Stock since the Grant Date and (y) the number of Restricted Stock Units that have vested pursuant to Paragraph 2 of this Agreement on such date.
6. Incorporation of Plan . Notwithstanding anything herein to the contrary, this Agreement shall be subject to and governed by all the terms and conditions of the Plan, including the powers of the Administrator set forth in Section 2(b) of the Plan. Capitalized terms in this Agreement shall have the meaning specified in the Plan, unless a different meaning is specified herein.
7. Tax Withholding . The Grantee shall, not later than the date as of which the receipt of this Award becomes a taxable event for Federal income tax purposes, pay to the Company or make arrangements satisfactory to the Administrator for payment of any Federal, state, and local taxes required by law to be withheld on account of such taxable event. The Grantee may elect to have, and the Company shall have the authority to cause, the required minimum tax withholding obligation satisfied, in whole or in part, by authorizing the Company to withhold from shares of Stock to be issued or released by the transfer agent a number of shares of Stock with an aggregate Fair Market Value that would satisfy the withholding amount due.
8. Section 409A of the Code. This Agreement shall be interpreted in such a manner that all provisions relating to the settlement of the Award are exempt from the requirements of Section 409A of the Code as “short-term deferrals” as described in Section 409A of the Code.
9. No Obligation to Continue Employment . Neither the Company nor any subsidiary is obligated by or as a result of the Plan or this Agreement to continue the Grantee in employment and neither the Plan nor this Agreement shall interfere in any way with the right of the Company or any subsidiary to terminate the employment of the Grantee at any time.
10. Clawback . This Award and any Restricted Stock Units granted hereunder (and any gains thereon) shall be subject to recovery or “clawback” by the Company if and to the extent that the vesting of such Restricted Stock Units was determined or calculated based on materially inaccurate financial statements or any other material inaccurate performance metric criteria. If the Company or its subsidiaries terminate the Grantee’s service relationship due to the Grantee’s gross negligence or willful misconduct (whether or not such actions also constitute Cause hereunder), which conduct, directly or indirectly results in the Company preparing an accounting restatement, and/or if the Grantee breaches any provision of the Non-Solicitation Agreement (or, if applicable, such other agreement referenced in Paragraph 1 above), any Restricted Stock Units granted hereunder, whether or not vested, (and any gains thereon) shall be subject to forfeiture, recovery and “clawback.”
11. Data Privacy Consent . In order to administer the Plan and this Agreement and to implement or structure future equity grants, the Company, its subsidiaries and affiliates and certain agents thereof (together, the “Relevant Companies”) may process any and all personal or professional data, including but not limited to Social Security or other identification number, home address and telephone number, date of birth and other information that is necessary or desirable for the administration of the Plan and/or this Agreement (the “Relevant Information”). By entering into this Agreement, the Grantee (i) authorizes the Company to collect, process, register and transfer to the Relevant Companies all Relevant Information; (ii) waives any privacy rights the Grantee may have with respect to the Relevant Information; (iii) authorizes the Relevant Companies to store and transmit such information in electronic form; and (iv) authorizes the transfer of the Relevant Information to any jurisdiction in which the Relevant





Companies consider appropriate. The Grantee shall have access to, and the right to change, the Relevant Information. Relevant Information will only be used in accordance with applicable law.
12. Notices . Notices hereunder shall be mailed or delivered to the Company at its principal place of business and shall be mailed or delivered to the Grantee at the address on file with the Company or, in either case, at such other address as one party may subsequently furnish to the other party in writing.
BOSTON PRIVATE FINANCIAL
HOLDINGS, INC.
By: _________________________________________         
Title:
The foregoing Agreement is hereby accepted and the terms and conditions thereof hereby agreed to by the undersigned. Electronic acceptance of this Agreement pursuant to the Company’s instructions to the Grantee (including through an online acceptance process) is acceptable.



Dated: ______________________             __________________________________________________        
Grantee’s Signature

Grantee’s name and address:
___________________________________________
___________________________________________
___________________________________________
    
    
    





EXHIBIT I (A): NON-SOLICITATION AND
CONFIDENTIALITY AGREEMENT FOR NON-CALIFORNIA RESIDENTS

I acknowledge that I enter into this Non-Solicitation and Confidentiality Agreement (the “Agreement”) in connection with an award of restricted stock, restricted stock units or a grant of a stock option (together, an “Award”) that is made on or about the date of the proposal of this Agreement, pursuant to the Boston Private Financial Holdings, Inc. 2010 Inducement Stock Plan or any subsequent stock option and/or restricted stock plan of Boston Private Financial Holdings, Inc. (together, the “Plan”) and that I shall forfeit the Award (whether vested or unvested) if I do not execute this Non-Solicitation and Confidentiality Agreement (the “Agreement”) within 60 days of the grant date of the Award.
For purposes of this Agreement, the “Company” refers to Boston Private Financial Holdings, Inc. (“BPFH”) and any and all of its wholly or partially owned subsidiaries.
In consideration for my eligibility for any Award, I hereby agree as follows:
1. Confidential Information . During my employment with the Company and at all times thereafter, I shall keep secret and retain in strictest confidence, and shall not disclose or use, other than in the proper performance of my responsibilities for the Company, any Confidential Information. “Confidential Information” means any information, whether or not in writing, concerning the Company’s business or activities that the Company has not released to the general public. I acknowledge that all Confidential Information is the property of the Company. I understand that the term “Confidential Information” includes, but is not limited to financial statements, business plans, document templates, term sheets, policies and procedures, proprietary training materials, personnel, board materials and minutes, operations, customer and client lists and identities, potential customers and clients, vendor lists and agreements, employees, servicing methods, strategies and strategic planning materials, analyses, profit margins and other proprietary information in connection with the Company; provided , however, that Confidential Information shall not include any information which is generally known to the public or becomes known in the industry through no wrongful act on my part. Confidential Information also includes information received in confidence by the Company from its customers, clients or other third parties.
2. Return of Confidential Information and Other Property . I shall deliver to the Company all copies of Confidential Information and other Company property (which includes but is not limited to any documents, notes or other work product connected with or derived from my services to or affiliation with the Company, whether in electronic or paper form) in my possession or control upon the earlier of a request by the Company or termination of my employment.
3. Non-Solicitation/Non-Accept .
(a) During my employment with the Company, and for the period ending on the first anniversary of the effective date of my termination of employment with the Company, I shall not directly or indirectly:
(i) solicit or accept for employment with another employer or employ any person then, or within the prior six (6) months, employed by the Company, or request, influence or advise any person who at the time of such communication is employed by the Company to leave such employment; or





(ii) influence or advise any business that is or may be competitive with the business of the Company to employ any person who is employed by the Company; or
(iii) solicit or accept any customer or client of the Company to do business with any person or entity other than the Company or request, induce or advise any customer or client of the Company to withdraw, curtail, diminish or cease his, her or its business with the Company.
(iv) For purposes of Section 3(a), I understand and acknowledge the following for purposes of this Agreement:
(A) A business is or may be “competitive” with the Company if such business is engaged in banking, investment management, financial planning, trust administration or other related financial services;
(B) to “employ” means to perform services as a common law employer or as an independent contractor for the Company or another person or entity;
(C) if I advise others concerning the process of encouraging a person to become employed or a customer to do business, I will be considered to have solicited such person or customer regardless of whether I directly engage in solicitation of the person;
(D) I shall be considered to “accept for employment” or “employ” any person who becomes employed by another employer if:
(1) I advise any bank or other business with which I am affiliated to consider such person for employment,
(2) I participate in any way in the consideration of any such person for employment, or
(3) such person becomes employed in a position in which I supervise such person;
(E) I shall be considered to “accept” a customer or client if I perform services for such customer or client;
(F) a “customer or client of the Company” means any person or entity who or which did business with the Company during my employment with the Company; provided that, if my employment with the Company is limited exclusively to Boston Private Bank & Trust Company and its predecessors (the “Bank”), a “customer or client of the Company” shall be limited to any person or entity who or which did business with the Bank during my employment with the Bank. for purposes of the post-employment restrictions in this Section 3.
(b) I hereby acknowledge the necessity of the protection provided to the Company under this Agreement. I have carefully considered the nature and scope of such protection. The Company and I hereby agree that the unique nature of the business of the Company and the nature of my services for the Company require the protection specified in this Agreement. The consideration described in this Agreement is sufficient and adequate to compensate me for agreeing to the restrictions contained herein. I acknowledge that I can continue to actively pursue my career and earn sufficient compensation without





breaching any of the foregoing restrictions. The period of the post-employment restrictions in this Agreement is expressly represented and agreed to be fair, reasonable and necessary.
4. Other Obligations . I represent and warrant to the Company that I am not under any contract, agreement or restrictive covenant, and have not previously executed any documents whatsoever with any other person, firm, association, or corporation, that will, in any manner, prevent me from performing any of the job duties and responsibilities that may be assigned to me from time to time by the Company. I also represent and warrant that I will not bring and have not brought with me to the Company and that I will not use in the course and scope of my employment with the Company any confidential, proprietary and/or trade secret materials, documents or information that I obtained from a former employer or other individual or entity, without the express written authorization of the pertinent former employer or other individual or entity. I further represent and warrant that, during my employment with the Company, I will not breach any obligation or duty to maintain confidential and not to disclose or use that I may owe to any former employer or other individual or entity, and I agree to fulfill and comply with any and all such obligations and duties during my employment by the Company.
5. Notice to Future Employers and of Future Employment .
(a) I agree that during my employment with the Company and for the period of one (1) year following the termination of my employment with the Company for any reason, I will inform each prospective new employer I may have, prior to accepting employment, of the existence of this Agreement, and I shall provide each prospective employer with a copy of this Agreement.
(b) I also agree that during my employment with the Company and for the period of one (1) year following the termination of my employment with the Company for any reason, I shall notify the Company in writing of any subsequent engagement, occupation or employment, whether as owner, employee, officer, director, agent, consultant, independent contractor or the like, and my duties and responsibilities with respect to any such position.
6. Enforcement and Remedies . I hereby acknowledge that upon my breach of any of the covenants contained in this Agreement, the Company will suffer irreparable harm for which the remedy at law will be inadequate, and that an injunction may be entered against me by any court having jurisdiction, restraining me from breaching any of the provisions of this Agreement or continuing the breach of any such provisions, without the necessity of posting a bond. Resort to such equitable relief shall not be construed to be a waiver by the Company of any other rights or remedies that the Company may have to recover damages or other relief. In addition, if the Company prevails in an action to enforce this Agreement, I shall compensate the Company for its reasonable attorneys’ fees and related expenses incurred in enforcing this Agreement.
7. At-Will Employment . It is my understanding that the Company or I may terminate my employment at any time, with or without cause; provided that if I have entered into or in the future enter into a separate written and fully executed employment agreement that expressly provides for employment on other than an at-will basis, my employment status pursuant to such agreement shall supersede the foregoing acknowledgment of at-will employment.
8. Amendment or Modification . This Agreement may not be changed or amended except in writing signed by myself and the Company.
9. Severability . All provisions, terms, conditions, paragraphs, agreements and covenants (“Provisions”) contained in this Agreement are severable and, in the event any one of them shall be held





to be invalid, this Agreement shall be interpreted as if such Provision was not contained herein, and such determination shall not otherwise affect the validity of any other Provision.
10. Survival and Assignment by the Company . The Company may assign the rights given to it in this Agreement, and this Agreement shall survive any sale of assets, merger, consolidation, or other change in corporate structure. I understand that my obligations under this Agreement will continue in accordance with its express terms regardless of any changes in my title, position, duties, salary, compensation or benefits or other terms and conditions of employment or any transfer between Company entities and that no such changes shall constitute a termination of my employment. I also acknowledge that provisions of this Agreement shall continue in effect following the termination of my employment as specified above. Notwithstanding the foregoing, if my employment terminates without Cause upon or following a Change of Control or a Sale Event, my obligations under Section 3 (“Non-Solicitation/Non-Accept”) shall no longer be in effect. For purposes of this Agreement, (i) a termination without “Cause” shall have the same meaning as a Job Elimination, as that term is defined in the BPFH Severance Pay Plan as in effect on the date of this Agreement; and (ii) the terms “Change of Control” and “Sale Event” shall have the same meanings as set forth in the Plan.
11. Waiver . The waiver by the Company of any breach of any provision of this Agreement shall not be construed as a waiver of any subsequent breach of such provision or the breach of any other provision contained in this Agreement.
12. Governing Law . This Agreement shall be construed in accordance with and governed by the substantive laws of the Commonwealth of Massachusetts without regard to conflict of law provisions.
13. Knowledge of Rights and Duties . I have carefully reviewed and completely read all of the provisions of this Agreement and understand my rights, duties, obligations and responsibilities under this Agreement. I acknowledge that I am knowingly and voluntarily entering into this Agreement.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date shown below.

___________________________________________         Martha T. Higgins, Executive Vice President     
EMPLOYEE (Print Name)
FOR THE COMPANY (Print name, title & employer)

____________________________________     ___________________________________________                            
Signature                          Signature


DATE: ______________________________





EXHIBIT I (B): NON-SOLICITATION AND
CONFIDENTIALITY AGREEMENT (FOR CALIFORNIA RESIDENTS ONLY)

I acknowledge that I enter into this Non-Solicitation and Confidentiality Agreement (the “Agreement”) in connection with an award of restricted stock, restricted stock units or a grant of a stock option (together, an “Award”) that is made on or about the date of the proposal of this Agreement, pursuant to the Boston Private Financial Holdings, Inc. 2010 Inducement Stock Plan or any subsequent stock option and/or restricted stock plan of Boston Private Financial Holdings, Inc. (together, the “Plan”) and that I shall forfeit the Award (whether vested or unvested) if I do not execute this Non-Solicitation and Confidentiality Agreement (the “Agreement”) within 60 days of the grant date of the Award.
For purposes of this Agreement, the “Company” refers to Boston Private Financial Holdings, Inc. (“BPFH”) and any and all of its wholly or partially owned subsidiaries.
In consideration for my eligibility for any Award, I hereby agree as follows:
1. Confidential Information . During my employment with the Company and at all times thereafter, I shall keep secret and retain in strictest confidence, and shall not disclose or use, other than in the proper performance of my responsibilities for the Company, any Confidential Information. “Confidential Information” means any information, whether or not in writing, concerning the Company’s business or activities that the Company has not released to the general public. I acknowledge that all Confidential Information is the property of the Company. I understand that the term “Confidential Information” includes, but is not limited to financial statements, business plans, document templates, term sheets, policies and procedures, proprietary training materials, personnel, board materials and minutes, operations, customer and client lists and identities, potential customers and clients, vendor lists and agreements, employees, servicing methods, strategies and strategic planning materials, analyses, profit margins and other proprietary information in connection with the Company; provided , however, that Confidential Information shall not include any information which is generally known to the public or becomes known in the industry through no wrongful act on my part. Confidential Information also includes information received in confidence by the Company from its customers, clients or other third parties.
2. Return of Confidential Information and Other Property . I shall deliver to the Company all copies of Confidential Information and other Company property (which includes but is not limited to any documents, notes or other work product connected with or derived from my services to or affiliation with the Company, whether in electronic or paper form) in my possession or control upon the earlier of a request by the Company or termination of my employment.
3. Non-Solicitation . During my employment with the Company, and for the period ending on the first anniversary of the effective date of my termination of employment with the Company, I shall not, directly or indirectly, solicit any person then, or within the prior six (6) months, employed by the Company, or request, influence or advise any person who at the time of such communication is employed by the Company to leave such employment.
4. Other Obligations . I represent and warrant to the Company that I am not under any contract, agreement or restrictive covenant, and have not previously executed any documents whatsoever with any other person, firm, association, or corporation, that will, in any manner, prevent me from performing any of the job duties and responsibilities that may be assigned to me from time to time by the Company. I also represent and warrant that I will not bring and have not brought with me to the Company





and that I will not use in the course and scope of my employment with the Company any confidential, proprietary and/or trade secret materials, documents or information that I obtained from a former employer or other individual or entity, without the express written authorization of the pertinent former employer or other individual or entity. I further represent and warrant that, during my employment with the Company, I will not breach any obligation or duty to maintain confidential and not to disclose or use that I may owe to any former employer or other individual or entity, and I agree to fulfill and comply with any and all such obligations and duties during my employment by the Company.
5. Notice to Future Employers . I agree that during my employment with the Company and for the period of one (1) year following the termination of my employment with the Company for any reason, I will inform each prospective new employer I may have, prior to accepting employment, of the existence of this Agreement, and I shall provide each prospective employer with a copy of this Agreement. I also agree that the Company has the right to independently contact any potential or actual future employer of mine to notify the future employer of my obligations under this Agreement and provide such future employer with a copy of this Agreement.
6. Enforcement and Remedies . I hereby acknowledge that upon my breach of any of the covenants contained in this Agreement, the Company will suffer irreparable harm for which the remedy at law will be inadequate, and that an injunction may be entered against me by any court having jurisdiction, restraining me from breaching any of the provisions of this Agreement or continuing the breach of any such provisions, without the necessity of posting a bond. Resort to such equitable relief shall not be construed to be a waiver by the Company of any other rights or remedies that the Company may have to recover damages or other relief. In addition, if the Company prevails in an action to enforce this Agreement, I shall compensate the Company for its reasonable attorneys’ fees and related expenses incurred in enforcing this Agreement.
7. At-Will Employment . It is my understanding that the Company or I may terminate my employment at any time, with or without cause; provided that if I have entered into or in the future enter into a separate written and fully executed employment agreement that expressly provides for employment on other than an at-will basis, my employment status pursuant to such agreement shall supersede the foregoing acknowledgment of at-will employment.
8. Amendment or Modification . This Agreement may not be changed or amended except in writing signed by myself and the Company.
9. Severability . All provisions, terms, conditions, paragraphs, agreements and covenants (“Provisions”) contained in this Agreement are severable and, in the event any one of them shall be held to be invalid, this Agreement shall be interpreted as if such Provision was not contained herein, and such determination shall not otherwise affect the validity of any other Provision.
10. Survival and Assignment by the Company . The Company may assign the rights given to it in this Agreement, and this Agreement shall survive any sale of assets, merger, consolidation, or other change in corporate structure. I understand that my obligations under this Agreement will continue in accordance with its express terms regardless of any changes in my title, position, duties, salary, compensation or benefits or other terms and conditions of employment or any transfer between Company entities and that no such changes shall constitute a termination of my employment. I also acknowledge that provisions of this Agreement shall continue in effect following the termination of my employment as specified above. I also acknowledge that provisions of this Agreement shall continue in effect following the termination of my employment as specified above. Notwithstanding the foregoing, if my employment terminates without Cause upon or following a Change of Control or a Sale Event, my obligations under





Section 3 (“Non-Solicitation”) shall no longer be in effect. For purposes of this Agreement, (i) a termination without “Cause” shall have the same meaning as a Job Elimination, as that term is defined in the BPFH Severance Pay Plan as in effect on the date of this Agreement; and (ii) the terms “Change of Control” and “Sale Event” shall have the same meanings as set forth in the Plan.
11. Waiver . The waiver by the Company of any breach of any provision of this Agreement shall not be construed as a waiver of any subsequent breach of such provision or the breach of any other provision contained in this Agreement.
12. Governing Law . This Agreement shall be construed in accordance with and governed by the substantive laws of the State of California without regard to conflict of law provisions.
13. Knowledge of Rights and Duties . I have carefully reviewed and completely read all of the provisions of this Agreement and understand my rights, duties, obligations and responsibilities under this Agreement. I acknowledge that I am knowingly and voluntarily entering into this Agreement.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date shown below.

___________________________________          Martha T. Higgins, Executive Vice President
EMPLOYEE (Print Name)
FOR THE COMPANY (Print name, title & employer)

___________________________________          ____________________________________
Signature                          Signature


DATE:_____________________________





Exhibit 31.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
I, Clayton G. Deutsch, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Boston Private Financial Holdings, Inc. (the “registrant”);
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
 
/s/    C LAYTON  G. D EUTSCH        
Date: November 7, 2017
 
Clayton G. Deutsch
Chief Executive Officer
 





Exhibit 31.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
  
I, David J. Kaye, certify that:
1.
I have reviewed this quarterly report on Form 10-Q of Boston Private Financial Holdings, Inc. (the “registrant”);
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
 
/s/    D AVID  J. K AYE
Date: November 7, 2017
 
David J. Kaye
Chief Financial and Administrative Officer
 





Exhibit 32.1*
CERTIFICATION PURSUANT TO
18 U.S.C. § 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned Chief Executive Officer of Boston Private Financial Holdings, Inc. (the “Company”) hereby certifies that the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
 
 
 
/s/    C LAYTON G. D EUTSCH
 
 
 
 
 
Clayton G. Deutsch
Chief Executive Officer
Date: November 7, 2017
 
 
 
 

*      This certification shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.





Exhibit 32.2*
CERTIFICATION PURSUANT TO
18 U.S.C. § 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned Chief Financial Officer of Boston Private Financial Holdings, Inc. (the “Company”) hereby certifies that the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2017 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
 
 
 
 
/s/    D AVID  J. K AYE
 
 
 
 
 
David J. Kaye
Chief Financial and Administrative Officer
Date: November 7, 2017
 
 
 
 

*      This certification shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.